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Problem Statement: Substance use, familial conflict, mental illness, and gender 
disparities may comprise a syndemic exacerbating African-Americans’ HIV disparities. 
Informal caregiving may be protective among persons who inject drugs (PWID). 
Therefore, the present dissertation assessed the associations between: 1) sex and HIV 
medical adherence; 2) a latent syndemic and HIV medical adherence; and 3) sex and 
social support as moderators between the latent syndemic and HIV medical adherence 
Methods: Data were from the BEACON study, of health outcomes among PWID who 
were persons living with HIV (PLHIV). Participants completed surveys and biomarker 
assays (N=351). Results: African-American females were less likely than males to 
achieve undetectable viral load (UVL; 67.1% vs. 65.9%; non-significant) and optimal 
acute care utilization (OAU; 53.9% vs. 48.5%; non-significant). Males with moderate 
physical functioning had 1.3 times the likelihood of UVL, as males with low functioning 
(Adjusted Incidence Rate Ratio [AIR] = 1.38; 95% Confidence Interval [95% CI] = 1.07, 
1.77; N=199). In latent class analyses, 9% of participants had high syndemic substance 
use/mental illness (Class 4); 23% had moderate levels of all factors (Class 3); 25% had 
high mental illness (Class 2); and 43% had moderate substance use/mental illness (Class 
1). In adjusted analyses, individuals whose supporter was their main partner had 35% 
higher likelihood of UVL, than individuals whose supporter was neither family nor a 
main supporter (Adjusted Incidence Rate Ratio [AIR] = 1.35; 95% Confidence Interval 
[95% CI] = 1.05, 1.74). Individuals with frequent health-related support had nearly 30% 
lower likelihood of OAU, as those with low health-related support (AIR = 0.73; 95% CI 
= 0.55, 0.97). Finally, individuals with informal main supporters, and higher physical 
functioning, had lower likelihood of OAU. Conclusions: Results suggest that female 
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PWID PLHIV have high levels of substance use, mental illness, and familial conflict and 
lower HIV medical adherence compared to males. Furthermore, social support was not 
clearly associated with increased viral suppression, particularly among females. 
Healthcare professionals should tailor interventions around constellations of risk factors 
and gender differences, to improve this population’s health outcomes. Additionally, 
dyadic-level interventions could improve the effects of social support on health outcomes.  
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I have often told people that a major goal in life of mine was to complete my 
schooling before the age of thirty. Indeed, school has been a major part of my life from 
an early age. From the age of ten years old, I knew that I was going to pursue a doctoral 
degree. While I still don’t know why I chose age thirty by which to accomplish this goal, 
it is with joy and pride that I can say that I accomplished this feat. And, I am forever 
grateful to my family, for the early educational training and enthusiasm they gave me, as 
I certainly did not instill this in myself! 
I was also lucky, in that my grandmother was both a formal and informal teacher 
of mine, as she taught at the Catholic preschool that I attended from the ages of three to 
five. Additionally, I will never forget Ms. Chin, Ms. Janice, and Father Seamus (rest in 
peace). Each of you encouraged me and supported me during those early years, and I will 
always be grateful. Indeed, Christ-the-King Catholic Preschool taught me bible verses, 
manners, and life skills that I still use to this day. And while I can’t say I reflect on my 
family’s time living in Odessa, Florida with much fondness, I will forever be grateful to 
Mrs. Susan Horowitz, one of the most brilliant, enthusiastic, and caring teachers I have 
ever had.  
For the most part, my formative school years were typical. I dabbled in guitar and 
theater, and discovered an aptitude for math, thanks to Mrs. Mayra Irizarry, the best 
algebra and calculus teacher Flanagan High School has ever had. I also had my social 
outlets as a peer counselor, thanks to the coolest teacher in our school, Mrs. Patty Mucha. 
I got good grades, had a small group of friends, and dreamed of going to college at the 
glorious school that I visited with my older sisters Monisha and Tresha. Ahh, the 
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University of Florida (Go Gators!) It is simply impossible for me to reflect on my recent 
accomplishments as a researcher, student, and teacher, without acknowledging the impact 
that school has had on me since the age of nine, when my older sister matriculated there.  
Before getting to college, I never would have guessed that so much of my time at 
UF would be consumed by Gator football and health research. My fondest memories as a 
college student are with my friends, Imani, Ja’Nelle, and Michelle at Gator games. Two 
words, ladies: Florida-Georgia game. Ironically, I found that I came to cherish those 
times with my friends more deeply, the more I became involved with health research that 
often required me to forgo weekend clubbing and parties. In a manner of speaking, at UF 
I learned how to work hard and play hard, and love every minute of it. I also nurtured a 
love of languages, so I credit my good friend and former professor Carolina Gutierrez-
Rivas for my fluent Spanish. Te agradezco con todo mi corazón, querida.  
All the same, I felt that my time at UF was coming to a close upon graduating 
with my MPH in 2009. I simply knew I needed a new experience beyond Gainesville. So, 
while applying to PhD programs and deciding my next move, I was an Adjunct Lecturer 
in Research Methods for the UF Bachelor’s of Health Science Program. It was both one 
of the most trying and useful times in my life, where I learned first-hand the pitfalls and 
triumphs of teaching at the university level. Daunting or not, it whet my appetite and I 
knew that academe was the right path. And while Hopkins wasn’t originally on my radar, 
an informal advisor in my MPH program by the name of Barbara Curbow, a former 
Hopkins professor, referred me to the Department of Health, Behavior, Society, Dr. 
Janice Bowie, and the Lighthouse Studies at Peer Point Research Center. Couple that 
with a prestigious Brown scholarship to come here, and as they say, the rest is history.  
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As my time at Hopkins comes to a close, I am ever more aware of the blessings I 
had in their many forms, one of which was Dr. Amy Knowlton, my advisor. As such, she 
is my “Research Mom”, who like my own mother, is both supportive of my independence 
and assertive when I need direction. Even when I had a difficult crisis that interrupted my 
studies here at Hopkins, her support and guidance were unwavering and I am forever 
indebted to her for that. I thank Mrs. Tami Ito, Ms. Tonya Johnson, Ms. Denise Mitchell, 
and Dr. Mary Mitchell, all of whom provided me constant support during my time at the 
Lighthouse. I thank Dr. Bob Blum, Dr. Joe Gallo, Dr. Janice Bowie, and Ms. Barbara 
Diehl for guiding me both personally and professionally with true caring and support.  
I thank Dr. Roland Thorpe for challenging and encouraging me, and I thank Dr. 
Adil Haider and Dr. Danielle German for seeing my potential and taking a chance on me 
in their current and future projects. I look forward to what the future holds at Harvard, 
and beyond. In sum, to my mother Monica Robinson, my favorite person and biggest fan; 
to my grandmother Myrtle Maragh and uncle Wayne Maragh, whom will always be my 
heart; to my sisters Monisha Swanson and Tresha Robinson, the best role models I will 
ever have; to Wilburn Daniel, the father figure, Craig Swanson, the brother, and Mahira, 
the niece I was blessed with; to my best friends, Imani Clenance, Ja’Nelle Simpson, 
Jessica Nielsen, Michele Eddie, Yotam Haimberg, Adam Bass, Liz Debes, Alicia von 
Lehe, and Qiana Brown, who love me in all of my many forms; and to Eddie and Sylvia 
Brown, who made my wildest dreams come true, thank you with all my heart.  
You were with me every step of the way on this journey, and your faith saw me 
through to the end. I am forever grateful, and thankful, to and for you all.  
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HIV prevalence and disparities in the United States     
      
In 2009, approximately 1.2 million people over the age of thirteen were living 
with human immunodeficiency virus (HIV) in the United States (CDC, 2010). Current 
epidemiological estimates suggest that nearly sixty thousand Americans become infected 
each year with HIV (Dept. of Health and Human Services, 2012). Of those infected with 
HIV, it is estimated that twenty percent are unaware of their status (CDC, 2010; Prejean 
et al., 2011). In 2009, African-Americans accounted for nearly fifty percent of new HIV 
infections, though they represent less than fifteen percent of the U.S. population (CDC, 
2010; Prejean et al., 2011). It is also estimated that African-Americans have HIV 
incidence rates that are seven times higher than that of White Americans (CDC, 2010).  
Recent estimates suggest that up to twenty-five percent of transmission occurs via 
injection drug use (CDC, 2010; Aral, Adimora, & Fenton, 2008). Between 2004 and 2007, 
fifty-eight percent of persons who inject drugs (PWID) with a new diagnosis of HIV 
infection were African-Americans, and seventy-five percent lived in urban areas at the 
time of their HIV diagnosis (CDC, 2010). While African-Americans are at higher risk of 
HIV infection than other racial and ethnic groups, African-American women bear the 
majority of the recent HIV/AIDS burden within this community. It is estimated that 
African-American women are twenty-three times more likely to be infected with HIV 
than White American women (Kaiser Daily Health Reports, 2006). In many U.S. states, 
they account for an estimated seventy percent of new HIV cases (Kaiser Daily Health 
Reports, 2006; CDC, 2010).  
Only twenty-eight percent of all persons living with HIV/AIDS (PLHIV) are  
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aware of their HIV seropositivity, and on medication (CDC, 2010). A large clinical trial 
of HIV medical adherence found patients receiving inpatient hospital care were seventy 
to eighty percent adherent (Mannheimer, Friedland, Matts, Child, & Chesney, 2002). 
Among those with mental illness, and among racial/ethnic minority women, adherence 
rates are much lower, approximately sixty-five percent while receiving managed hospital 
care (Wolf et al., 2007; Mannheimer et al., 2002). Adherence rates have been estimated 
to be fifty to sixty percent among inner-city residents and persons who inject drugs (Wolf 
et al., 2007). Non-adherence contributes to adverse HIV health outcomes, including more 
frequent physical sickness and faster progression to AIDS as well as to increased drug 
resistance (CDC, 2010; Wolf et al., 2007; Mannheimer et al., 2002).  
Among all populations impacted by HIV/AIDS in the U.S., African-Americans 
are least likely to be tested for HIV or have access to antiretroviral therapy (ART; CDC, 
2010; Hall et al., 2008; Celentano et al., 2001). Identifying factors that are associated 
with ART adherence among this population is critical to improving their health outcomes. 
Additionally, African-American substance users, as compared to those of white race or 
non-substance users, have low rates of access to ART, as well as the lowest rates of ART 
adherence (Reynolds et al., 2004; Broadhead et al., 2002; Kalichman & Rompa, 2003; 
O’Connell et al., 2003; Baker, Kochan, Dixon, Heather, & Wodak, 1994).  
African-American substance users are less likely than other racial/ethnic groups to 
achieve optimal medical adherence. Thus, they are at highest risk for negative health 
outcomes including higher rates of hospitalization, faster progression of AIDS, and 
higher mortality rates (Heron, 2010; Barrow, Newman, & Douglas 2008; Shapiro et al., 
1999; Reynolds et al., 2004; Buseh & Stevens, 2008). However, while HIV transmission 
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is usually via unprotected sex or injection drug use, rates of these behaviors do not differ 
considerably by race, which suggests disparities in outcomes rather than absolute risk 
(CDC, 2010; Muturi, 2008; Buseh & Stevens, 2008). Nonetheless, African-Americans 
and PWID are more likely to be PLHIV, have higher rates of HIV transmission, and to 
have benefited least from the advent of antiretroviral therapy (ART).  
Also, while ART has reduced the number of AIDS-related deaths in the U.S. the 
rates have simultaneously increased among African-American women (CDC, 2010; 
Holtgrave et al., 2009; Kaiser Daily Health Reports, 2006; DiClemente & Wingood, 
1995; Turner, Laine, Cosler, & Hauck, 2003; Wyatt, 2002; CDC, 2010; Prejean et al., 
2011). African-American women may have higher risk for HIV infection due to factors 
such as lack of sexual empowerment, mental illness, and increased stress from gender 
discrimination, interpersonal conflict and racism (Hall et al., 2008; Knowlton et al., 2011; 
Muturi, 2008). For these reasons, the present study sought to contribute findings to 
inform HIV interventions among African-American persons who inject drugs, to improve 
their health outcomes. 
RATIONALE FOR RESEARCH 
Social support, gender, and HIV-related syndemic factors    
     
Kalichman, Ramachandran, and Catz (1999), Broadhead et al., (2002), and 
Parsons, Cruise, Davenport, and Jones, (2006) found that low socioeconomic status, 
history of mental illness, and strained levels of social support disproportionately impact 
African-American substance users, and are associated with lower ART adherence. 
Conversely, it is well-established that social support is predictive of ART adherence 
(Edwards, 2006; Parsons et al., 2006). Despite this association, most social support 
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measures do not make distinctions such as absence or presence of social support as it 
relates to viral suppression and adherence outcomes (Carrieri et al., 2003; Strine et al., 
2008). Distinguishing factors such as type, intensity, and varying needs for social support 
is crucial for understanding the role of social support in PLHIVs’ ART adherence, and 
ultimately, their ability to achieve successful viral suppression (Wagner & Rabkin, 2000; 
Carrieri et al., 2003). One type of social support, informal care, may be most common 
among African-American PLHIV, as compared to than other racial/ethnic groups. 
Informal care refers to unpaid care provided by one’s social support network (Pearlin, 
Semple, & Turner, 1988; Chander, Himelhoch, & Moore, 2006).  
Increasing need for informal caregivers in this population may be because 
HIV/AIDS rates are ever-increasing in African-American communities. Many PLHIV in 
this group are low-income, and less likely to access routine HIV medical care (Tucker, 
Burnam, Sherbourne, Kung, &Gifford, 2003; Knowlton et al., 2007). Therefore, they 
may be more reliant on social support networks, and network members who provide them 
any amount of informal care. Informal care refers to unpaid emotional or instrumental 
support, normally given to individuals with serious chronic conditions. Informal 
caregiving is usually performed by family members, close friends, and significant others, 
and may include vital assistance such as transportation to and from medical visits, 
management of ART regimens, and other forms of care coordination (Knowlton & Latkin, 
2007; Muturi, 2008; Kalichman et al., 1999; Baker et al., 1994; Edwards, 2006). Thus, 
social support network members, which may include informal caregivers, may have 
direct involvement in HIV medical adherence and health outcomes of these individuals. 
Moreover, informal caregiving may represent a pathway through which ART adherence  
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and HIV-related outcomes can be improved in African-American and women PLHIV. 
Low-income African-American women report lower ART use and HIV medical 
adherence than higher income groups and other racial/ethnic groups (Mosack, & Petroll, 
2009; Knowlton et al.., 2011; Chander, Himelhoch, & Moore, 2006). Thus, ART 
adherence is crucial to reducing the impact of HIV/AIDS in this community (Edwards, 
2006; Knowlton et al., 2011; Carrieri et al., 2003). Understanding more about the roles of 
social support, particularly informal caregiving provided by family and social network 
members, is critical in ensuring the likelihood of achieving these outcomes (Edwards, 
2006; Chander, Himelhoch, & Moore, 2006). Among African-American women, barriers 
to HIV medical adherence may include stigma, and/or feeling uncared for by family 
members (Edwards, 2006; Knowlton et al 2011).  
In the U.S., women as compared to men living with HIV tend to begin ART at a 
later stage of their HIV illness progression, and are less likely to achieve optimal 
medication adherence and undetectable viral load (Knowlton et al., 2011; Turner et al., 
2003; Parsons et al., 2006). Compared to men, women are also more likely to report 
elevated depression levels after HIV diagnosis, and poorly health outcomes due to lower 
perceived social support once diagnosed with HIV (Knowlton et al., 2011; Latkin et al., 
2002; Parsons et al., 2006; Eaton et al., 2003; Kalichman & Rompa, 2003). This is in 
contrast to much of the literature in health research, as women are usually more engaged 
in their health care, and report more engagement in health-promotion behaviors (Marmot, 
2006; Malmusi, Artacoz, Benach, Borrell, 2011; Malmusi, Borrell, Benach, 2010).  
As defined by Singer (1996), a syndemic refers to multiple co-morbid conditions,  
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which are mutually reinforcing, and increase disease burden in a population. Among all 
PLHIV, HIV diagnoses can incite and reinforce syndemic factors such as substance use, 
mental illness, and familial conflict (Edwards, 2006; Parsons et al., 2006; Kalichman & 
Rompa, 2003). Additionally, gender differences in HIV health outcomes among African-
Americans suggest that women fare worse in achieving undetectable viral loads and 
engagement in medical care than men. Therefore, more research is needed to understand 
the role of syndemic factors in HIV medical adherence among African-American PLHIV 
who are also PWID and at risk of non-adherence.  
Finally, the present dissertation research is in response to several major policy 
initiatives. For example, in 1984, the federal government created block grant legislation 
requiring every state to set aside five percent of its block grant allocation to provide new 
or expanded substance abuse treatment services for women (Tracy & Martin, 2007; Bride, 
2001; Breitbart, Chavkin, & Wise, 1994). Since then, research has documented 
widespread variation in implementation of “women’s set-aside”, as well as declining 
priority of this initiative, in lieu of funding cuts for HIV research (Tracy & Martin, 2007). 
Recommendations have been made for further research within this population, yet 
relatively few studies have examined unique barriers to optimal acute care outcomes 
among African-American HIV-positive persons who inject drugs, particularly those 
already enrolled in care (Parsons et al., 2006; Broadhead et al., 2002; Wilkinson et al., 
2007). Therefore, the purpose of the proposed study was to identify correlates of HIV 
medical adherence among African-American adult persons who inject drugs in Baltimore, 
Maryland. Research which identifies correlates of medical adherence and outcomes is an 
understudied precursor to behavior change research. Current behavior change 
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interventions are predominantly individual-focused and exclusive of social support 
structures (Beatty, Wheeler, & Gaiter, 2004; Neumann et al., 2002). Moreover, most of 
these interventions only consider UVL as ART adherence, and no prior research has 
shown post-intervention effects on maintenance of viral suppression among persons who 
inject drugs. Therefore, the current study included analyses that considered informal care 
and social support networks, and multiple dimensions of adherence. 
STUDY AIMS 
The purpose of the proposed study was to identify correlates of HIV medical 
adherence in a sample of African-America persons who inject drugs in Baltimore, 
Maryland. Also depicted in Figure 2.1, the study’s aims were to: 
    1) examine the association between sex and HIV medical adherence (defined as 
optimal acute care utilization and ART adherence) among a sample of urban African- 
American adult persons who inject drugs currently engaged in HIV medical care; 
            2) determine the relationship between the ‘SUMIC’ Syndemic (e.g. Substance  
Use, Mental Illness, and Familial Conflict), and HIV medical adherence among a sample  
of urban African-American adult persons who inject drugs currently engaged in HIV  
medical care; 
            3) examine sex and social support as potential moderators in the relationship  
between the SUMIC Syndemic and HIV medical adherence among a sample of urban 




The proposed study also had three hypotheses: 
  1) females would report lower rates of HIV medical adherence; 
2) individuals with higher SUMIC Syndemic burden would report lower HIV 
medical adherence than individuals with lower syndemic burden;   
3) females would report higher rates of the SUMIC Syndemic and lower rates of 
HIV medical adherence as compared to males.  
Hypothesis 1 is rationalized by aforementioned findings which suggest that HIV-
positive African-American women are at highest risk of HIV medication non-adherence 
(Knowlton et al., 2011; Latkin et al., 2002; Turner et al., 2003). Research has also shown 
that African-Americans and persons who inject drugs (PWID) are at risk of suboptimal 
acute care utilization and ART adherence, thereby justifying Hypothesis 2 (Knowlton et 
al., 2011; Connell, 1987; Wingood & DiClemente, 2000).  
Finally, African-American women are at risk of substance use due to mental 
illness and/or HIV status, and therefore to higher risk of the SUMIC Syndemic, thus 
justifying Hypothesis 3 (Turner et al., 2003; Muturi, 2008; Connell, 1987; Wingood & 
DiClemente, 2000; Kelly & Kalichman, 2002).  
DISSERTATION ORGANIZATION 
 The organization of this dissertation consists of seven major sections, or chapters. 
The present chapter, Chapter One contains a brief summary of the issues of interest, 
along with research literature substantiating the proposed research aims, the specific 
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research aims, and their accompanying hypotheses. The second chapter, Chapter Two, is 
a review of the research literature detailing disparities in HIV–related outcomes, and 
theoretical considerations of these issues. Chapter Three contains detailed description of 
the research methodology, including the parent study, study population, and detailed 
operationalization of study variables utilized in quantitative analyses.  
Chapters Four, Five, and Six  are all manuscripts. Chapter Four assesses sex 
differences in viral suppression among African-American PWID. Chapter Five present 
latent class analyses of the SUMIC Syndemic, and also assess HIV medical adherence 
within syndemic classes. Chapter Six assesses correlates of medical adherence among 
African–American PWID PLHIV, defined as viral suppression and optimal acute care 
utilization. Each manuscript chapter presents individual studies based on the study’s 
research aims, all analyses conducted to address these aims, results, and discussion and 
implications of all findings.  
All three chapters detail separate sets of analyses in the proposed research. 
Chapter Seven concludes the dissertation with consideration of the overall contribution of 
the research, including its strengths, limitations, and implications for researchers and 
practitioners. For the purposes of this study and all analyses, “sex” and “gender” are used 
interchangeably, the implications of which are also discussed in Chapter Seven. Finally, 
an ancillary appendix provides a brief summary and tables of additional analyses 
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Racial and gender disparities in HIV/AIDS  
Between 2004 and 2007, fifty-eight percent of persons who inject drugs (PWID) 
with a new diagnosis of HIV infection were African-Americans, and seventy-five percent 
lived in urban areas at the time of their HIV diagnosis (CDC, 2010). While the majority 
of HIV transmission in the U.S. occurs through sexual contact, up to twenty-five percent 
of transmission occurs via injection drug use (CDC, 2010; Aral, Adimora, & Fenton, 
2008). Though they comprise less than fifteen percent of the U.S. population, African-
Americans have accounted for half of incident HIV cases since 2009 (CDC, 2010; 
Prejean et al., 2011). African-Americans have approximately seven times the HIV 
incidence of White Americans. (Centers for Disease Control and Prevention [CDC], 
2010). Therefore, African-Americans and PWID are at greatest risk of negative HIV-
related health outcomes and disparities.  
While all racial and ethnic groups are affected by HIV/AIDS, African-Americans 
have the highest HIV incidence, and lowest rates of access to antiretroviral therapy 
(ART; CDC, 2010; Hall et al., 2008; Celentano et al., 2001). African-American substance 
users have even lower rates of access to ART, as well as the lowest rates of ART 
adherence compared to both Whites and/or non-substance users (Reynolds et al., 2004; 
Broadhead et al., 2002; Kalichman & Rompa, 2003; O’Connell et al., 2003; Baker, 
Kochan, Dixon, Heather, & Wodak, 1994).  
Non-adherence among African-American substance users leads to higher rates of 
hospitalization, faster progression to AIDS, and higher mortality (Heron, 2010; Barrow, 
Newman, & Douglas 2008; Shapiro et al., 1999; Reynolds et al., 2004; Buseh & Stevens, 
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2008). Moreover, while AIDS-related deaths have declined overall since the onset of 
antiretroviral therapy (ART) in the U.S., the rates have simultaneously increased almost 
three-fold among African-American women (CDC, 2010; Holtgrave et al., 2009; Kaiser 
Daily Health Reports, 2006; DiClemente & Wingood, 1995; Turner, Laine, Cosler, & 
Hauck, 2003; Wyatt, 2002; Prejean et al., 2011).  
Additionally, women are a growing number of incident HIV cases (CDC, 2010). 
They are also predisposed to HIV infection due to their increased likelihood of 
experiencing intimate partner violence and/or rape, as compared to men (United Nations 
Population Fund, 2002). Given the exponentially higher rates of HIV within African-
American communities and likelihood of having same-race sexual partners, African-
American women who are unaware of their partner’s HIV status are often unknowingly 
infected with HIV, may be diagnosed at a more advanced stage of illness, and are 
therefore less likely to achieve viral suppression and other positive HIV health outcomes 
(Edwards, 2006; Turner, Laine, Cosler, & Hauck, 2003; Payne, 1997; Fowler & Hill, 
2004; Kalichman et al., 1999).  
African-American women may have increasing risk of HIV partly due to higher 
rates of HIV within the African-American community compared to other racial/ethnic 
groups, which suggests that unique contextual factors exist for this group. One reason for 
the increasing prevalence of HIV infection among African-American women, rather than 
men, may be having male partners who have sex with men (Muturi, 2008; Hall et al., 
2008; Melkote et al., 2000; Prejean et al., 2011; CDC, 2010). Pervasive stigma of 
homosexual activity leads many African-American men to maintain heterosexual 
relationships, yet are unlikely to use condoms with either their male or female sexual  
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partners (Melkote et al., 2000).  
They are also less likely than heterosexual African-American men to regularly get 
tested for HIV, and therefore unknowingly serve as ‘bridge’ populations that spread HIV 
in both African-American men and women (Muturi, 2008, Buseh & Stevens, 2008). 
African-American women may also be at higher risk of HIV infection due to 
psychosocial factors such as lack of sexual empowerment, and increased stress sexism 
and racism, as compared to men and/or other racial groups (Hall et al., 2008; Knowlton et  
al., 2011). 
Medical mistrust among African-Americans – a barrier to HIV-related care 
 Race and gender disparities place African-American women at risk for increased 
incidence of HIV infection than their male African-American counterparts, and also other 
racial/ethnic groups. In addition, medical mistrust is pervasive in the African-American 
community, which reduces likelihood of seeking medical care (Gaston & Alleyne-Green, 
2013). As a result, advancements such as reduction in morbidity due to AIDS-related 
opportunistic infections (OI) have not been seen among African-Americans (Gaston & 
Alleyne-Green, 2013).  
Between 1991 and 2001, rates of OIs simultaneously reduced among White 
Americans, and increased among their African-American counterparts (Gaston & 
Alleyne-Green, 2013; Metha, Moore, & Graham, 1997; Malebranche, 2005; Tobias, 
Cunningham, Cunningham, & Pounds, 2007). Recent estimates also suggest that 
compared to White Americans, African-Americans are between 9 and 20 times more 
likely to die from AIDS-related illnesses (Gaston & Alleyne-Greene, 2013; Office of 
Minority Health, 2006).  
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Several researchers posit that medical mistrust in the African-American 
community remains due to recent humans rights violations such as the Tuskegee Syphilis 
Study (Gaston & Alleyne-Green, 2013; Boulware, Cooper, Ratner, LaVeist, & Powe, 
2003; Washington, 2006). Jones (2000) also cites institutional racism as a formidable 
barrier to African-Americans engagement in health care, such that even when they access 
medical services, they are treated differentially and usually with inferior care compared 
to White Americans. As a result, recent controversy around the Henrietta Lacks legacy, 
coupled with existing medical mistrust, has engendered deep resentment in the African-
American community toward the medical establishment (Gaston & Alleyne-Greene, 
2013; Thornburn-Bird & Bogart, 2005; Washington, 2006).  
Finally, Ross et al (2006) found that HIV-related conspiracy beliefs about medical 
care were more deeply held among African-American women than men, and that HIV-
related conspiracy beliefs among African-American men were associated with reduced 
rates of condom use, irrespective of the sexual orientation of these men (Gaston & 
Alleyne-Greene, 2013; Ross, Essien, & Torres, 2006). In a similar vein, research suggests 
that when African-Americans are engaged in care, better patient-provider communication 
was associated with increased HIV medical adherence among PLHIV (Bakken et al., 
2000; Knowlton et al., 2010). Therefore, more research is needed to understand the roles 
of medical mistrust and patient-provider engagement in HIV medical adherence.  
SOCIAL SUPPORT 
Social support, informal care, and HIV medical adherence 
Irrespective of race and gender differences, it is established that social support is  
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associated with health behaviors, including HIV viral suppression and acute care 
utilization (Glass, Perrin, Campbell, & Soeken, 2007; Marmot, 2006; Robertson, 2006; 
Knowlton et al., 2011; Edwards, 2006; Parsons et al., 2006; Strine, Chapman, Balluz, & 
Mokdad, 2008). In the research literature, social support is usually defined as perceived 
availability of basic support, whether instrumental, informational, or emotional (Eaton et 
al., 2003; Carrieri et al., 2003; Burke & Dunbar-Jacob, 1995; Coker et al., 2003). For 
example, research suggests many PLHIV belong to an organized religion, and use their 
religion to cope with their illness, which may predict higher HIV medical adherence 
(Cotton et al., 2006). However, most social support measures do not distinguish absence 
or presence of social support that is specific to HIV-related care. Additionally, factors 
such as the reciprocity, or mutual exchange, of support within social networks are under-
identified (Carrieri et al., 2003; Strine et al., 2008). It is possible that within in the context 
of HIV, social support in the form of informal (unpaid) care receipt may impact 
adherence-related outcomes. 
Low income African-American PLHIV are more likely than other racial/ethnic 
groups to report informal care provision (Pearlin, Semple, & Turner, 1988; Chander, 
Himelhoch, & Moore, 2006). This may be because HIV/AIDS rates are ever-increasing 
in African-American communities, and many PLHIV in this group are low-income, and 
less likely to access routine HIV medical care (Tucker et al., 2003; Knowlton et al., 2007). 
Informal care refers to unpaid support normally given to individuals with serious chronic 
conditions, usually performed by family members, close friends, and significant others.  
Informal caregivers may provide vital assistance for PLHIV such as transportation 
to and from medical visits, management of ART regimens, and other forms of care 
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coordination (Knowlton & Latkin, 2007; Jones, 2000; Muturi, 2008; Kalichman et al., 
1999; Baker et al., 1994; Edwards, 2006). Thus, social support network members, which 
may include informal caregivers, likely have direct involvement in HIV medical 
adherence and health outcomes of these individuals.  
These individuals may be responsible for much of the care of PLHIV, such as 
accompanying individuals to medical appointments, household chores, and assisting with 
their medications (Tucker et al., 2003; Knowlton et al., 2007; Knowlton et al., 2011; 
Edwards, 2006; Tucker et al., 2003; Mosack, & Petroll, 2009). Differentiating type, need 
for, and amounts of social support and informal care is crucial for understanding 
subsequent effects on PLHIVs’ ART adherence, and ultimately, their ability to achieve 
successful HIV viral suppression and positive health outcomes (Wagner & Rabkin, 2000; 
Carrieri et al., 2003). More research is needed, therefore, to understand the pathways 
through which ART and HIV medical adherence of PLHIV is impacted by family 
structure, social support, and informal caregiving. 
Gender differences in social support and HIV health outcomes  
In the U.S., women PLHIV tend to begin ART at a later stage of their HIV illness 
progression than men, and are less likely to achieve optimal medication adherence and 
undetectable viral load (Knowlton et al., 2011; Turner et al., 2003; Parsons et al., 2006). 
Also, compared to men, women are also more likely to report elevated depression levels 
after being diagnosed with HIV (Knowlton et al., 2011; Latkin et al., 2002; Parsons et al., 
2006; Eaton et al., 2003; Kalichman & Rompa, 2003). However, this is contrary to extant 
health services research literature, given that women are usually more engaged than men 
in their health care, and report more engagement in health-promotion behaviors (Marmot,  
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2006; Malmusi, Artacoz, Benach, & Borrell, 2011; Malmusi, Borrell, & Benach, 2010).  
While women report higher levels of social support in general, HIV-positive 
women are at higher risk of treatment interruptions, discontinuation of ART, and faster 
AIDS progression than men (Kalichman & Rompa, 2003; Vitiello et al., 2003). 
Therefore, more research is needed to identify the role of social support as a buffer of 
mental illness and other factors which reduce engagement in care among women. Among 
low-income African-American women in particular, lower rates of adherence are 
reported, as compared to higher income groups and/or other racial and ethnic groups 
(Mosack, & Petroll, 2009; Knowlton et al.., 2011; Chander, Himelhoch, & Moore, 2006).  
Because HIV/AIDS incidence is increasing more quickly among African-Americans than 
in any other segment of the U.S. population, ART adherence is crucial to reducing the 
impact of HIV/AIDS in this community (Edwards, 2006; Knowlton et al., 2011; Carrieri 
et al., 2003).  
HIV CO-MORBIDITIES AND SYNDEMIC FACTORS 
Co-occurrence of mental illness, substance use, and violence  
Irrespective of HIV status, mental illness is a growing issue among adults in the 
United States. According to the National Survey on Drug Use and Health, in 2012, an 
estimated 44 million adults aged eighteen or older in the United States had some form in 
mental illness in the past year, which is nearly twenty percent of the general population 
(Substance Abuse and Mental Health Services Administration [SAMHSA], 2013). This 
rate is increasing, as prevalence of mental illness in the U.S. was eighteen percent in 2008 
(SAMHSA, 2013; Aldworth et al., 2009; Novak, Colpe, Barker, & Gfroerer, 2010). Adult 
women are more likely than men to be diagnosed with serious mental illnesses, which 
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include major depression, bipolar disorder, post-traumatic stress disorder (PTSD), and 
schizophrenia (SAMHSA, 2013; Aldworth et al., 2009; Novak, Colpe, Barker, & 
Gfroerer, 2010). A growing body of literature also suggests that mental illness is both a 
major risk factor for, and consequence of, HIV infection (Kaaya et al., 2013).  
Several studies suggest that depression is a least twice as high among persons 
living with HIV (PLHIV) as compared to non-infected individuals (Maj, Janssen, Starace, 
Zaudig, & Satz, 1994; Kaaya et al., 2013; Owe-Larsson, Sall, Salamon, & Allgulander, 
2009). Moreover, among PLHIV, mental illnesses are more common than physical co-
morbidities such as diabetes or hypertension (Goulet et al., 2007; Kaaya et al., 2013). 
Similarly, mental illness and substance use often co-occur, in the general populations and 
also among PLHIV. In 2012, illicit drug use was twice as prevalent among individuals 
who had some form of mental illness, as compared to those who did not have mental 
illness (26.7% vs. 13.2%, respectively; SAMHSA, 2013). This trend remained after 
accounting for type of mental illness, and types of substances (including marijuana, 
cocaine, hallucinogens, and prescription drugs).  A 2014 study suggests that those with 
severe mental illness were between three to five times more likely to use either licit 
and/or illicit substances (Hartz et al., 2014).  
Substance use and mental illness are factors that increase the health burden of 
PLHIV. In addition, these factors often create tension and stressors in the PLHIV’ social 
environment, including familial conflict and violence. PLHIV often experience stigma 
and alienation from their own family members and community, which often creates a 
hostile environment with less social support available to them (Hossain & Kippax, 2010; 
Parker & Aggleton, 2003). Therefore, conflict represents a common predictor and  
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outcome of HIV, similar to both substance use and mental illness.  
Mental illness, substance use, and familial conflict – a syndemic among African-
American PLHIV 
The dearth of theoretically-informed, tertiary HIV prevention programs geared 
towards African-Americans represents a gap in the literature (Johnson et al., 2008; Gielen, 
McDonnell, O'Campo, & Burke, 2005; Tobin, Kuramoto, Davey-Rothwell, & Latkin, 
2011; McDaid & Hart, 2010). Health behavior theories such as Syndemic Theory help to 
characterize the experiences of those most vulnerable to HIV/AIDS disparities: African-
Americans who may experience multiple (or syndemic) health threats from mental illness, 
substance use, and familial conflict.  
Singer (1996) defines a syndemic as multiple risk factors that synergistically 
contribute to increased disease burden in a given population. What can be referred to as 
the ‘SUMIC’ Syndemic (e.g. Substance Use, Mental Illness, and Familial Conflict), 
places African-American women at high risk of death and/or disability related to 
HIV/AIDS in the United States. Despite the critical need for research to inform 
culturally-tailored interventions within this community, African-Americans remain 
underrepresented in public health research (Muturi, 2008; Johnson et al., 2008; 
Lichtenberg, Brown, Jackson, & Washington, 2004; Jones, 2000). Research is needed 
that includes African-Americans, and identifies race as more than a sociodemographic 
factor to be controlled for. In light of well-established differences in HIV-related 
outcomes due to race, gender, and culture, more research is needed to identify factors 
which may reduce these adverse outcomes, such as social support and informal care 
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receipt (McDaid & Hart, 2010; Kelly & Kalichman, 2002; LaVeist, 2005; Newman, 
Williams, Massaquoi, Brown, & Logie, 2008; Woodward, Taylor, Bullard, Neighbors, 
Chatters, & Jackson, 2008).  
Among PLHIV experiencing the ‘SUMIC’ Syndemic, there is considerable debate 
regarding whether presence of syndemic factors can be established temporally. First, for 
persons who inject drugs, risk of HIV infection is much higher than for non-users, 
because injection drug use is a more efficient route of HIV transmission than unprotected 
sex (CDC, 2010). Next, mental illnesses frequently co-occur with substance use, both of 
which are associated with higher rates of ART non-adherence, and vice versa (Kaaya et 
al., 2013; Senn & Carey, 2008; Wyatt, 2002; Zierler & Krieger, 1997). Mental illness 
may predispose individuals to substance use, while substance use may affect mental 
illness symptoms. As a result, a disproportionate number of substance users report having 
been diagnosed and treated for depression, schizophrenia, manic depressive disorder, 
and/or other serious mental illness (Senn & Carey, 2008; Latkin et al., 2002; Johnson et 
al., 2008). From a treatment perspective, however, temporality of substance and mental 
illness is unnecessary to establish presence of the SUMIC Syndemic; instead 
comprehensive treatment strategies are paramount.  
Familial conflict refers to disagreements between family members, between 
family members who are often same household residents (Dunbar, 1990; Chesney & 
Folkman, 1994; Feaster et al., 2010). Such conflict may arise from acute events such as 
moving, divorce, or financial strain (Dunbar, 1990; Chesney & Folkman, 1994; Semple et 
al., 1997). Chronic familial conflict, however, refers to ongoing clashes between kin 
which can result in verbal and/or physical abuse (Dunbar, 1990; Chesney & Folkman, 
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1994). Much of the literature on familial conflict and HIV proposes that an HIV 
diagnosis represents a chronic stressor in households which may subsequently trigger 
familial conflict, substance use and/or mental illness (Semple et al., 1997; Chesney & 
Folkman, 1994; Zea, Reisen, Poppen, Bianchi, & Echeverry, 2005; Li, Ji, Ding, Tian, & 
Lee, 2012).  
Examination of familial conflict as a syndemic factor builds on extant research in 
intimate partner violence (IPV) and HIV risk, which establishes a relationship between 
IPV and increased risk of HIV infection (Singer, 1996). Moreover, most of this literature 
establishes the link between IPV and HIV infection among women, who are most often 
low-income and racial/ethnic minorities (Feaster et al., 2010). Therefore, gender 
disparities in HIV include intimate partner violence as a syndemic factor which places 
African-American women at increased risk for adverse HIV health outcomes (Singer, 
1996; Feaster et al., 2010). However, intimate partner violence can be viewed as a subset 
of a familial conflict, which is a larger construct and less gender-specific (Minze, 
McDonald, Rosentraub, & Jouriles, 2010).  
Few studies examine the larger construct of familial conflict as a non-gender-
specific health determinant, to establish new ways to prevent tertiary complications 
among PLHIV (Sanders-Phillips, 2002; Jones, Beach, Forehand, & Foster, 2003). 
Therefore, the proposed study was unique in examining the role syndemic factors in 
tertiary prevention of HIV rather than primary prevention of infection (Sanders-Phillips, 
2002). Moreover, this study considers the threat of familial conflict as non-gender 
specific (Semple et al., 1997; Li et al., 2012). Active substance use, mental illness, and 
familial conflict may represent formidable barriers to HIV medical adherence, by  
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complicating HIV medical regimens themselves.  
Cognitive impairment may result due to substance use, which can reduce 
likelihood of HIV medical adherence. Additionally, medications which may be used to 
treat mental illness and/or substance use may interact with ART adherence regimens (Zea 
et al., 2005; Li et al., 2012). Among African-Americans experiencing the ‘SUMIC’ 
Syndemic, little research has been conducted to identify protective factors that may 
predict their ART adherence and outcomes (Kelly & Kalichman, 2002; Robertson, 2006; 
Knowlton et al., 2011; El-Bassel et al., 2009). Knowlton et al. (2011) and Latkin et al. 
(2002) have both demonstrated that social networks were highly predictive of HIV 
adherence related behaviors among African-American PWID PLHIV, and may be 
protective in achievement of viral suppression and other adherence-related outcomes.  
 Social support appears to be an important moderator in the relationship between 
‘SUMIC’ Syndemic status and HIV medical adherence. As mentioned, HIV positive 
women in the U.S. are more likely to report history of mental illness (Knowlton et al., 
2011; Marmot, 2006; Fremont et al., 2007). Among PWID PLHIV African-American 
women, rates of social support are typically lower than their male counterparts, as is their 
likelihood of achieving viral suppression (Buseh & Stevens, 2008; CDC, 2010). Their 
reported rates of mental illness are concurrently higher, suggesting that they are most 
vulnerable to the ‘SUMIC’ Syndemic as well (Fremont et al., 2007). Therefore, the 
proposed study explored gender differences in HIV medical adherence. 
GENDER AND SYNDEMIC FACTORS 
Gender, SUMIC Syndemic factors, and PLHIV’ health – a conceptual framework  
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Prevention efforts for women living with HIV have been less funded and less 
successful as compared interventions with other groups (CDC, 2010). Possible reasons 
for this include a lack of research that is theoretically-informed and inclusive of African-
American women who are the new face of HIV (Connell, 1987; Wingood & DiClemente, 
2000). Moreover, most prevailing theories of health behavior emphasize cognitive 
processes and assume such processes occur identically in men and women (Eaton, Flisher, 
& Aarø, 2003). Findings by King (1999), Chang (2003), and Melkote, Muppidi, and 
Goswami, (2000) suggest that race, gender roles, and social status impact women 
differently than men, and these effects are compounded in African-American women.  
As mentioned, Syndemic Theory can illuminate theoretical rationale for HIV 
disparities experienced by African-American PLHIV (Singer, 1996). Additionally, Social 
Cognitive Theory of Gender Differentiation, and Theory of Gender and Power can offer 
insight into HIV disparities seen within this group, where African-American fare 
consistently worse than their male counterparts in ART adherence and other HIV-related 
health outcomes (Singer, 1996; Glanz, Lewis, & Rimer, 2002). Collectively, these 
theoretical considerations identify African-American women with highest risk of both 
SUMIC Syndemic factors and HIV medical non-adherence.  
Social cognitive theory (SCT) states that the learning process is shaped by a 
multidimensional relationship between behavior, environmental factors, and personal 
factors (Bandura, 1998; Bussey & Bandura, 1999). This process can refer to a variety of 
developmental processes, such as the emergence of personality traits, or the adoption of 
health promotion behaviors (Bandura, 1998). SCT, when applied to public health, posits 
there are only certain conditions under which a person will adopt a health preventive 
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action (Bandura, 1998). First, a person must believe that the benefits of performing the 
behavior outweigh the costs. Second, a person must be willing to set and achieve goals 
for themselves, such that their progress has adequate incentive. Lastly, the person must 
have a sense of personal agency (self-efficacy) with respect to performing the preventive 
behavior (Bandura, 1998).  
Two key constructs of SCT, self-efficacy and observational learning, provide a 
useful framework within which gender differences in HIV health outcomes can be 
conceptualized. As mentioned, self-efficacy refers to an individual’s personal agency or 
belief in their ability to produce desired outcomes as a direct result of their actions 
(Bussey & Bandura, 1999; Bandura, 1998). People will only be pro-active in their health 
behaviors if they are cognitively aware of their risk, feel capable of making changes, and 
believe that said changes will be of positive benefit. African-American women 
consistently report lower levels of perceived self-efficacy with respect to engaging in 
HIV health related behaviors, such as condom use with their primary sexual partners 
(Gullette, Wright, Booth, & Stewart, 2010; Edwards, 2006; Buseh & Stevens, 2008; 
Schröder, Hobfoll, Jackson, & Lavin, 2001). Reynolds et al., (2004) and Schneider, 
Kaplan, Greenfield, Li, and Wilson (2004) found interventions to increase self-efficacy 
among African-American females were predictive of increased ART adherence and 
increased engagement in care with HIV health care providers. However, findings by 
Knowlton et al (2007) suggest that ART-related self-efficacy was not associated with 
undetectable viral load. Therefore, more research is needed to assess factors associated 
with viral suppression among African-American female PLHIV.  
Gender serves as a sociodemographic factor which places African-American  
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women at risk for lower rates of HIV medical adherence and lower rates of optimal acute 
care utilization. Additionally, observational learning within the context of SCT states that 
individuals learn much of their health behaviors via direct observation and modeling of 
others’ behaviors (Bussey & Bandura, 1999; Bandura 1998). This concept, therefore, 
considers gender differentiation, due to societal roles, as a potential modifier of the 
relationship between HIV risk and health outcomes among African-Americans. Applying 
this concept to development, much of what African-American females learn about their 
sexuality and roles is via peers, media, and familial structure (Bussey & Bandura, 1999; 
Glass et al., 2007; Gullete et al., 2010). 
In this light, media and cultural factors are sociocultural determinants of health 
which influence norms around sex roles. Media portrayals objectify African-American 
females placing them at risk for reduced sexual health awareness and empowerment, 
while rap music culture which perpetuates a hyper-sexualized cultural stereotype for 
African-American females (Prachakul, Grant, & Keltner, 2007; Edwards, 2006; Connell, 
1987; Wingood & DiClemente, 2000). Among African-Americans, the common single-
parent family household also usually correlates to lower socioeconomic status (Ehrhardt, 
Yingling, Zawadzki, & Martinez-Ramirez, 1992; Robertson, 2006). These family 
structure characteristics are explicative of the aforementioned lower social support levels 
experienced by African-American women PLHIV.  
The cultural acceptability of the single-parent household structure represents a 
family/household level health determinant, as African-American youth are most likely to 
have little parental supervision and interaction (Herek, Capitanio, & Widaman, 2002; 
Edwards, 2006; Broadhead et al., 2002).  Thus, they are less likely to have parental 
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guidance regarding sexual health, substance use, all of which may contribute to 
disproportionate rates of HIV/AIDS within the African-American community. African-
American culture defines social norms, collective efficacy and social cohesion around 
health-related behaviors (Latkin et al., 2002; Parsons et al., 2006; Edwards, 2006; Fowler 
& Hill, 2004).  
Gender differences in HIV-related outcomes – theoretical underpinnings  
Theories such as Gender Differentiation of SCT suggest that unique risk factors 
for HIV risk impact women, particularly in the African-American community (Glass et 
al., 2007; Coker et al., 2003; Knowlton et al., 2011). Theory of Gender and Power 
provides a useful theoretical framework for gender differences in HIV outcomes among 
African-American PWID PLHIV (Connell, 1987; Wingood & DiClemente, 2000). 
According to the Theory of Gender and Power, the relationship between men and women 
is gendered, and possesses three social structures (Connell, 1987; Wingood & 
DiClemente, 2000). The first, sexual division of labor, refers to the gendered tendency of 
men and women to assume distinct occupations, which typically subordinate women to 
men. The second social structure identified by the theory is the sexual division of power. 
This refers to the unequal access to societal goods due to the power differential between 
the sexes (Connell, 1987; Wingood & DiClemente, 2000).  
Finally, the third social structure identified is cathexis, which refers to the social 
norms and sexual attachments differentially created and reinforced between the sexes. 
The theory of gender and power can be used to examine well-established gender 
disparities among African-American females as compared to other groups (Connell, 
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1987; Wingood & DiClemente, 2000). The sexual division of labor is characterized by 
societal concepts such as “women’s work”, the socially accepted view that women are 
incapable of pursuing certain professions and thereby have limited career advancement 
potential, thereby referring to the differential created by the sexual division of power 
(CDC, 2005; Jones, 2000; Dreachslin, Weech-Maldonado, & Dansky, 2004). For 
African-Americans, disparities exist in educational attainment as compared to other races, 
where they have the lowest rates of baccalaureate and/or graduate education (U.S. Census 
Bureau, 2008; LaVeist, 2005; Kalichman & Rompa, 2003; Harrison & Beck, 2005). 
Even among college-educated African-Americans, lower salary attainment is 
demonstrated in every professional field, and these disparities in work status and 
advancement are consistent in substance abusing populations as well (Jones, 2000; 
Dunlap, Golub, & Johnson, 2006). African-American women are more likely to have 
college degrees than African-American men, but are less likely than their white and/or 
male counterparts to receive promotions or salary increases with equivalent training and 
experience (Jones, 2000; Nunez-Smith, Curry, Bigby, Berg, Krumholz, & Bradley, 2007). 
Thus, they are less likely to have medical insurance and regular access to medical care, 
resulting in disproportionate risk of syndemic outcomes, particularly depression, and 
lower rates of ART adherence if they are PLHIV (Knowlton et al., 2001; Kelly & 
Kalichman, 2002; Latkin et al., 2002; LaVeist, 2005; Muturi, 2008).  
Given the likelihood of single-parent household familial structure, African-
American women are usually under more financial strain than other groups. Often, in 
single-parent households, female children are given more household responsibility, and 
are expected to care for younger siblings more than male children (Prachakul, Grant, & 
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Keltner, 2007; Edwards, 2006). Gender roles in the African-American community 
prescribe expectations of women to share their limited resources with family members 
and main partners, more than African-American men (LaVeist, 2005; Dunlap, Golub, & 
Johnson, 2006; Kelly & Kalichman, 2002). Also, African-American women are more 
likely to provide informal care, and less likely to receive informal care as compared to 
other racial/ethnic groups and their African-American male counterparts (Dunlap, Golub, 
& Johnson, 2006; Feaster et al., 2010; Broadhead et al., 2002). This creates the social 
norms and reinforcement referred to as cathexis, which perpetuates reduced societal 
power, access to labor, and social norms resulting in poor health outcomes for African-
American PLHIV women (Herek et al., 2002; Edwards, 2006; Broadhead et al., 2002). 
HIV MEDICAL ADHERENCE 
Operationalization of HIV medical adherence – research considerations 
 Aforementioned research suggests that African-American race, female sex, active 
substance use, mental illness, and familial conflict represent factors which may predict 
negative health outcomes among PLHIV.  Social support is a purported protective factor 
against these negative health consequences, though more research is needed to 
understand nuances including perceived versus enacted support, types of social support, 
and support reciprocity between PLHIV and their informal caregivers. A related 
consideration, however, is the definition of HIV medical adherence itself. In the present 
study, viral suppression is conceptualized as a proxy for medication adherence. Similarly, 
optimal acute care is conceptualized as an outcome of therapeutic adherence.  
 However, the broader adherence literature in HIV builds on extant chronic disease  
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research of patients with Type 2 diabetes and hypertension, which are often co-morbid 
with HIV (Crane, Van Rompaey, & Kitahata, 2006). With respect to chronic illnesses 
including HIV, however, necessary distinctions must be made between two dimensions 
of adherence – therapeutic adherence and medication adherence. In contrast, therapeutic 
adherence has been defined as the extent to which a person’s behaviors (i.e., taking 
medication, getting health screenings, eating healthily, and attending clinics for follow-up 
appointments) coincide with the health behaviors recommended by his/her health care 
provider (Jin, Sklar, Min Sen Oh, & Li, 2008; Shearer & Evans, 2001).  
In contrast, medication adherence, or medication compliance, is defined as an 
individual’s conformity to their healthcare provider’s recommendations about day-to-day 
treatment respect to the timing, dosage, and frequency of prescription medications 
(Cramer et al., 2008). Therefore, for PLHIV, therapeutic adherence is a global term to 
define a patient’s ability to maintain behaviors including: accessing HIV primary care, 
engaging in healthy lifestyle choices, and abstaining from substance use (Mannheimer et 
al., 2002; Chesney, 2006). Medication adherence, however, is a specifically used term to 
define a patient’s compliance to ART (Howard et al., 2002; Chesney, 2006). While 
therapeutic adherence includes medication adherence, the latter does not include the 
former. Therefore, while medication adherence refers solely to prescription regimes, HIV 
therapeutic adherence encompasses a broad array of factors, including these regimens, 
and early engagement and sustained retention in care (Chesney, 2006; Howard et al., 
2002). Both dimensions of adherence are vital to positive health outcomes among PLHIV, 
and distinguishing correlates of each type of adherence remains a gap in the literature. 
 Much of the literature in HIV-related adherence literature focuses on medication  
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adherence, and utilizes viral suppression as primary biomarker data. However, it is an 
outcome of medication adherence, not a direct measure of medication adherence itself. 
Findings by DiMatteo, Giordani, Lepper, and Croghan, (2002) and Mannheimer, 
Friedland, Matts, Child, and Chesney (2002) estimate HIV-related medication adherence 
rates at roughly seventy to eighty percent, even under hospital-supervised care. Among 
those with mental illness, and among racial/ethnic minority women, adherence rates are 
much lower, approximately sixty-five percent under the supervision of managed hospital 
care (DiMatteo et al., 2002; Wolf et al., 2007; Mannheimer et al., 2002). Moreover, 
adherence rates have been estimated to be even lower among PWID PLHIV, roughly fifty 
to sixty percent (Wolf et al., 2007). Therefore, even with formal care, PLHIV rates of 
medication adherence vary widely in the literature, and do not include distinctions of 
operationalization and measurement of HIV therapeutic adherence.  
Additionally, measurement within, and between, each of these adherence domains 
varies. Lack of a gold standard of HIV medication adherence, therefore, encompasses a 
range of data collection methods. Viral suppression is often used as a proxy for 
medication adherence, as several clinical studies of virologic biomarkers and ART have 
established the predictive value of ART adherence on viral suppression (Chesney, 2006; 
Mannheimer et al., 2002; Howard et al., 2002; Paterson et al., 2000; DiMatteo et al., 
2002). Self-report measures of medication adherence are also frequently utilized, partly 
due their relative accuracy and cost-effectiveness (National Collaborating Centre for 
Primary Care, 2009; Garfield, Clifford, Eliasson, Barber, & Willson, 2011).  
Finally, studies of HIV medication adherence in recent years have also 
implemented a Medication Event Monitoring System, whereby an electronic bottle cap 
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records the number of bottle openings and the date and time (National Institutes of Health 
[NIH], 2014). Each of these approaches are valid measures of medication adherence 
(NIH, 2014; Garfield et al., 2011). Chesney (2006) purports that the more useful 
distinctions of HIV adherence are in research versus clinical implications, rather than 
therapeutic versus medication adherence implications. In this sense, the 
operationalization and measurement of adherence depends entirely on its application to 
address individual patient factors, literacy barriers, time and money constraints, and other 
relevant factors (Chesney, 2006).  
In acknowledgment of the vast disparities in therapeutic adherence outcomes 
among PLHIV, the concept of an HIV “treatment cascade” denotes this spectrum. 
Specifically, Gardner, McLees, Steiner, del Rio, and Burman (2011) describe the 
treatment cascade as the process of HIV testing, linkage to care, initiation of effective 
ART, adherence to treatment, and retention in care. The CDC (2012) estimates that 
within the cascade, less than forty percent of PLHIV in the United States are prescribed 
ART and, among these individuals, only seventy-six percent have achieved viral 
suppression. Moreover, rates of therapeutic adherence are likely lower than those of 
medication adherence (Machtinger & Bangsberg, 2005). Similarly, overuse of acute care 
services is related to non-adherence among this population, as individuals whom report 
the Emergency Department as a usual source of care may be more likely to report lower 
linkage to care and effective ART (Unni, Ashment, Miller, & Draper, 2014). 
           In consideration of all of these concerns, the proposed study advocates the term 
“HIV medical adherence”. Specifically, as mentioned, HIV medical adherence, was 
defined as both viral suppression and optimal acute care utilization. First, viral 
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suppression was defined as an HIV viral load of 40 copies per milliliter or less, measured 
by viral load assays (Schumacher et al., 2007). As mentioned, viral suppression is a 
widely accepted biomarker proxy of medication adherence (Chesney, 2006; Mannheimer 
et al., 2002; Howard et al., 2002; Paterson et al., 2000; DiMatteo et al., 2002).  
The HIV Cost and Service Utilization Study (HCSUS) defines optimal HIV 
medical services utilization as prompt engagement in HIV care after diagnosis, minimal 
Emergency Department visits and inpatient care, and management of HIV illness through 
access to and use of ART (Shapiro et al., 1999; Fremont et al., 2007). In the present 
analyses, all of the participants were insured, and enrolled in primary care, and therefore 
should have had reduced need for acute care utilization. However, research suggests that 
optimal acute care utilization may be dependent on factors such as HIV illness stage, 
particularly among persons who inject drugs. Therefore, this focused on optimal acute 
care, defined as no Emergency Department visits or overnight hospitalizations in the 
prior six months. As such, HIV medical adherence is inclusive of viral suppression 
(medication adherence) and optimal acute care utilization (therapeutic adherence); both 
of which are meaningful constructs in research and clinical settings (Chesney, 2006).  
SYNTHESIS AND CONCEPTUAL MODEL 
Rationale for proposed study 
African-American drug-using populations are disproportionately affected by HIV 
infection and poor ART adherence, as compared to non-drug-using African-American 
PLHIV (CDC, 2010; CDC, 2012). In addition to HIV status, the syndemic factors of 
substance use, mental illness, and violence are common precursors to, and outcomes of, 
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HIV infection (Buseh & Stevens, 2008; Singer, 1996; Broadhead et al., 2002; Kelly & 
Kalichman, 2002; Holtgrave, 2004). Few studies have engaged persons who inject drugs 
and are persons living with HIV (PWID PLHIV) in research to identify possible means of 
intervention to improve ART adherence and outcomes.  
Next, African-American women PLHIV are at highest risk of HIV infection due 
to less condom negotiation, less access to health care due to barriers such as lower 
educational attainment and non-insurance, and more strains on social support, compared 
to all other groups. Finally, adherence is controversial to define and measure, irrespective 
of its variation among PLHIV. Currently, there remains a dearth of research targeting 
HIV-positive African-Americans to identify their unique barriers and facilitators to 
engagement in optimal ART adherence, as well as medical adherence. Given the critical 
gaps in research within this population, the purpose of the proposed study was to identify 
correlates of HIV medical adherence among a sample of urban adult persons who inject 
drugs in Baltimore, Maryland.  
CONCEPTUAL MODEL 




 Conceptual model 
 Figure 2.1 depicts the conceptual model of the dissertation research. As 
mentioned, the SUMIC Syndemic was defined as current use of one or more illicit 
substances, diagnosis of one or more mental illnesses, and presence of familial conflict. 
Next, sex was a predictor of interest due to a substantial body of literature which suggests 
that women fare worse than men with HIV-related outcomes such as medical adherence. 
For the purposes of analyses, sex and gender were interchangeable terms. Third, social 
support was a central focus of the analyses, such that distinguishing types of social 
support as they relate to HIV medical adherence was crucial. While not depicted in the 
framework, relevant sociodemographic factors such as income level, educational 
attainment, and age were conceptualized and included in dissertation analyses.  
 Therefore, several dimensions of social support were included in analyses, 
ranging from ART-related support, health-related support from the PLHIV’s social 
network, to support reciprocity from PLHIV to their informal caregiver. Finally, the 
outcome of interest was HIV medical adherence, defined as viral suppression and optimal 
acute care utilization.  Additionally, the proposed study was unique in scope because it 
evaluated several dimensions of social support as predictive of HIV medical adherence, 
and gender-related differences in these dimensions. Finally, this study contributes an 
innovative approach to defining a latent syndemic of PLHIV. Previous literature has 
defined HIV syndemics based on gender or sexual practice, and predictive of primary 
HIV prevention. The proposed study contributes a race-considerate syndemic, focused on 
correlates of HIV tertiary prevention among already-infected PLHIV. Results have 
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This study utilized baseline data from a NIH-funded study entitled “Being Active 
and Connected: Informal Caregiving and Medical Adherence among HIV+ Injection 
Drug Users” (BEACON) (Principal Investigator (PI): Amy Knowlton, ScD). The parent 
project was a longitudinal study which explored pathways through which psychosocial 
factors and substance use influence HIV-related outcomes among HIV-positive current 
and former injection drug users. 
 The BEACON study examined the role of social support in inner city drug users’ 
successful HIV treatment, and social network and informal HIV caregiving research after 
the advent of highly active antiretrovirals. The proposed dissertation research sought to 
identify correlates of HIV medical adherence. The findings will inform subsequent 
interventions to ultimately improve HIV health outcomes among PLHIV. 
STUDY AIMS AND HYPOTHESES 
Study aims and hypotheses     
The purpose of the proposed study was to identify correlates of HIV medical  
adherence among a sample of urban adult persons who inject drugs in Baltimore,  
Maryland. As previously depicted in Figure 2.1, the study’s aims were to: 
    1) understand the association between sex and HIV medical adherence (defined as 
optimal acute care utilization and ART adherence) among a sample of urban African-
American adult persons who inject drugs currently engaged in HIV medical care; 
            2) determine the relationship between the ‘SUMIC’ Syndemic (e.g. Substance Use, 
Mental Illness, and Familial Conflict), and HIV medical adherence among a sample  
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of urban African-American adult persons who inject drugs currently engaged in HIV 
medical care; 
            3) examine sex and social support as potential moderators in the relationship  
between the SUMIC Syndemic and HIV medical adherence among a sample of urban 
African-American adult persons who inject drugs engaged in HIV medical care.  
Study hypotheses 
The proposed dissertaion had also three hypotheses: 
1) Females would report lower rates of HIV medical adherence than males; 
2) Individuals with higher SUMIC Syndemic burden would report lower rates of 
medical adherence as compared to individuals who had lower syndemic burden; and 
3) Females would report higher levels of the SUMIC Syndemic and lower rates of 
medical adherence as compared to males.  
POPULATION AND DATA SOURCES 
Study population, data sources, and data collection 
The BEACON parent study examined the role of psychosocial factors, sex, and 
active drug use on HIV health outcomes among disadvantaged PLHIV. The BEACON 
study built on previous research within prior studies on the influence of social networks 
and social support on health outcomes including substance use and mental illness among 
similar disadvantaged groups (Knowlton & Latkin, 2007). The project goals were to:  
(a) understand influences of social support networks and informal caregivers 
(“main supporters”) on ART adherence and medical services among the target 
population;    
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(b) utilize study findings to inform the development and implementation of 
interventions to increase ART adherence among the target population.  
Study participants were HIV-positive former and current substance users 
(Indexes) and their main HIV-related supporters who were recruited to the study. All 
participants (e.g. Indexes and main supporters) completed baseline (Time 1), a 6-months 
follow-up assessment (Time 2), and 12-months follow-up assessment (Time 3).  Plasma 
viral load, CD4 count data, and toxicology tests were collected at baseline and 6 month 
visits for all Index participants. The present study utilized data from a total of 383 
Indexes, who completed baseline data collection for the BEACON study.  
Inclusion criteria for Indexes were: (a) age of 18 years or older; (b) documented 
HIV seropositive status; (c) current or former injection drug use; and (d) current use of 
ART medication defined as use in the prior 30 days. Participants were recruited through 
street outreach through the PI’s research center, the Lighthouse housed within the Johns 
Hopkins Bloomberg School of Public Health but located off-campus. Indexes were 
recruited using community sampling, and targeted recruitment strategies that were 
utilized successfully by the PI in previous interventions and studies. Index participants 
were also recruited via the Johns Hopkins University’s Moore Clinic, an HIV-specialty 
clinic located in Baltimore, Maryland. Finally, main supporters were identified by 
Indexes, and invited to participate in the study. 
 Only data provided from Indexes were included in this study. Participants used 
audio-computer-assisted self-interviewing procedures (ACASI) to complete the sensitive 
topic items of the surveys, such as drug use, ART adherence, and history of mental illness. 
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Data on other survey topics were collected in face-to-face interviews using Questionnaire 
Development System (QDS) computer programmed survey instruments (Nova Research 
Company, 2006). Trained interviewers with extensive experience working with the study 
population conducted interviews at the Lighthouse research facility. All interviewers who 
administered assessments were trained in conducting research with vulnerable 
populations and sensitive subject matter, and trained staff also collected all biomarker 
data from Index participants. 
STUDY VARIABLES 
Operationalization of predictor variables 
Active substance use (syndemic factor)     
 Inclusion criteria for the BEACON study specified that all Index participants 
endorse former or current injection drug use. Therefore, participants were classified as 
active substance users if they reported having used any of the following substances in the 
past 30 days: alcohol, stimulants, opiates, barbiturates, heroin, cocaine/crack, 
hallucinogens, or prescription drugs. Principal component factor analyses were conducted 
to assess the factor structure and internal reliability of the items. Six of the items were 
retained, with a one-factor solution. The items retained assessed opiates, marijuana, 
heroin, cocaine/crack, hallucinogens, and prescription drug use in the last 30 days. Binary 
items were created for each of the six substance use items, and summed to create a scale 
in order to assess the internal consistency of the items. Factor analyses was conducted to 
account for a latent factor structure and binary items, which yielded acceptable fit (Chi-
square [2] = 11.37; Degrees of freedom [df] = 9; Root Mean Square Error of 
Approximation [RMSEA] = 0.03; Comparative Fit Index [CFI] = 1.00; Rasch, 1980). 
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These items were summed, and ranged from 0 to 6. Items were used in both Poisson 
regressions and latent class regression analyses (Chapter Four, Chapter Five, Chapter Six 
and Appendix A).  
Mental illness (syndemic factor)      
 Participants were classified as having mental illness if they responded ‘yes’ to any 
of the following: (a) “Have you ever received any counseling, therapy, or medication for 
your nerves or any emotional problems, not including drug treatment?”; (b) “Have you 
been told by a doctor or other health care provider that you have depression or major 
depression?”; (c) “Have you been told by a doctor (or other health care provider) that you 
have manic depression or bipolar disorder?”; (d) “Have you been told by a doctor (or 
other health care provider) that you have anxiety, panic attacks, or post-traumatic stress 
disorder (PTSD)?”; (e) “Have you been told by a doctor (or other health care provider) 
that you have schizophrenia or psychosis, that is, hearing voices or seeing things that 
aren't there?”; (f) “Have you been told by a doctor (or other health care provider) that you 
have any other emotional or psychiatric conditions?” Binary items were created for each 
of the six items, and summed. Factor analyses was conducted to account for a latent 
factor structure and binary items, which yielded acceptable fit with items (b) through (f), 
and a one-factor solution (2 = 2.41; df = 5; RMSEA = 0.00; CFI = 1.00). Responses 
ranged from 0 to 5. These items were used in both Poisson regression and latent class 
regression analyses (Chapter Four, Chapter Five, Chapter Six, and Appendix A).  
 Familial conflict (syndemic factor)      
 Familial conflict will be assessed via a measure adapted from the Conflict Tactics 
Scale, which assesses constructs of intra-family aggression, violence, and conflict 
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resolution (Straus, 1979). Sample survey items include, “In my family when we are angry 
or upset we don't talk to each other”, and “In my family if someone is having problems, 
other family members get too involved, they meddle in their business”. Due to data 
missingness, three of the items were retained, with a one-factor solution. The items 
retained were: (a) “In my family we talk about our problems with each other”, (b) “In my 
family if someone has a problem, we work together to deal with it” and (c) “In my family 
we show that we care for each other.”  
Each item had a 5-point Likert scale ranging from “Strongly Agree” to “Strongly 
Disagree”. Binary items were created for each of the three items, and summed to create a 
scale. Factor analyses was conducted to account for a latent factor structure and binary 
items, which yielded acceptable fit (2 = 0.00; df = 0; RMSEA = 0.00; CFI = 1.00). 
These items were used in Poisson regressions and latent class regression analyses 
(Chapter Four, Chapter Five, Chapter Six, and Appendix A). Previous research defines 
familial conflict as any any disagreements between family members; thus the present 
items were conceptualized are reflective of this operationalization (Semple, Strathdee, 
Zians, & Patterson, 2009).  
 SUMIC Syndemic (latent class)      
 For the purposes of multivariate Poisson regression, the individual scales were 
categorized. For substance use, the six binary items were summed, and ranged from 0 to 
6, where higher scores indicated higher concurrent substance use. Due to low responses 
rates in each category, categories were collapsed, such that 0 = no substances used, 1 = 1-
2 substances used, and 3 = 3-6 substances used. For mental illness items, the five binary 
items of participants’ use of each substance were summed, and ranged from 0 to 5, where 
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higher scores indicated higher concurrent substances used. Due to low responses rates in 
each category, categories were collapsed, such that 0 = no mental illness diagnoses, 1 = 
1-2 mental illness diagnoses, and 2 = 3-5 mental illness diagnoses.  
 Familial conflict scores ranged from 0 to 3, where higher scores indicated higher 
endorsement of familial conflict (e.g. low endorsement of family problem solving and/or 
affection). Categories were retained for each of the scores. As mentioned, separate 
structural equation measurement models were fit for each syndemic factor, to account for 
their underlying latent structure prior to latent class regression analyses (Chapter Five and 
Appendix A). Finally, the syndemic classes were used as a categorical predictor in 
Poisson regression analyses where HIV medical adherence was the outcome of interest 
(Chapter Six). 
Social support         
 Due to the importance of distinguishing between types of social support and their 
associations with HIV medical adherence, several dimensions of social support were 
operationalized and analyzed.  
1. Health-related support - Health-related support refers to supportive 
persons that Index PLHIV have whom assist them in engagement in health-
related behaviors. The items were developed based on the Arizona Social 
Support Inventory (Barrera, Jr. & Gottlieb, 1981), and has proven a valid 
measure in previous studies with similar populations (Latkin et al., 1996). 
Items included “In the last year, has anyone gone with you to a doctor's 
appointment or to the ER to get medical care?”; “In the last year, has anyone 
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brought or prepared food or cleaned for you?”; “In the last year, has anyone 
run errands for you, for example, picked up medicine or gone shopping for 
you?”; and “In the last year, has anyone helped you with your medication?” 
Principal component factor analyses were conducted to assess the factor 
structure and internal reliability of the items. All six items were retained with 
a one-factor solution, with good reliability (Cronbach’s  = 0.81). Cronbach’s 
alpha is mathematically equivalent to KR-20 for dichotomous data, therefore 
Cronbach’s alpha was used computationally (Tan, 2009). Due to the binary 
nature of the data and skewed distribution of responses, responses were 
dichotomized at the median, where 0 = low health-related support, and 1 = 
high health-related support (MacCallum, Zhang, Preacher, & Rucker, 2002).  
 
2. ART-related support - ART-related support was assessed by a single item 
which asked participants “How often does your main supporter talk to you 
about your HIV medications or side effects?” The single item was a useful 
variable to include in analyses, to identify specific main supporter behaviors 
that may impact HIV medical adherence among Indexes. The item was also 
developed and informed by the Arizona Social Support Inventory (Barrera, Jr. 
& Gottlieb, 1981), and previous research with similar populations (Latkin et 
al., 1996).  Responses were on a 4-point Likert scale, ranging from “Never” to 
“Very often”. Responses were trichotomized at the tertiles where 0 = low 
ART-related support, and 1 = moderate ART-related support, and 2 = high 
ART-related support (Fong, 2014).  
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3. Negative social exchange - Negative social exchange refers to 
interpersonal events or stressors, such as unwanted advice, or experiencing 
others' insensitive behaviors (Newsom, Nishishiba, Morgan, Rook, & 2003). 
The scale, based on Newsom et al.’s (2003) scale consisted of nineteen items, 
including “In the past 30 days, how often did someone you know let you 
down when you needed help?”; “In the past 30 days, how often did someone 
you know fail to spend enough time with you?”; and “In the past 30 days, how 
often did you feel that someone you know was not paying enough attention to 
you?” Participants’ responses were on a 3-point Likert scale, ranging from 
“Rarely or none of the time” to “Most or all of the time”. Principal component 
factor analyses were conducted to assess the factor structure and internal 
reliability of the items. Thirteen of the items were retained with a one-factor 
solution, with good reliability (Cronbach’s  = 0.80). Due to the categorical 
nature of the data and skewed distribution of responses, responses were 
dichotomized and/or trichotomized for subsequent analyses (Chapter Four and 
Chapter Six; MacCallum et al., 2002). 
 
4. Reciprocity of support - Based on the scale by Pearlin, Mullan, 
Aneshensel, and Wardlaw (1994), informal caregiver reciprocity refers to the 
activities that Indexes reported providing to their main supporters in the past 
12 months. The nine items include “How much have you helped your main 
supporter around the house in the past year?”; “How much have you cared for 
your main supporter's children, family, or friends in the past year?”; and 
“How much have you expressed affection and appreciation for your main 
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supporter in the past year?” Participants’ responses were on a 3-point Likert 
scale, ranging from “None” to “A lot”. Principal component factor analyses 
were conducted to assess the factor structure and internal reliability of the 
items. Seven items were retained with a one-factor solution, with acceptable 
internal consistency (Cronbach’s  = 0.78). Responses were trichotomized at 
the tertiles, where 0 = low reciprocity, 1 = medium reciprocity, and 2 = high 
reciprocity (Fong, 2014).   
 
5. Relationship to main supporter - Main supporter relationship was assessed 
by a single item which asked Indexes what their relationship was to the most 
supportive person to them. Responses were recoded as: “Kin (Older 
generation, same generation, or younger generation)”; “Main Partner 
(Significant other)”, “Friend”; and/or “Professional”. Due to a skewed 
distribution of responses, categories were collapsed, such that 0 = other main 
supporter (Professional, friend, or no main supporter identified), 1 = main 
partner (Significant other), and 2 = kin (Older, same, or younger generation). 
This item was useful for assessing whether associations with Indexes’ HIV 
medical adherence differed, based on the Index’s relation to their informal 
caregivers (Chapter Four, Chapter Five, Chapter Six, and Appendix A).  
 
6. Religious activity - Religious activity was assessed by a single item which 
asked “How often do you go to religious services?” Responses were on a 6-
point Likert scale, ranging from “Never” to “More than once a week”. Due to 
a skewed distribution of responses, categories were collapsed and 
trichotomized at the tertiles, such that 0 = low attendance, 1 = moderate 
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attendance, 2 = frequent attendance (Fong, 2014). This item was useful for 
assessing whether difference existed in Indexes’ HIV medical adherence, 
based on their engagement in organizational religious services. Research 
suggests many PLHIV belong to an organized religion, and use their religion 
to cope with their illness, which may predict higher HIV medical adherence, 
thereby justifying inclusion of this item in analyses as a form of organizational 
support (Chapter Four; Cotton et al., 2006).  
 HIV stigma         
 HIV-related stigma refers to perceived discrimination or judgment that PLHIV 
may experience and/or internalize, based on their HIV seropositivity (Wight, Aneshensel, 
Murphy, Miller-Martinez, & Beals, 2006). Participants completed nine items based on 
the scale by Wight et al (2006), including, “Thinking about having HIV, how much do 
you feel that you need to hide it?”; “Thinking about having HIV, how much do you feel 
that people think that it's not such a big deal?”; and “Thinking about having HIV, how 
much do you fear your family will reject you?” Responses were on a 4-point Likert scale, 
ranging from “Not at all” to “Very much”. Principal component factor analyses were 
conducted to assess the factor structure and internal reliability of the items. Six items 
were retained with one factor and acceptable reliability (Cronbach’s  = 0.75). Due to the 
categorical data and distribution of responses, responses were trichotomized at the tertiles, 
where 0 = low stigma, 1 = medium stigma, and 2 = high stigma (Fong, 2014). 
 Doctor-patient communication      
 Doctor-patient communication was assessed by a ten-item scale based on the 
Engagement with Healthcare Provider Scale (Bakken et al., 2000). These items assess 
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patient-provider communication and patient satisfaction, and includes items such as “My 
doctor involves me in decisions”, “My doctor knows me as a person”; and “My doctor 
respects my choices.” Responses were on 4-point Likert scale, ranging from “Never” to 
“Always”. Principal component factor analyses were conducted to assess the factor 
structure and internal reliability of the items. Nine items were retained with a one-factor 
solution, with good reliability (Cronbach’s  = 0.86). Responses were dichotomized at 
the median, where 0 = low patient/provider communication and1 = high patient/provider 
communication (MacCallum et al., 2002). Bakken et al. (2000) found that better patient-
provider communication was associated with increased HIV medical adherence among 
PLHIV, thereby justifying its inclusion in analyses (Chapter Four and Chapter Six).  
 Physical functioning/activities of daily living (ADLs)    
 Physical health (physical functioning and ADLs) was assessed by a ten-item scale 
based on the Medical Outcomes Study Physical Functioning Measure (McDowell& 
Newell, 1996). These items included “How much does your health affect your ability to 
bend, lift, or squat down?”; “How much does your health affect your ability to do 
moderate activities like moving a table, carrying groceries, or walking a mile?”; and 
“How much does your health affect your ability to eat, dress, or bathe?” Responses were 
on 3-point Likert scale, ranging from “Not at all” to “A lot”. Items were reverse-scored, 
such that higher scores indicated higher levels of physical functioning, rather than 
physical limitations. Next, principal component factor analyses were conducted to assess 
the factor structure and internal reliability of the items.     
 Nine of the ten items were retained with a one-factor solution, with acceptable 
reliability (Cronbach’s  = 0.77). Responses were trichotomized at the tertiles, where 0 = 
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low physical functioning, 1 = moderate physical functioning, and 2 = high physical 
functioning (Fong, 2014). Included in analyses are self-reports of both mental and 
physical health, as both are associated with HIV medical adherence (Burgess, Dayer,  
Catalan, Hawkins, & Gazzard, 1993; Batchelder, Gonzalez, & Berg, 2014).  
 Sociodemographic variables       
 The following demographic variables were included in analyses: educational 
attainment, sex, and age, each of which were assessed by single items. Relevant variables 
were summarized for each analysis (Chapter Four, Chapter Five, Chapter Six).  
Operationalization of outcome variables 
 HIV medical adherence        
 HIV medical adherence was defined as both level of optimal acute care utilization 
and HIV viral suppression (Figure 2.1). Also included in analyses was SUMIC Syndemic 
class as an outcome variable (Chapter Five). 
1. Optimal acute care utilization - Optimal acute care utilization was measured 
as a cumulative score of access to health care services and level of engagement in 
acute HIV medical services. This definition of optimal acute care utilization is 
based on The HIV Cost and Service Utilization Study terminology (e.g., 
minimization of acute care; Shapiro et al., 1999; Fremont et al., 2007). 
Respondents were asked the following six questions: (a) “Where do you usually 
go for health care?  What type of facility is it?”; (b) “Enter the [name of the 
place]”; (c) “In the past 6 months, how many times have you gone to an 
emergency room (ER) for your health care?”; (d) “In the past 6 months, other than 
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an emergency room, how many times have you seen a health care provider to get 
medical care for yourself?”; (e) “In the past 6 months, how many times were you 
admitted to a hospital, that means that you stayed there overnight?”; and (f) “In 
the past 6 months, how many nights did you stay at a hospital? This could include 
for drug detox or mental health care.”  
 Respondents entered a text (nominal) response to items (a) and (b), and 
numeric responses to questions (c) through (f), therefore only numeric responses 
were considered for inclusion in analyses. Given that Indexes were all enrolled in 
care, and had insurance, and attended the same clinic, there was little variation in 
their responses, Therefore, items (c) and (e) were retained for analyses as an 
outcome measure, and dichotomized at the median, where 0 = 1 or more ER visits 
and/or overnight hospitalizations in the last 6 months, and 1 = 0 ER visits or 
overnight hospitalizations in the last 6 months (MacCallum et al., 2002). Optimal 
acute care utilization was conceptualized as a behavioral proxy for therapeutic 
adherence of Indexes, nearly all of whom were insured and should have had little 
reason to access acute care services such as the ER.  
2.  HIV viral suppression - HIV viral suppression was defined as an undetectable 
viral load of 40 copies per milliliter (mL) or less, as measured by the Roche 
Cobas Amplicor viral load assay (Schumacher et al., 2007). Viral suppression is 
generally accepted as a standard measure of medication adherence (Chesney, 
2006). Therefore, a dichotomous variable of viral suppression was constructed, 
where 0 = detectable viral load, and 1 = non-detectable viral load, or viral 
suppression (< 40 copies/mL).  
69 
 
While pill counts were also available in the present dataset, controversy persists 
over what defines an acceptable cut-off rate of “adherence” (Steel, Nwokike, Joshi, & 
2007; Fairley, Permana, & Read, 2005). Therefore, viral suppression is a commonly 
accepted biomarker proxy of medication adherence (Chapter Two; Chesney, 2006; 
Mannheimer et al., 2002; Howard et al., 2002; Paterson et al., 2000; DiMatteo et al., 
2002).  
3.  SUMIC Syndemic class membership - While the outcome of interest was HIV 
medical adherence, latent class analyses (LCA) were conducted to identify unique 
patterns of behavioral risk, as identified by Indexes’ active substance use, mental 
illness(es), and levels of familial conflict. LCA can be used as a data reduction 
technique by which to categorize individuals into their most likely class 
membership along the spectrum of the SUMIC Syndemic. (e.g. non-observable 
latent variable, based on latent conditions such as substance use and mental 
illness; Ahn et al., 2008; Bastard at al., 2011; Collins & Lanza, 2010). Therefore, 
the SUMIC Syndemic latent classes were participants’ most likely membership 
classes, based on their posterior probability of endorsing the previously identified 
14 items included in analyses (Ahn et al., 2008; Collins & Lanza, 2010). 
 In addition, the syndemic classes were also treated as a categorical outcome 
variable in LCA regression based on three relevant correlates: sex, viral suppression, and 
optimal acute care utilization. In this light, comparisons were made about class 
membership as a function of sex and HIV medical adherence. Therefore, class 
membership was treated as both a predictor and an outcome, which was a decision that 
was theoretically based, and has direct implications for future research and interventions 
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(Chapter Two and Chapter Six; Ahn et al., 2008; Bastard at al., 2011; Collins & Lanza, 
2010; Chesney, 2006; DiClemente & Wingood, 1995; Bussey & Bandura, 1999). Finally, 
all of the analyses of interest were conducted to predict HIV medical adherence among 
African-Americans. Therefore descriptive and univariate statistics were run on the full 
sample (N=383), while bivariate and multivariate analyses were run solely on the subset 
of African-American participants (N=351), for both statistical and theoretical relevance to 
research aims and hypotheses.   
STATISTICAL ANALYSES FOR RESEARCH AIMS 
Statistical analyses to address research aims 
Research Aim 1. Association between sex and HIV medical adherence  
In order to assess the association between sex and HIV medical adherence, 
descriptive analyses were conducted. First, univariate frequencies of demographic 
characteristics of participants were run on the entire sample, and also by sex. (Tables 4.1. 
5.1, and 6.1). Demographic characteristics of interest included: race (African-
American/White/Other), sex (male/female), education (8th grade or less/some high 
school/high school or GED/some college or above), and age (numerical).  
All variables except age were categorical, and descriptive summaries were 
examined to assess the distribution of responses for each. Categories were collapsed as 
necessary, to account for skewed distributions and/or missing data. Finally, the outcome 
variables were dichotomized from continuous variables (age, service utilization, and viral 
suppression), for regression analyses (Chapter Six).  
Hypothesis 1.1. Females would have lower HIV medical adherence than males. 
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In order to test this hypothesis, Chi-square analyses were conducted to determine 
statistically significant associations between each of the demographic variables (other 
than sex), HIV medical adherence, and sex (Table 4.1). Variables that were marginally 
significant (p<.10) and/or statistically significant (p<.05) were retained and included in 
subsequent multivariate Poisson regression models run separately by sex (Gordon, 2012; 
Chapter Four). For Poisson regression analyses by sex, viral suppression was retained as 
an outcome variable.  
Poisson regression is appropriate for binary outcome data for non-rare events 
(McNutt, Wu, Xue, & Hafner, 2003). To account for heteroskedasticity (inconstant 
variation), robust standard errors were estimated (Long, 1997). This decision was based 
on the higher number of significant associations at the bivariate level, as compared to 
optimal acute care utilization. Chapter Four summarizes sex differences in correlates of 
viral suppression only. Relevant tests of interaction effects were assessed. 
Research Aim 2. Association between the ‘SUMIC’ Syndemic, social support, 
and HIV medical adherence 
As mentioned, syndemic risk was assessed via construction of a categorical 
variable indicating number of factors for each Index. Associations between these factors 
and medical adherence were assessed with Chi-square analyses. These analyses are 
summarized in Appendix A. Next, factor analyses were conducted to assess the latent 
factor structure of all three factors (e.g. substance use, mental illness, familial conflict).  
After testing first-order measurement models per factor, second-order factor 
measurement models were tested. All second-order measurement model combinations 
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were assessed: (a) substance use/mental illness/familial conflict; (b) substance use/mental 
illness; (c) substance use/familial conflict; and (d) mental illness/ familial conflict. Latent 
class analyses were decided upon, due to poor fit of the second-order models.   
As such, LCA regression identified syndemic classes, and also correlates of 
syndemic class membership (sex and HIV medical adherence; Chapter Five). After LCA 
regression analyses, multivariate Poisson regression with robust standard errors was 
conducted, with syndemic class membership as a categorical predictor, and HIV medical 
adherence (binary viral suppression and optimal acute care utilization), as detailed in 
Chapter Six. Based on findings by Israelski, Gore-Felton, Power, Wood, and Koopman 
(2001) and Mills et al. (2006), the following sociodemographic variables were included 
in analyses as potential confounders and controlled for: (a) educational attainment; (b) 
income; and (c) age. Due to lack of statistical variation, race was excluded as a control 
variable. Instead, analyses were conducted only on African-American Indexes. 
Hypothesis 2.1 Individuals within higher SUMIC Syndemic burden would report 
lower rates of HIV medical adherence as individuals with lower Syndemic burden. 
Chapter Five details the results of these analyses. After factor analyses, first-order, 
and second-order measurement models, latent class analyses were conducted. This 
decision was made due to poor fit of the second-order measurement models, such that 
syndemic factors were unable to be combined reliably. This hypothesis was alternatively 
assessed utilizing Chi-square tests and categorical variables of Indexes’ active substance 
use, mental illness, and familial conflict. It was decided that treating each factor as a 
categorical count variable was inadequate for two main reasons, thus it was not included  
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in final analyses in manuscript chapters, and instead summarized in Appendix A.  
First, a simple count of each substance use, mental illness, and familial conflict 
(absence/presence as defined by inclusion of any endorsement per factor) does not detail  
important variations within each factor such as the most commonly used substance and/or 
most prevalent mental illness. Second, summing all factors as one categorical syndemic 
variable does not differentiate absence or presence of each factor(s); it simply identifies 
absence/presence of some factor(s). Therefore, each factor was summed separately as a 
scale, and used as separate categorical correlates of viral suppression in Chapter Four. 
LCA analyses utilizing SUMIC Syndemic classes as an outcome are detailed in Chapter 
Five, and syndemic classes as a categorical predictor are detailed in Chapter Six.    
Research Aim 3. Assess sex and social support as potential moderators in the  
relationship between the SUMIC Syndemic and HIV medical adherence  
 As mentioned, descriptive frequencies of the outcome variable and predictor 
variables were calculated (Tables 4.1. 5.1, and 6.1). Next, bivariate associations were 
conducted between all categorical correlates and the outcome variables (Chi-square). In 
order to assess age as a potential confounding variable, it was dichotomized as a binary 
variable and assessed for statistical association with HIV medical adherence in the 
multivariate Poisson regression models. Associations that were marginally significant 
(p<.10) and/or statistically significant (p<.05) were entered in subsequent Poisson 
regression models (Gordon, 2012).A backwards deletion approach was employed, in 
order to trim the resulting model to include only statistically significant correlates, and/or 
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those theoretically relevant to the specific analyses. Therefore, all social support variables 
and sex were included in analyses, despite non-significant associations.  
Hypothesis 3.1. Females would report higher rates of the SUMIC Syndemic and 
lower rates of medical adherence as compared to males. 
The aforementioned multivariate Poisson regression models were specified to 
regress HIV medical adherence on sociodemographic variables, social support 
dimensions, and SUMIC Syndemic class. Main effects models were specified utilizing 
these correlates, and a backwards deletion approach reduced the models. In order to test 
Hypothesis 3.1, interaction terms were included to assess the following potential effect 
modifications on the relationship between syndemic class and HIV medical adherence:   
1.) Sex X SUMIC Syndemic class 
2.) Health-related support X SUMIC Syndemic class 
3.) ART-related support X SUMIC Syndemic class 
4.) Negative social exchange X SUMIC Syndemic class 
5.) Reciprocal support X SUMIC Syndemic class 
6.) Main supporter type X SUMIC Syndemic class 
Other theoretically relevant interactions were also assessed between correlates of 
interest and their impact on HIV medical adherence (Chapter Six). Finally, goodness of 
fit and internal consistency measures were used to compare all models. Cronbach’s alpha 
was calculated for all scales, as a reliability estimate (Osburn, 2000; Tan, 2009; 
Croasmon & Ostrom, 2011). However, while it may underestimate reliability among 
Likert scale items (Gadermann, Gruhm, & Zimbo, 2012; Osburn, 2000), Cronbach’s 
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alpha is appropriate to use as long as unidimensionality is maintained as was the case 
with the measures used in the present analyses (Schmitt, 1996).     
  Moreover, it is a widely recognizable measure and, as stated by Peterson and 
Kim (2013), the impact of the underestimation is negligible in practical applications. Also, 
Cronbach’s alpha was used as computationally equivalent to the KR-20 for handling 
binary data (Tan, 2009). Next, use of single-item variables was minimized where possible, 
in order to improve reliability of measures used in statistical analyses (Gliem & Gliem, 
2003; Blalock, 1970).  
Additionally, Root mean square error approximation (RMSEA), Comparative Fit 
Indices (CFI), and Chi-square tests (2) were used to compare measurement models for 
SUMIC Syndemic factors (Rasch, 1980). Latent class analyses models were compared 
using Akaike’s Information Criteria (AIC), Bayesian Information Criteria (BIC), Entropy, 
and Likelihood-ratio test chi-square statistics (Akaike, 1973). AIC and BIC did not 
determine Poisson regression model acceptability due to theoretical significance for 
included variables, some of which were not statistically significant.  
QUALITY CONTROL AND OTHER CONSIDERATIONS 
Quality assurance 
 Much of the necessary quality assurance of the parent study ensures reduced 
methodological issues within the proposed study. Firstly, all assessments completed by 
study participants were the result of pilot testing and previous research by the PI in 
similar populations. Moreover, all research assistants and interviewers employed by the 
Lighthouse research facility have extensive experience and training in recruitment, data 
collection, and intervention work with the target population. Additionally, retention of 
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study participants remained at over ninety percent for follow-up assessments due to the 
expertise of Lighthouse staff at updating all contact records and maintaining 
correspondence with participants.  
All interviews, conducted for screening as well as data collection purposes, were 
conducted appropriately for the sensitive nature of the subject matter (e.g. self-
administered and/or confidential individual interviews with experienced interviewers).  
Reliability estimates were calculated for all quantitative scales completed by study 
participants. The internal consistency of the scales used for these analyses were 
determined via calculation of Cronbach’s alpha coefficients for all included continuous 
measures, and factor analyses as appropriate. The proposed study conducted secondary 
data analyses of baseline data provided by Indexes.  
Protection of human subjects 
All proposed study protocol were conducted in accordance with the guidelines set 
forth by the Johns Hopkins Bloomberg School of Public Health Institutional Review 
Board (IRB), as identified by the parent study procedures. Utmost diligence was 
exercised in protecting the rights and confidentiality of study participants. Recruitment 
was conducted via street outreach, and interested individuals contacted the Lighthouse 
and the study was described to them. Eligibility screening was conducted via telephone or 
face-to-face interview, and eligible persons were invited to participate. Research staff 
contacted participants directly, unless authorized to leave messages with others.  
Participants were contacted via the method and address they provided, for the 
purposes of appointment reminders and re-screening to verify eligibility at baseline 
(Time 1) assessment. All information was retained in an encrypted Client Tracking 
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Database, and all paper forms were kept in locked file cabinets.  No contact information 
was collected for individuals who were not deemed eligible to enroll in the parent study.  
Names were kept confidential via use of ID codes to identify participants, which were 
only assigned to actual data for the purposes of data analysis and coding. All research 
facility staff involved in the parent study were also HIPAA certified to uphold all privacy 
laws set forth by the by the Institutional Review Board at the Johns Hopkins Bloomberg 
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ABSTRACT   
Introduction: Research suggests sex differences exist in achieving undetectable viral 
load (UVL) among persons living with HIV (PLHIV). Extant research also suggests that 
social support is protective of UVL among PLHIV, and may vary by factors such as 
physical functioning and sex. Therefore, the purpose of this study was to identify 
correlates of UVL among African-American PLHIV. Method: Data were from the 
BEACON study of injection drug-using PLHIV on ART. Poisson regression with robust 
standard errors was implemented. Results: Males with moderate physical functioning 
had 1.4 times the likelihood of UVL as males who reported low physical functioning 
(Adjusted Incidence Rate Ratio [AIR] = 1.38; 95% Confidence Interval [95% CI] = 1.07, 
1.77; N=199). Females who were actively using 1-2 substances had a 30% lower 
probability of UVL, as compared to females were not actively using substances (AIR = 
0.73; 95% CI = 0.52, 1.03).  Discussion: Findings suggests that social support, active 
substance use, and mental illness function differently among males and females in their 
association with UVL. Therefore, healthcare professionals should develop sex-specific 












At the end of 2009, an estimated 1.1 million Americans aged thirteen and over 
were persons living with HIV (PLHIV) in the United States (Centers for Disease Control 
and Prevention [CDC], 2012). Among these individuals, eighteen percent were 
undiagnosed, and unaware of their HIV status (CDC, 2012). In 2010, there were 
approximately fifty thousand new HIV infections, nearly half of which were among 
African-Americans (CDC, 2012). In addition to race differences in HIV infection, gender 
differences exist in HIV-related outcomes. Compared to men, women are more likely to 
delay getting tested for HIV, lack access to regular medical care, and are more likely to 
convert from HIV to AIDS within a year of diagnosis (CDC, 2008; CDC, 2012). 
Due to race and gender disparities, African-American women are estimated to 
have an HIV incidence approximately eight times that of White-American women (CDC, 
2012; Prejean et al., 2011). In addition to higher incidence and prevalence of HIV, 
African-American women also have lower rates of achieving viral suppression than other 
groups, since the advent of highly active antiretroviral therapy (ART) in the U.S. (CDC, 
2012; Holtgrave, Hall, Rhodes, & Wolitski, 2009; Kaiser Daily Health Reports, 2006). 
More research is needed to illuminate the factors which place African-Americans, and 
more specifically African-American women at increased risk of negative HIV-related 
health outcomes. 
Race and gender disparities in HIV outcomes 
Comprehensive consideration of HIV-related disparities illuminates macro-level 
(e.g. race and gender), mezzo-level (e.g. interpersonal relationships), and micro-level risk 
factors (e.g. individual health behaviors; Berkman, Glass, Brissette, & Seeman, 2000). At 
85 
 
the macro level, African-Americans are often subjected to institutional racism, which 
predicts differential access to good and services on the basis of race (Jones, 2000). 
Institutional racism has predicated less medical care access among African-American 
PLHIV. Moreover, due to cultural and communication barriers between patients and 
providers, even when care is accessed, African-American PLHIV receive inferior care 
compared to other races (Randall & Randall, 1993; Jones, 2000; Hall, An, Hutchinson, & 
Sansom, 2008; CDC, 2012). These disparities are seen in conditions distinct from, yet co-
morbid with HIV, including mental illness, cancer, cardiovascular disease, and chronic 
pain (Randall & Randall, 1993;Agency for Healthcare Research and Quality [AHRQ], 
2012; CDC, 2012). 
Both African-American race, and female sex, correlate with higher risk of HIV-
related burden (AHRQ, 2012; CDC, 2012; Prejean et al., 2011). Thus, African-American 
women represent the PLHIV most at risk for non-adherence to ART, detectable viral load, 
and faster progression to AIDS (Turner, Laine, Cosler, & Hauck, 2003; Wyatt, 2002; 
CDC, 2012; Prejean et al., 2011; AHRQ, 2012). Reasons for these disparities include 
more experiences of HIV stigma, lower perceived social support, and competing 
(caregiving) priorities that interfere with medical adherence, such as having an HIV-
positive significant other for whom they provide care (Edwards, 2006; Knowlton et al., 
2011; Office of Women’s Health, 2012). More research is needed to disentangle the 
multi-level complexities between race, gender, and other correlates of HIV-related 
outcomes.  
Barriers to viral suppression among PLHIV: co-morbidities 
Compared to the general population, PLHIV experience higher rates of several 
co-morbidities which impede viral suppression (Undetectable viral load [UVL]; Kaaya et 
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al., 2013). First, depression is at least twice as prevalent among PLHIV, as compared to 
non-infected individuals (Maj, Janssen, Starace, Zaudig, & Satz, 1994; Kaaya et al., 
2013; Owe-Larsson, Sall, Salamon, & Allgulander, 2009). Compared to men, adult 
women are more likely to be diagnosed with serious mental illnesses, which include 
major depression, bipolar disorder, post-traumatic stress disorder (PTSD), and 
schizophrenia (SAMHSA, 2013; Novak, Colpe, Barker, & Gfroerer, 2010). Women are 
also less likely to achieve UVL than men, with larger disparities between men and 
women seen among African-Americans (Turner et al., 2003; CDC, 2012; Prejean et al., 
2011).  
Similarly, mental illness and substance use often co-occur. Hartz and colleagues 
(2014) found that those with severe mental illnesses were between three and five times 
more likely to engage in substance use. Among PLHIV, between 2004 and 2007, nearly 
sixty percent of persons who inject drugs (PWID) who were newly HIV-positive were 
African-American, and up to thirty percent of non-injection users are PLHIV (CDC, 
2012). Adherence to ART is the single best predictor of achieving UVL; therefore UVL 
often serves as a proxy for measuring ART adherence (Chesney, 2006; Mannheimer, 
Friedland, Matts, Child, & Chesney, 2002; Howard et al., 2002; Paterson et al., 2000; 
DiMatteo, Giordani, Lepper, & Croghan, 2002). However, a further complication in 
achieving UVL is that medications used to treat mental illness and/or substance use may 
interact with ART regimens and reduce their effectiveness (Zea, Reisen, Poppen, Bianchi, 
& Echeverry, 2005; Li, Ji, Ding, Tian, & Lee, 2012).  
Finally, substance use, mental illness, and HIV are all factors which may create 
tension in the PLHIV’ social environment, resulting in familial conflict. Familial conflict 
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refers to disagreements between family members, often immediate family who are same 
household residents, which can be either acute or chronic (Dunbar, 1990; Chesney & 
Folkman, 1994; Feaster et al., 2010).  Literature on familial conflict suggests that HIV 
diagnosis represents a chronic stressor, which may reinforce substance use and/or mental 
illness (Semple et al., 1997; Chesney & Folkman, 1994; Zea, et al., 2005; Li, et. al, 2012). 
Facilitators of viral suppression among PLHIV: social support 
Research suggests that social support is predictive of health behaviors (Glass, 
Perrin, Campbell, & Soeken, 2007; Marmot, 2006; Robertson, 2006; Knowlton et al., 
2011; Edwards, 2006; Parsons et al., 2006; Strine, Chapman, Balluz, & Mokdad, 2008). 
Social support generally refers to perceived and/or enacted instrumental, informational, 
or emotional support (Eaton, Flisher, & Aarø, 2003; Carrieri et al., 2003; Burke & 
Dunbar-Jacob, 1995; Coker, Watkins, Smith, & Brandt, 2003). Within the context of HIV, 
social support is often informal care provided by family members or main partners, and 
includes vital transportation to medical visits and management of ART regimens 
(Knowlton & Latkin, 2007; Jones, 2000; Kalichman, Cherry, & Brown, 1999; Baker, 
Kochan, Dixon, Heather, & Wodak, 1994; Edwards, 2006). A previous study found 
informal care correlated with ART adherence among male PLHIV, but only if they   
reciprocated, or mutually exchanged, support to their caregivers (Knowlton et al., 2011). 
Research suggests that social support, specifically health-related support and 
reciprocity, may facilitate PLHIV’ achievement of UVL (Edwards, 2006; Tucker et al., 
2003; Knowlton et al., 2011; Mosack, & Petroll, 2009). African-American PLHIV are 
more likely than other racial/ethnic groups to report informal care receipt (Pearlin, 
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Semple, & Turner, 1988; Chander, Himelhoch, & Moore, 2006; Knowlton et al., 2011). 
However, they are still more likely than other racial groups to have low ART adherence, 
and detectable viral loads. The same trend is seen with women PLHIV, such that they 
report higher levels of social support in general, yet more ART non-adherence, and viral 
non-suppression than men (Kalichman & Rompa, 2003; Vitiello et al., 2003). Therefore, 
differentiating types and amounts of social support and informal care is necessary to 
understanding their role in PLHIVs’ ART adherence, and their facilitation of viral 
suppression (Wagner & Rabkin, 2000; Carrieri et al., 2003). 
Purpose 
In sum, African-American PLHIV are at highest risk for negative HIV outcomes 
such as detectable viral load. Moreover, evidence suggests risks and protective factors of 
UVL may differ between men and women PLHIV. The purpose of this study was to 
identify correlates of viral suppression among predominantly low-income, African-
American injection drug-using PLHIV. Specifically, the study sought to: (a) identify 
correlates of viral suppression among these individuals; and (b) assess sex differences in 
the relationship between these correlates and UVL. Findings have implications for 
interventions to improve health outcomes among disadvantaged PLHIV.  
METHODS 
Procedure 
Data were from baseline of the BEACON study, which examined social factors 
associated with health outcomes among disadvantaged PLHIV (N=383). Participants 
(Indexes) were former and/or current persons who inject drugs residing in Baltimore. 
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Inclusion criteria included being: (a) adult; (b) HIV-positive; (c) on antiretroviral therapy 
(ART); (d) a Baltimore City resident; (e) a current or former injection drug user; and (f) 
willing to invite one’s main supportive tie(s) to participate in the study. Participants were 
recruited through an HIV clinic and street outreach. The study was approved by the Johns 
Hopkins Bloomberg School of Public Health Institutional Review Board. 
Measures                        
Dependent variable 
Viral suppression was defined as <40 copies per mL, as measured by the Roche  
Cobas Amplicor (Schumacher et al., 2007). Viral load was dichotomized, where 0 = 
detectable viral load, and 1 = undetectable viral load (UVL). 
Independent variables 
Predictor variables included active substance use, mental illnesses diagnoses,  
familial conflict, patient-provider communication, and social support (e.g. main supporter 
relationship, religious activity, health-related support, and support reciprocity). Active 
substance use was coded as use of opiates, marijuana, heroin, cocaine or crack, 
hallucinogens, and/or prescription drug use in the past month, where  0 = no active 
substance use, 1 = 1 to 2 substances used, and 2 = 3 or more substances. Mental illness 
was coded as having ever been diagnosed by a doctor with major depression, bipolar 
disorder, anxiety or post-traumatic stress disorder (PTSD), schizophrenia, and/or any 
other psychiatric condition, where 0 = no mental illness diagnoses, 1 = 1 to 2 diagnoses, 
and 2 = 3 or more diagnoses.         
 Familial conflict was coded as family members rarely discussing problems, 
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problem-solving together, and/or show caring for one another, where 0 = low familial 
conflict, 1 = moderate familial conflict, and 2 = frequent familial conflict. Familial 
conflict questions were based on the Conflict Tactics Scale, which assesses constructs of 
intra-family aggression, violence, and conflict resolution (Straus, 1979). Patient-provider 
communication was assessed by a ten-item scale based on the Engagement with 
Healthcare Provider Scale (Bakken et al., 2000). These items included “My doctor 
involves me in decisions”; and “My doctor respects my choices.” Responses were on 4-
point Likert scale, ranging from “Never” to “Always”. Responses were dichotomized at 
the median, where 0 = low patient/provider communication and1 = high patient-provider 
communication (MacCallum, Zhang, Preacher, & Rucker, 2002).  
Main supporter relationship to Indexes was coded as 0 = other relationship/or no 
main supporter identified, 1 = main partner, and 2 = kin. Religious activity 
conceptualized as a dimension of organizational support, and was assessed by “How 
often do you go to religious services?” Responses were on a 6-point Likert scale, from 
“Never” to “More than once a week”. Categories trichotomized at the tertiles, such that 0 
= low attendance, 1 = moderate attendance, 2 = frequent attendance (Fong, 2014). 
Health-related support refers to support that Indexes have which assists them in 
engagement in health-related behaviors. Items were based on the Arizona Social Support 
Inventory (Barrera, Jr. & Gottlieb, 1981), and included “In the last year, has anyone gone 
with you to a doctor's appointment or to the ER to get medical care?” Responses were 
dichotomized at the median, where 0 = low health-related support, and 1 = high health-
related support (MacCallum et al., 2002). 
Support reciprocity was assessed with items based on the scale by Pearlin, Mullan,  
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Aneshensel, and Wardlaw (1994), which assessed activities that Indexes reported 
providing to their main supporters in the past 12 months. The items included “How much 
have you helped your main supporter around the house in the past year?”; and “How 
much have you expressed affection and appreciation for your main supporter in the past 
year?” Participants’ responses were on a 3-point Likert scale, ranging from “None” to “A 
lot”. Responses were trichotomized at the tertiles, where 0 = low reciprocity, 1 = medium 
reciprocity, and 2 = high reciprocity (MacCullum et al., 2002).  
Physical functioning and educational attainment were included as 
sociodemographic control variables. Physical functioning was assessed by a ten-item 
scale based on the Medical Outcomes Study Physical Functioning Measure (McDowell & 
Newell, 1996). These items included “How much does your health affect your ability to 
bend, lift, or squat down?”; and “How much does your health affect your ability to eat, 
dress, or bathe?” Responses were trichotomized at the tertiles, where 0 = low physical 
functioning, 1 = moderate physical functioning, and 2 = high physical functioning (Fong, 
2014). Educational attainment was assessed by a single item, “What is the highest level 
of education you've had?” Responses were collapsed into categories, where 0 = 8th grade 
or less, 1 = some high school, 2 = high school diploma or GED, 3 = some college or 
above. All analyses were conducted separately by sex due to evidentiary support which 
suggests that correlates of interest may function differently by gender (CDC, 2012; 
AHRQ, 2012). Sex was assessed by a single item, and coded 1 = males, and 2 = females.  
Data analyses 
Univariate frequencies were generated for the dependent and independent  
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variables, on the total sample (N=383) and also separately by sex (male/female). Next, 
unadjusted incidence rate ratios were calculated. Variables marginally significant at the 
bivariate level (p<.10; Gordon, 2012), in at least one group, were entered into a 
multivariate Poisson regression, to regress UVL on correlates separately by sex. Poisson 
regression is appropriate for binary outcomes for non-rare events. Robust standard errors 
accounted for heteroskedasticity (inconstant variation; Long, 1997). The same model was 
run on both groups. Regression analyses were only run with African-American 
participants, due to lack of statistical variation in race, and theoretical significance. 
Educational attainment and physical functioning were retained as control variables in the 
final model, despite non-significance. Finally, post-hoc analyses were conducted to test 
for potential interactions between control variables and social support variables, and 
substance use, mental illness, and/or familial conflict. Analyses were conducted on 
complete cases only, due to acceptable missingness (up to 10%; Bennett, 2001). All 
analyses were conducted in STATA Version 11.2 SE (StataCorp, 2009). 
RESULTS 
Descriptive statistics 
Table 4.1 reports demographic characteristics of all study participants (N=383). 
Participants were predominantly male (61.4%), African-American (91.6%), with a 
monthly income of $500-$999 (57.2%). The vast majority of participants also had a usual 
healthcare provider at a hospital-based outpatient HIV clinic (70.5%), were heterosexual 
(85.4%), and had a lifetime history of incarceration (84.1%). Regarding sex differences, 
females were less likely than males to have at least a high school education (32.4% vs. 
41.3% respectively; p<.10). Females were also less likely than males to report good 
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health in the past 6 months (29.1% vs. 40%, respectively; p<.05), and to have an 
undetectable viral load (66.4% versus 64.9%, respectively; non-significant). Females 
were also younger than males on average (45.6 years vs. 49.6 years, respectively; p<.001).  
Poisson regression results: African-American males 
In adjusted analyses, males with 1 to 2 mental illness diagnoses had 1.3 times the  
likelihood of UVL as males with no mental illness diagnoses (Adjusted Incidence Rate 
Ratio [AIR] = 1.28; 95% Confidence Interval [95% CI] = 1.00, 1.63). Similarly, males 
with high rates of familial conflict had 1.4 times the likelihood of UVL, as males with no 
familial conflict (AIR = 1.48; 0.98, 1.91). Next, males who had attended or completed 
college each had 1.9 times the likelihood of UVL, as compared to males who completed 
8th grade or less (AIR = 1.89; 95% CI = 0.94, 3.79).  
Results also indicated that males who reported moderate or high physical 
functioning had 1.4 times the probability of UVL, as compared to males with low 
physical functioning (95% CI = 1.07, 1.77). Males who reported moderate religious 
activity had 1.3 times the likelihood of UVL as males who reported low religious activity 
(AIR = 1.26; 95% CI = 0.98, 1.62). Finally, males who reported having a main partner or 
kin as their main supporter had 1.3 to 1.4 times the likelihood of UVL, as males who 
reported some other or no main supporter (p<.05 and p<.10, respectively). 
Poisson regression results: African-American females 
In the adjusted analyses, results indicated that females who were actively using 1-
2 substances had a 30% lower probability of UVL, as compared to females were not 
actively using substances (Table 4.2; Adjusted Incidence Rate Ratio [AIR] = 0.73; 95% 
Confidence Interval [95% CI] = 0.52, 1.03). Results also indicated that females with 1-2 
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mental illness diagnoses had a 40% higher probability of UVL, as compared to females 
with no mental illness diagnoses (AOR = 1.39; 95% CI = 0.99, 1.94). Though marginally 
significant, females with moderate familial conflict had 50% higher probability of UVL 
as females with no familial conflict (AIR = 1.37; 95% CI = 1.08, 2.04). Next, females 
who attended religious activities moderately or frequently had 1.4 to 1.5 times the 
likelihood of UVL as females who rarely attended religious activities (p<.10 and p<.05, 
respectively). Females who had either a kin or partner main supporter had 1.5 to 1.6 times 
the likelihood  of UVL, compared to females with another main supporter (p<.05).  
Females who reciprocated support often to their main supporters had one-third the 
likelihood of UVL as compared to females who rarely reciprocated support (AIR = 0.69; 
95% CI = 0.47, 1.01). This is in contrast to previous literature, which suggests that higher 
reciprocity would be associated with higher likelihood of UVL (Knowlton et al., 2011). 
Finally, females who reported high doctor-patient communication had nearly 1.3 times 
the probability of UVL, as females who reported low doctor-patient communication (AIR 
= 1.35; 95% CI = 1.06, 1.72).  
Post-hoc analyses 
Marginal effects of the predicted probability of UVL were calculated holding the 
other covariates at their means to assess the relationship between social support and viral 
suppression among African-American Indexes (StataCorp, 2009). Figure 4.1 depicts the 
marginal effects UVL by sex, as a function of all four social support variables, (e.g. main 
supporter relationship, religious activity, health-related support and support reciprocity; 
N=321). Compared to females, males had higher probability of UVL when engaging in 
moderate religious activity (0.75 vs. 0.65, respectively; non-significant), as well as 
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frequent religious activity (0.59 vs. 0.47, respectively; non-significant). For both males 
and females, probability of UVL was higher when main supporters were main partners. 
Finally, neither frequent health-related support nor frequent support reciprocity were 
protective, as both correlated with lower probability of UVL for males and females.  
DISCUSSION 
It is evident from study results that there were significant gender differences in 
the effects of substance use, mental illness, and social support on viral suppression. This 
is intuitive, considering the plethora of research which suggests that men and women 
differ in their access of HIV health services, risk for HIV infection. Findings suggest that 
sex differences may also exist in utilization of informal caregivers and social support 
networks to engage in health behaviors among PLHIV. Our results revealed that in this 
PLHIV population, contrary to expectation, social support was often associated with 
lower likelihood of viral suppression (Table 4.2). Specific mechanisms which explain 
this, however, may differ by gender (Figure 4.1).  
First, findings indicated reciprocating support was negatively associated with 
UVL for females, such that high reciprocity was associated with only one-third the 
likelihood of undetectable viral load, as compared to females reporting low reciprocity to 
caregivers. It is plausible that female care recipients were more likely to give support 
rather than receive support in their relationships, and therefore reciprocated support to 
their main partners, which is thereby detrimental to their ART outcomes. Similarly, 
higher rates of health-related support predicted lower likelihood of UVL among females. 
One reason for this may be that accessing health-related support is non-normative for 
women, as they are more likely than men to report providing informal care, rather than  
receiving it (Squires et al., 2011).  
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Recent findings by Drabe et al. (2014) suggest that female patients’ depression 
and quality of life were much more strongly associated with their male partners’ 
resources, as compared to males, for whom there was a very low association of 
depression and quality of life with their female partners. While not statistically 
significant, African-American female Indexes were more likely than African-American 
male Indexes to report that their main supporter was their main partner (36% vs. 28%, 
respectively; p<.05), and also less likely to achieve viral suppression than males (67.1% 
vs. 65.9%, non-significant). It is possible that communication is complicated when male 
main partners provide care, and that communication may be more important to female 
PLHIV. Communication in the healthcare setting also appears more important to females 
than males as high patient-provider communication was associated with a 35% increase 
in likelihood of UVL among females. Similar findings on this association were also 
found by Bakken et al. (2000) and Schneider, Kaplan, Greenfield, Li, and Wilson (2004). 
Finally, a few similarities can be identified between males and females’ correlates 
of viral suppression. First, physical health and mental health are quality of life measures 
which are often included in analyses of HIV-related outcomes. In the present study, these 
factors were statistically significant correlates of increased likelihood of viral suppression 
among males (physical health and mental illness), and females (mental illness). Among 
males, physical functioning was predictive of viral suppression among males, as males 
who reported moderate to high physical function had 1.3 times the likelihood of UVL, as 
males who reported low physical functioning. Also, for both sexes, it was protective to 
have main supporters who were either main supporters or kin. Therefore, while the 
communication barriers are great, healthcare providers should include these individuals 
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in treatment recommendations for PLHIV. Finally, religious activity was protective for 
both males and females, which supports previous findings which suggest that religiosity 
is a common coping mechanism among PLHIV (Ironson, Stuetzle, & Fletcher, 2006).   
Post-hoc analyses revealed that two-thirds of males achieved viral suppression  
(67.1%). Among these virally-suppressed males, nearly one-third reported low physical  
functioning (27.9%). Therefore, future research should consider health-related physical  
functioning and quality of life, and UVL outcomes, such that interventions with men and 
women PLHIV should account for improving relevant dimensions of health-related 
quality of life. Next, religious activity was associated with viral suppression for both 
sexes, while the following were associated with lower viral suppression: higher health-
related support, and reciprocal support (still, not all results were statistically significant).  
Limitations 
Several limitations exist in consideration of study findings. First, viral suppression 
as a measure of ART adherence relies solely on biomarker data, without consideration of 
relevant factors such as pain symptomology, adverse reactions to ART, or quality of life. 
Second, the data were cross-sectional, which prevents the ascertainment of fluctuations 
over time in the variables of interest. Third, other correlates may have fit the data better, 
such as adherence to medications to treat disorders such as mental illnesses, which were 
common in this study population. Fourth, running analyses separately by sex among may 
have led to a loss of statistical power to detect significant findings. Fifth, gender and sex 
were considered equivalent both theoretically and analytically, which may be simplistic 
given that sex is biological while gender is sociocultural and more subjective. Finally, 
participants were predominantly African-American, middle-aged, persons who inject 
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drugs, enrolled in medical care and on ART. Thus, while this population is often 
underrepresented in research, these characteristics limit the generalizability of findings.  
Conclusions 
Despite these limitations, results support the need for further exploration of social  
factors in the health outcomes of PLHIV. Specifically among the African-American 
participants, attention should be paid their close relationships outside of the care 
recipient-caregiver dyad, in terms of explaining greater variations in the role of health-
related support in viral suppression and other HIV outcomes. Social support and informal 
caregiving ties have been theorized to affect care recipients’ chronic illness outcomes, 
and ultimately, achievement of viral suppression (Strine, Chapman, Balluz, & Mokdad, 
2008). This study is one of few which examined sex differences in several dimensions of 
enacted social support concurrently, including support reciprocity and the nature of the 
relationship between main supporters and care recipients (Knowlton et al., 2011). 
Therefore, interventions to improve ART outcomes among PLHIV should address 
substance use and mental illness, and stressors such as familial conflict. 
Another important contribution of this study was the examination of purported 
facilitators of viral suppression (e.g. social support), and barriers (e.g. substance use). 
Future studies should also examine these factors to make treatment recommendations. 
Results suggest the following impact viral suppression, among males and females: 1) 
physical and/or mental health; 2) active substance use; and 3) dynamics of the caregiver-
care recipient dyad. This lends support for programs to improve caregiver that focus on 
both individual and dyad-level factors. Comprehensive interventions could directly  
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Table 4.1. Demographic characteristics of all participants by sex (N=383) 
Characteristic              Males (N=235)        Females (N=148)                   Total                                                        
N(%) or Mean (SD)    N(%) or Mean (SD)  N(%) or Mean (SD) 
Race    
  African-American/Black 219  (93.2) 132 (89.2) 351   (91.6) 
  White 12      (5.1) 15   (10.1) 27       (7.0) 
  Other 4        (1.7) 1       (0.7) 5         (1.4) 
Education    
  8th grade or less 15      (6.4) 11     (7.4) 26       (6.8) 
  Some high school 81    (34.4) 69   (46.6) 150   (39.2) 
  High school diploma/GED 97    (41.3) 48   (32.4) 145   (37.9) 
  Some college/above 42    (17.9) 20     (3.5) 62     (16.1) 
Active substance use    
  0 substances 130  (55.3) 79   (53.4) 209   (54.6) 
  1-2 substances 81    (34.5) 46   (31.1) 127   (33.2) 
  3 or more substances 24    (10.2) 23   (15.5) 47     (12.2) 
Mental illness    
  0 diagnoses 90    (38.3) 32   (21.6) 122   (31.9) 
  1-2 diagnoses 90    (38.3) 69   (46.6) 159   (41.5) 
  3 or more diagnoses 55    (23.4) 47   (31.8) 102   (26.6) 
Familial conflict    
  None 
  Low 
144  (61.3) 
28    (11.9) 
98   (66.2) 
16   (10.8) 
242   (63.2) 
44     (11.5) 
  Medium 
  High 
45    (19.1) 
18      (7.7) 
28   (18.9) 
6       (4.1) 
73     (19.1) 
24       (6.3) 
 Religious activity    
  Low 46    (19.6) 25   (16.9) 71     (18.5) 
  Medium 104  (44.3) 68   (45.9) 172   (44.9) 
  High 85    (36.1) 55   (37.2) 140   (36.5) 
Physical functioning    
  Low 78    (33.2) 57   (38.5) 135   (35.2) 
  Medium 69    (29.4) 47   (31.8) 116   (30.3) 
  High 88    (37.4) 44   (29.8) 132   (34.5) 
Main supporter type    
  Other 65    (27.7) 24   (16.2) 89     (23.3) 
  Main partner 66    (28.0) 55   (37.2) 121   (31.6) 
  Kin 
Dr-Pat communication 
104  (44.3) 69   (46.6) 173   (45.2) 
  Low 138  (60.3) 77   (53.5) 215   (57.6) 
  High 91    (39.7) 67   (46.5) 158   (42.4) 
Support reciprocity    
  Low 76    (34.7) 31   (22.1) 107   (29.8) 
  Medium 
  High 
65    (29.7) 
78    (35.6) 
61   (43.6) 
48   (34.3) 
126   (35.1) 
126   (35.1) 
Health-related support    
  Low 141  (60.0) 59   (39.9) 200   (52.2) 
  High 94    (40.0) 89   (60.1) 183   (47.8) 
Viral suppression 
Age (years) 
156  (66.4) 
49.6   (5.7) 
96   (64.9) 
45.9  (6.4) 
252   (65.8) 
48.2    (6.3) 
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Table 4.2. Correlates of viral suppression by sex among African-American Indexes  
 
                                 Males (N=199)                                                Females (N=122)              
             IRRa           CIc           AIRb            CI            IRR              CI             AIR              CI  
             ____       ________      ____       ________      ____        ________       ____       ________      
Active substance use         
 1-2 substances 0.87 (0.70, 1.08) 0.88 (0.70, 1.09) 0.69* (0.51, 0.94) 0.73ǂ (0.52, 1.03) 
 3 or more substances 0.99 (0.74, 1.33) 0.91 (0.65, 1.28) 0.61* (0.37, 1.00) 0.71 (0.45, 1.14) 
 (ref: 0 substances) 1.00  1.00  1.00  1.00  
         
Mental illness         
 1-2 diagnoses 1.16 (0.94, 1.44) 1.28* (1.00, 1.63) 1.22 (0.87, 1.72) 1.39ǂ (0.99, 1.94) 
 3 or more diagnoses 1.12 (0.86, 1.45) 1.24 (0.98, 1.91) 1.10 (0.75, 1.62) 1.38 (0.92, 2.08) 
 (ref: 0 diagnoses) 1.00  1.00  1.00  1.00  













































 Some high school 1.37 (0.74, 2.53) 1.64 (0.82, 3.29) 1.72 (0.69, 4.30) 2.05 (0.80, 5.30) 
 High school/GED 1.54 (0.84, 2.82) 1.75 (0.88, 3.48) 1.74 (0.69, 4.37) 2.03 (0.76, 5.39) 
 Some college/above 
 (ref: 8th grade/less) 
1.57 
1.00 
(0.85, 2.92) 1.89ǂ 
1.00 
(0.94, 3.79) 2.25ǂ 
1.00 
(0.90, 5.63) 2.60* 
1.00 
(1.00, 6.77) 
        
 
Physical function         
 Med physical func 1.31* (1.02, 1.69) 1.38* (1.07, 1.77) 1.00 (0.72, 1.39) 0.94 (0.69, 1.29) 
 High physical func 1.28* (1.00, 1.63) 1.27ǂ (0.99, 1.64) 1.21 (0.91, 1.61) 1.04 (0.77, 1.41) 










Religious activity         
 Medium  1.29* (1.04, 1.61) 1.26ǂ (0.98, 1.62) 1.31 (0.90, 1.92) 1.38ǂ (0.96, 1.98) 
 High 
 (ref: Low) 
1.05 
1.00 
(0.82, 1.35) 0.98 
1.00 
(0.75, 1.29) 1.46* 
1.00 
(1.03, 2.08) 1.45* 
1.00 
(1.01, 2.08) 
         
Main support rel’n 
 Partner 
 Kin 
































Support reciprocity  
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 High 
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Objective: Extant research suggests that substance use, mental illness, and familial 
conflict are associated with negative health outcomes among persons living with HIV 
(PLHIV). Research also suggests that among African-Americans, women may have 
higher prevalence of these factors, and consequently, lower likelihood of HIV medical 
adherence.  Therefore, the proposed study explored these factors as a potential latent 
syndemic among persons who inject drugs (PWID) PLHIV. Methods: Data were from 
baseline of the BEACON study of adult former or current PWID PLHIV on ART, living 
in Baltimore, Maryland. Latent class analyses (LCA) identified classes representing 
syndemic risk among African-American participants. LCA regression assessed class 
membership as a function of sex and of HIV medical adherence, defined as viral 
suppression and optimal acute services utilization (no ER visits or hospitalizations in the 
past 6 months). Results: Participants were 92% African-American and 61% male 
(N=383). Fifty-seven percent of participants earned $500-999 monthly, and average age 
was 48.2 years. Based on LCA, 9% of participants had high substance use/mental illness 
prevalence (Class 4); 23% had moderate levels of all 3 factors (Class 3); 25% had high 
mental illness (Class 2); 43% had moderate substance use/mental illness (Class 1; 
N=331). Compared to Class 4, females had 79% lower odds of being in Class 1 or Class 3 
(p<.01). Compared to Class 4, viral suppression odds were 4.6 times higher in Classes 2 
or 3 (p<.05). Discussion: Odds of HIV medical adherence were 2 to 4 times higher in 
Classes 1-3 as compared to Class 4. Moreover, Class 4 was overwhelmingly female 
(68%). While not statistically significant, African-American females were less likely than 
males to achieve both viral suppression (67.1% vs. 65.9%, non-significant) and optimal 
acute care utilization (OAU; 53.9% vs. 48.5%, non-significant; N=351). Interventions are 
needed tailored to African-American PWID PLHIV females, as they are most vulnerable 
to HIV medical non-adherence and other negative health outcomes. Findings suggest a 
need for a comprehensive syndemic approach to HIV treatment and adherence 
interventions, rather than addressing singular vulnerabilities.  
  





Thirty-five years into the HIV pandemic, advancements have been made in the 
availability of antiretroviral therapy (ART), reduction of AIDS-related mortality, and 
awareness of HIV risk among at-risk groups such as men who have sex with men 
(MSM), and persons who inject drugs (PWID). During the same period, the public’s 
perceptions and demographic characteristics of people living with HIV/AIDS (PLHIV) 
have also changed.  Once viewed as a “gay man’s disease”, the new faces of PLHIV, are 
less White-American MSM, and more racial/ethnic minorities and women (Towner, 
2008; Centers for Disease Control and Prevention [CDC], 2012). No longer a death 
sentence, many PLHIV are aging well into older adulthood, though with more co-
morbidities than their non-PLHIV counterparts (CDC, 2012; Havlik et al., 2011).  
 Common HIV co-morbidities, irrespective of age, include viral Hepatitis and 
tuberculosis, which may complicate the treatment of HIV with ART, due to issues such 
as multi-drug resistance (CDC, 2012). However, some co-morbidities of HIV stem from 
behavioral roots, rather than biological causes, and may also complicate HIV-related 
health behaviors. These common co-occurrences include substance use, mental illness, 
and interpersonal violence (Kaaya et al., 2013). Irrespective of etiology, when biologic or 
behavioral occurrences co-present with HIV, and interact in both etiology and prognosis, 
they comprise a syndemic (Singer, 1996; Singer & Clair, 2003; Goodman & Leatherman, 
2001).  
Syndemic Theory and HIV-related disparities 
 Syndemic Theory refers to two or more co-morbid conditions, which interact 
synergistically, and collectively increase disease burden in a given population (Singer, 
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1996; Singer & Clair, 2003). As noted by Milstein (2001), syndemics result when health-
related problems cluster together either by person, place, or time. The resulting problems 
have nested or overlapping relationships; therefore, prevention of a syndemic requires 
prevention and control of each disease, as well as of the forces that cluster them together 
(Milstein, 2001; Singer & Clair, 2003). Singer (1996) first proposed the ‘SAVA’ 
syndemic, referring to concurrent and mutually reinforcing substance abuse, violence, 
and HIV infection among low-income and racial/ethnic minority women. A recent study 
by Illangasekare et al (2013) found that compared to women who with no SAVA 
Syndemic factors, women who had experienced all three factors were significantly more 
likely to report depressive symptoms.  
 Since the appearance of the SAVA Syndemic in the public health literature, several 
other syndemics have been proposed and extensively studied to understand HIV-related 
disparities in infection rates as well as risk behaviors. Meyer et al (2011) reviewed 45 
studies related to the SAVA Syndemic. Their review of the literature found that the SAVA 
Syndemic relationship relationship among substance use, violence, and HIV was 
associated with increased engagement in HIV-risk behaviors, mental illness, and lower 
rates of HIV medical adherence among those infected (Meyer et al., 2011). Their results 
also noted that individuals with a history in the criminal justice system, irrespective of 
gender, (i.e., substance use, violence, and HIV infection), had increased rates of violence 
and drug use which often preceded their incarceration (Meyer et al., 2011).    
Related syndemics have also been identified in Hispanic/Latino populations. 
Gonzalez-Guarda et al (2010) demonstrated that Hispanic/Latino-American men are 
disproportionately affected by substance abuse, perpetration of intimate partner violence, 
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and HIV risk. A follow up study in 2011 found a similar syndemic present in 
Hispanic/Latina-American women, with the additional burden of depressive symptoms, 
intimate partner violence victimization, and with correlation between the syndemic 
factors and increased socioeconomic disadvantage (Gonzalez-Guarda et al., 2011). 
Horner and Nassiri (2013) posit another syndemic may be present among 
Hispanic/Latinos in the Dominican Republic, comprised of neighborhood effects (e.g. 
violence), malnutrition (e.g. lack of nutritional food sources), and HIV/AIDS infection 
(e.g. social inequalities and lack of medical care predisposing individuals to HIV).  
 Much like racial/ethnic minorities and/or women, MSM are at disparate risk of 
HIV and ill-health outcomes. An MSM syndemic involving the additivity of substance 
abuse, emotional distress, adult victimization, and history of sexual abuse, irrespective of 
race, has been extensively described (Stall et al., 2003; Mustanski et al., 2007; Kurtz, 
2008; Starks et al., 2014). Halkitis et al (2013) found that syndemic mental health burden 
and drug use were associated with unprotected sex, and Halkitis et al (2012) found these 
syndemic factors present among older MSM PLHIV. Finally, due to victimization and 
marginalization and increased rates of commercial sex work, transgender individuals 
experiencing syndemic threats of mental illness, violence, and substance abuse, are 
subsequently at increased risk of unprotected sex and HIV risk, and may experience more 
stigmatization than MSM and other PLHIV (Brennan et al., 2012; DeSantis 2009; 
Operario & Nemoto, 2010). 
Finally, several commonalities exist among the various HIV-related syndemics. 
First, nearly all of the syndemics that have been investigated posit that substance use and 
violence predict increased HIV risk, and primarily occur in low-income and racial/ethnic 
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minority populations (Senn et al., 2010). Next, among women and MSM, mental illness 
is a common syndemic factor as well (Meyer et al., 2011). Moreover, the majority of 
syndemic models that have been investigated conceptualize women as having greater risk 
of factors precipitating HIV infection – including higher prevalence of intimate partner 
violence victimization, mental illnesses, and socioeconomic disadvantange. Lastly, nearly 
all of these syndemics examine primary HIV prevention by focusing on HIV-related risk 
behavior and HIV infection outcomes, in lieu of tertiary prevention of HIV-related 
burden among PLHIV. 
A new framework – The SUMIC Syndemic and African-American PLHIV 
Disparities in HIV-related outcomes due to race and gender are well documented, 
such that African-Americans and women bear the largest burden of the disease (CDC, 
2012). Theoretical orientations such as Syndemic Theory help to characterize the 
hypothesis that those most vulnerable to these dispairities are African-Americans 
experiencing syndemic health threats from mental illness, substance use, and familial 
conflict. The ‘SUMIC’ Syndemic (e.g. Substance Use, Mental Illness, and Familial 
Conflict), places African-Americans, and particularly African-American women, at high 
risk of death and/or disability related to HIV/AIDS in the United States. Among African-
American PLHIV within the SUMIC Syndemic, temporal patterns in risk may vary. 
First, persons who inject drugs are at increased risk of HIV infection compared to 
non-users, as injection drug use is a more efficient route of HIV transmission than 
unprotected sex (CDC, 2012). Mental illness often co-occurs with substance use, both of 
which may predict increased risk of negative HIV outcomes, from primary infection to 
ART non-adherence (Kaaya et al., 2013; Senn & Carey, 2008; Wyatt, 2002; Zierler & 
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Krieger, 1997). Consequently, many substance users report having been diagnosed and 
treated for depression, schizophrenia, manic depressive disorder, and other serious mental 
illness (Senn & Carey, 2008; Latkin et al., 2002; Johnson et al., 2008). Finally, familial 
conflict refers to verbal and/or physical abuse between kin members, which is often if 
chronic (Dunbar, 1990; Chesney & Folkman, 1994).  
Literature on familial conflict and HIV posits that an HIV diagnosis represents a 
chronic stressor, which may then trigger substance use and/or mental illness (Semple et 
al., 1997; Chesney & Folkman, 1994; Zea et al., 2005; Li et al., 2012). Consideration of 
familial conflict as a syndemic factor builds upon literature in the aforementioned SAVA 
Syndemic, which refers to intimate partner violence among women and HIV risk (Singer, 
1996). Extant literature posits that syndemic health threats such as mental illness, 
substance use, and intimate partner violence are associated with increased likelihood of 
HIV risk. However, few studies have examined the larger construct of familial conflict as 
a non-gender-specific health determinant, to inform tertiary prevention of HIV health 
complications (Minze et al., 2010; Sanders-Phillips, 2002; Jones, Beach, Forehand, & 
Foster, 2003).  
Purpose 
The dearth of theoretically-informed, tertiary HIV prevention programs geared 
towards African-Americans is a gap in the literature (Johnson et al., 2008; Gielen et al., 
2005; Tobin et al., 2011; McDaid & Hart, 2010). To date, only two studies have applied 
Syndemic Theory to assess the effects of syndemic factors on ART adherence (Blashill et 
al., 2014; Mizuno et al., 2014). Blashill et al (2014) found that syndemic effects of factors 
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including childhood abuse, current violence, and alcohol or substance abuse were 
associated with lower ART adherence. Additionally, Mizuno et al (2014) found that 
persons with four or more syndemic problems, were less likely to be virally suppressed 
than those with less syndemic problems. However, assessment of Syndemic Theory in a 
sample of all African-American PWID PLHIV, using latent class analyses, has not been 
conducted to our knowledge. Therefore, the purpose of the proposed research was to 
examine the presence and correlates of a potential latent syndemic in a cohort of African-
American PLHIV. Specifically, study aims were to: (a) assess active substance use, 
mental illness, and familial conflict as a potential latent syndemic; and (b) examine 
syndemic patterns as a function of HIV medical adherence and sex.  
Previous research suggests that, compared to African-American men, African-
American women have higher rates of mental illness, and lower rates of access to HIV 
care (Buseh & Stevens, 2008; Gullette et al., 2010). Thus, it was hypothesized that: 1) 
women comprise the individuals with the highest prevalence of the proposed SUMIC 
Syndemic; and 2) individuals with higher syndemic burden would have lower prevalence 
of HIV medical adherence than individuals with lower syndemic burden. This study was 
unique in examining tertiary prevention of HIV medical adherence, rather than primary 
prevention of HIV infection among African-Americans, to improve HIV health outcomes. 
METHODS 
Procedure 
Data were from the baseline survey of the Being Active and Connected 
(BEACON) study, which examined psychosocial factors associated with health outcomes 
and well-being among disadvantaged PLHIV. Study participants were HIV-positive 
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former and current persons who inject drugs residing in Baltimore City. Inclusion criteria 
were: (a) age of 18 years or older; (b) documented HIV seropositive status; (c) current or 
former injection drug use; (d) current use of ART regimen defined as use in the prior 30 
days; and (e) willingness to recruit at least one supportive partner to the study. All 
participants completed baseline and follow-up assessments. Serum viral load, CD4 count 
data, and toxicology tests were collected at baseline and 6 month visits for all participants. 
Participants were recruited through street outreach, community sampling, and targeted 
strategies. The Johns Hopkins Bloomberg School of Public Health Institutional Review 
Board approved the study. 
Measures                 
Dependent variable 
SUMIC Syndemic latent class membership was the outcome of interest. Latent 
class analyses (LCA) were conducted to identify unique patterns of behavioral risk. 
Therefore, the SUMIC Syndemic latent classes were participants’ most likely 
membership classes, based on posterior probability of endorsing items referring to 
Participants’ active substance use, mental illness diagnoses, and familial conflict (Ahn et 
al., 2008; Collins & Lanza, 2010). Active substance use was made up of six items, coded 
as use of opiates, marijuana, heroin, cocaine or crack, hallucinogens, and/or prescription 
drug use in the past month; each item was binary (coded 0 = no use and 1 = use in past 30 
days). Mental illness was made up of five items, coded as having ever been diagnosed by 
a doctor with major depression, bipolar disorder, anxiety or post-traumatic stress disorder 
(PTSD), schizophrenia, and/or any other psychiatric condition. Each item was binary 
(coded 0 = not diagnosed and 1 = ever diagnosed). Familial conflict was made up of three 
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items, coded as if current family members rarely discussing problems, problem-solving 
together, and/or show caring for one another. Each item was binary, where 0 = no 
conflict, and 1 = frequent conflict. Familial conflict questions were based on the Conflict 
Tactics Scale, which assesses constructs of intra-family aggression and conflict resolution 
(Straus, 1979). 
 Independent variables 
 HIV medical adherence was defined as level of optimal acute care utilization and 
HIV viral suppression. Optimal acute care utilization (OAU) was measured via a 
cumulative score of access to health care services and level of engagement in HIV 
medical services. This definition is based on The HIV Cost and Service Utilization Study 
(HCSUS), which defines optimal service utilization as prompt engagement in HIV care 
after diagnosis, minimization of acute care, and successful ART adherence (Fremont et 
al., 2007). Respondents reported numeric responses to the following: “In the past 6 
months, how many times have you gone to an emergency room (ER) for your health 
care?”, and “In the past 6 months, how many times were you admitted to a hospital, that 
means that you stayed there overnight?” Responses were summed and dichotomized at 
the median, where 0 = 1 or more ER visits and/or overnight hospitalizations in the last 6 
months (suboptimal acute care utilization), and 1 = 0 ER visits or overnight 
hospitalizations in the last 6 months (OAU; MacCallum et al., 2002). In the present study, 
participants were nearly all insured and enrolled in care, and therefore should have had 
less reason to access acute care services. Therefore, while informed by the HCSUS study, 
the outcome of interest OAU focused specifically on acute care, as opposed to other types 
of healthcare utilization.  
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 HIV viral suppression was defined as a viral load of 40 copies per milliliter (mL) 
or less, as measured by the Roche Cobas Amplicor viral load assay (Schumacher et al., 
2007). A dichotomous variable of viral suppression was constructed, where 0 = 
detectable viral load (greater than 40 copies/mL) and 1 = undetectable viral load (UVL), 
or viral suppression (less than 40 copies/mL). Finally, sex was a binary variable included 
in survey questionnaires, coded as 1= Males, and 2 = Females.  
Data analyses 
First, univariate statistics were calculated among the entire sample of participants 
(N=383). Relevant summary statistics were generated for: (a) demographic variables: sex, 
age, race, educational attainment, and monthly income; (b) substance use, mental illness, 
and familial conflict items; and (c) HIV medical adherence (viral suppression and optimal 
acute care utilization). Next, factor analyses were conducted to assess the factor structure 
and internal reliability of the items for each SUMIC Syndemic factor. A latent one-factor 
structure of the 6 binary active substance use items yielded acceptable fit (Chi-square [2] 
= 11.37; Degrees of freedom [df] = 9; Root Mean Square Error of Approximation 
[RMSEA] = 0.03; Comparative Fit Index [CFI] = 1.00; Rasch, 1980). A latent one-factor 
structure of the 5 binary mental illness items yielded acceptable fit (2 = 2.41; df = 5; 
RMSEA = 0.00; CFI = 1.00; Rasch, 1980).  
Factor analyses was conducted to account for a latent one-factor structure of the 3 
binary familial conflict items, which yielded acceptable fit (2 = 0.00; df = 0; RMSEA = 
0.00; CFI = 1.00; Rasch, 1980). Third, LCA was used as a data reduction technique by 
which to categorize individuals into their most likely class membership along the 
spectrum of the SUMIC Syndemic (e.g. non-observable latent variable, based on the 
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latent conditions of active substance use, mental illness, and familial conflict; Bastard et 
al., 2011; Ahn et al., 2008; Collins & Lanza, 2010). Fourth, the syndemic classes were 
regressed on the three relevant correlates: sex, viral suppression (UVL), and optimal 
acute care utilization (OAU). Comparisons were made about class membership as a 
function of sex and HIV medical adherence (e.g. UVL and OAU). Odds ratios were 
analyzed as an acceptable approximation of relative risk, given that the LCA outcome of 
interest, SUMIC Syndemic Class 4 was rare (less than 10%; McNutt et al., 2003).  
 LCA were run with solutions ranging from two classes to six classes with 
African-American Participants only (N=351). Analyses were conducted on complete 
cases only, due to acceptable missingness (less than 10%; Bennett, 2001). Both theory 
and fit statistics were utilized to select the best model for the data, including Akaike’s 
Information Criteria (AIC; Akaike, 1973). Descriptive analyses were run in Stata Version 
11.2 SE (StataCorp, 2009), and all latent factor analyses and LCA were run using MPlus 
Version 7.0 (Muthén & Muthén, 2011). 
RESULTS 
Descriptive statistics 
Table 5.1 reports demographic characteristics of all participants (N=383). 
Participants were predominantly African-American (91.6%), male (61.4%), and earned a 
monthly income between $500 to $999 (57.2%). Most participants had attended high 
school and/or had earned a high school diploma or GED (39.2% and 37.9%, non-
significant), and also had a history of ever being in jail or prison (84.1%). Half of 
participants achieved optimal acute care utilization (50.9%). Two-thirds achieved viral 
120 
 
suppression (65.8%). Mean age was 48.2 years. Among African-American participants 
only, cocaine/crack (33.7%) and heroin (20.8%) were the substances most frequently 
used (N=351; Table 5.2). Depression (59.5%) and bipolar disorder (33.1%) were the most 
common mental illness diagnoses. The most frequent familial conflicts were families 
rarely or never talking about problems (29.9%), and rarely or never problem-solving 
(28.2%).  
Class 1: Moderate Substance use/Mental illness  
 Individuals in Class 1 (43% of the sample population) were less likely than 
Classes 3 and 4 to report active use of all substances except prescription drug use (e.g, 
opiates, marijuana, heroin, cocaine, hallucinogens). Their active substance use was 
moderate, compared to Class 2 (higher rates) and/or Class 4 (lower rates). Class 1 
individuals were least likely of all class members to report a mental illness diagnosis, 
though nearly 30% had a depression diagnosis (p<.01). These individuals were least 
likely to endorse experiencing familial conflict, such that only 6.6% endorsed rarely or 
never talking about problems with their families (p<.01). Thus, Class 1 has the lowest 
burden of the SUMIC Syndemic, and were the sample majority (Table 5.3 and Figure 5.1).  
Class 2: High Mental illness  
 Individuals in Class 2 were the least likely of all class members to report active 
substance use (25% of sample population; Table 5.3). They also had the second lowest 
rates of familial conflict (12.4%; p<.05). However, these individuals reported the second 
highest rates of depression diagnoses (92.5%; p<.001) and the second-highest rates of 
anxiety/PTSD diagnoses (43%; p<.01). Additionally, over two-thirds of Class 2 
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individuals had been diagnosed with bipolar disorder (68.6%; p<.001). This class had low 
prevalence of active substance use and familial conflict overall; thus they have lower 
SUMIC Syndemic burden than both Classes 3 and 4 (Table 5.3 and Figure 5.1).  
Class 3: Moderate Substance use and Mental illness/High Familial conflict  
 Class 3 individuals had moderate to high rates of all SUMIC Syndemic factors 
(23% of sample; Table 5.3). These individuals reported the second-highest rates of active 
cocaine use (41.4%), marijuana use (21.8%), and heroin use (23.6%) out of all 4 classes. 
Nearly two-thirds of Class 3 individuals had a depression diagnosis (p<.001), and one-
third had a bipolar disorder diagnosis (p<.001). These individuals reported the highest 
rates of familial conflict, where over 93% of individuals reported that their families rarely 
or never talk about problems and rarely or never problem solves together (93.9% and 
95.9%, respectively; p<.001; Figure 5.1). 
Class 4: High Substance use/High Mental illness  
 Individuals in Class 4 (9% of the sample) were most likely to report active 
cocaine use (100%), marijuana use (47.9%), and heroin use (71.3%) out of all 
participants. While individuals reported 4% or less endorsement of prescription drug use 
in Classes 1-3, one-quarter of Class 4 individuals reported active prescription drug use 
(p<.01). These individuals also had the highest rates of all mental illness diagnoses (e.g. 
depression – 95.2%, bipolar disorder – 75.6%, anxiety/PTSD – 61.2%). Class 4 
individuals had the highest rates of active substance use and mental illness, and the 
second-highest rates of familial conflict; thus they comprise the class with the highest 
SUMIC Syndemic burden (Figure 5.1). 
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Latent class logistic regression results 
 Table 5.4 reports latent class regression odds ratios, where SUMIC Syndemic 
class membership was regressed on viral suppression (UVL), optimal acute care 
utilization (OAU), and sex among African-American participants (N=351). Compared to 
the class with the highest SUMIC Syndemic burden (Class 4), individuals with the lowest 
SUMIC Syndemic burden (Class 1) had 80% fewer odds of being female (Odds Ratio 
[OR] = 0.21; 95% Confidence Interval [95% CI] = 0.01, 0.61). Class 1 individuals were 5 
times as likely to achieve OAU as Class 4 individuals (OR = 5.03; 95% CI = 1.38, 18.39). 
Females were more likely to be in Class 4 than males, and less likely to be in Class 1. 
Therefore, females were more likely to have highest SUMIC Syndemic burden, and less 
likely to achieve OAU than males. Post-hoc analyses show that 69% of Class 4 
individuals were females (Figure 5.2).  
Compared to Class 4, individuals with high mental illness only (Class 2) had 4.6 
times the odds of UVL (95% CI = 1.48, 14.29). Individuals in Classes 1 and 4 were more 
likely to have detectable viral load than to have achieved UVL (Figure 5.3). In contrast, 
individuals in Classes 2 and 3 were mostly virally suppressed. Individuals in Classes 1 
and 3 were more likely to have achieved OAU, as opposed to suboptimal acute care 
utilization. Compared to Class 4, individuals with moderate rates of all SUMIC Syndemic 
factors (Class 3) had odds of UVL and OAU between 4 and 6 times greater; they were 
significantly more likely to be male, and to have achieved HIV medical adherence. 
Finally, Classes 2 and 4 individuals were more likely to have suboptimal acute care 
utilization than other classes (Figure 5.4). Fifty-one percent of Class 2 were female. 
Females were less likely to achieve medical adherence than males, and were the majority  
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of the individuals in Classes 2 and 4, thereby supporting both study hypotheses. 
DISCUSSION 
Our study results suggest that, among disadvantaged African-American PLHIV, 
active substance use, mental illness, and familial conflict are very common. This is 
logical, given that extant research suggests that these factors are both common 
predecessors of HIV infection as well as frequent outcomes after HIV diagnosis (Kaaya 
et al., 2013; Senn & Carey, 2008; Wyatt, 2002; Zierler & Krieger, 1997; Johnson et al., 
2008; Chesney & Folkman, 1994; Zea et al., 2005; Li et al., 2012). Furthermore, our 
results suggest that these factors lend themselves well to application of Syndemic Theory. 
Our latent class analyses (LCA) reveal that the ‘SUMIC’ Syndemic (e.g. Substance Use, 
Mental Illness, and Familial Conflict) approach yielded four distinct classes of behavioral 
risk patterns within the study population (Table 5.3 and Figure 5.1), each with differential 
burden of the aforementioned factors.  
Several previous investigations of syndemic classes have utilized LCA as a 
meaningful way to classify subtypes of individuals based on their unique behavioral 
patterns of HIV risk, to inform treatment interventions (Keiser et al., 2012; Noor et al., 
2014; Brinkley-Rubinstein & Craven, 2014; Halkitis et al., 2012; Konda et al., 2011). 
Present LCA yielded a four-class solution, with low AIC, Bayesian Information Criteria, 
and high Entropy, along with theoretical meaningfulness (Akaike, 1973; Table 5.5). The 
majority of participants were individuals whose most likely class membership was Class 
1 (43%; N=351). Post-hoc analyses revealed that 56% of Class 1 individuals were aged 
49 and older, and most had achieved HIV medical adherence (both UVL and OAU = 
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60%). Therefore, the majority of African-American PLHIV in this study had relatively 
low SUMIC burden and older age, both of which correlate with viral suppression 
(Nicholas et al., 2014; CDC, 2012).  
In sharp contrast, findings indicated that 69% of the individuals with the largest 
burden of SUMIC Syndemic factors (Class 4: High substance use/Mental illness) were 
females, thereby supporting our first study hypothesis. Next, we hypothesized that 
females would report lower HIV medical adherence, as a result of increased SUMIC 
Syndemic burden. While not statistically significant, post-hoc analyses revealed that 
African-American females were less likely than African American males to achieve both 
viral suppression (UVL; 67.1% vs. 65.9%, non-significant) and optimal acute care 
utilization (OAU; 53.9% vs. 48.5%, non-significant). Moreover, latent class regression 
analyses indicated that all three other classes had higher odds of both UVL and OAU as 
compared to Class 4 (Table 5.3), thereby supporting our second hypothesis. These results 
suggest that interventions to increase HIV medical adherence among African-American 
PLHIV should target African-American women, as they are more likely than men to 
suffer from concurrent and mutually reinforcing SUMIC Syndemic factors and low 
adherence (Towner, 2008; CDC, 2012; Prejean et al., 2011). Classes 2 and 3 were 
individuals with moderate SUMIC Syndemic burden (N=351). Nearly 80% of individuals 
in both classes had achieved UVL; however, only 38% of Class 2 individuals, and 64% 
of Class 3 individuals achieved OAU. Therefore, these syndemic factors do not have 
similar effects on UVL and acute services use, and higher prevalence and substance use, 
regardless of familial conflict level, is associated with increased acute services use.  
While few studies have examined Syndemic Theory among African-American  
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PLHIV, there are some similarities between our results and previous investigations. First, 
congruent to most previous syndemic models, the present sample was low-income racial 
minorities, with high rates of substance use, mental illness, and moderate to high rates of 
familial conflict (violence; Senn et al., 2010). Next, the only other studies to date which 
have investigated Syndemic Theory and ART outcomes, multiple syndemic issues, 
including but not limited to childhood abuse, current violence (familial conflict), and 
substance use were associated with lower ART adherence and viral suppression (Mizuno 
et al., 2014; Blashill et al., 2014). Our results suggest that Class 4 individuals, with the 
highest rates of concurrent substance use and mental illness diagnoses, were least likely 
of all classes to achieve either viral suppression or optimal acute care utilization and were 
mostly women (Table 5.4). Similarly, Illangasekare et al (2013) found that women with 
syndemic substance use, violence, and HIV-seropositivity had seven times the risk of 
depression as women with no syndemic factors, suggesting high disadvantage due to 
syndemic risk among women. The present study expands these findings, by assessing 
these factors among both males and females, whom have a similar history of drug use.  
Therefore, interventions to increase HIV medical adherence in this population 
should promote use of usual healthcare providers, which 70% of study participants 
reported having access to. Finally, results suggest that interventions to increased HIV 
medical adherence among African-American PLHIV within the SUMIC Syndemic must 
address mental illness, as all 4 classes of Syndemic individuals reported at least moderate 
depression (range: 27% to 95.2%) and bipolar disorder (range: 33.5% to 75.6%), among 
other diagnoses. This is congruent with extant literature, given that rates of depression 




There are several limitations to consider in this study. First, the median time since 
diagnosis was ten years prior to the beginning of the BEACON study, and participants 
were nearly all African-American, middle-aged, current or former persons who inject 
drugs, with access to regular healthcare and ART. Therefore, these population 
characteristics limit the generalizability of our findings beyond other similar populations. 
Second, as reported in Table 5.4, several logistic regression odds ratios had large 
confidence intervals, suggesting that the sample size may have been insufficient to detect 
all statistically significant findings. Third, while the use of optimal acute care utilization 
builds on the prior HCSUS study definition (Fremont et al., 2007), reasons for acute care 
utilization in the sample were unknown and therefore use may not be suboptimal.  Fourth, 
the data were cross-sectional, while study constructs such as adherence may change over 
time. Finally, there is controversy about the establishment of causal associations 
(temporality) of syndemic factors. However, from a treatment perspective, presence of 
SUMIC Syndemic factors may hold more precedence than temporality. 
Conclusions 
Despite these limitations, this study is the first to theorize and test the SUMIC 
Syndemic among a cohort of African-American PLHIV, and the second to apply 
Syndemic Theory to ART adherence outcomes (Blashill et al., 2014). This study builds 
upon previous research in Syndemic Theory (Milstein, 2001; Singer & Clair, 2003; Senn, 
Carey, & Variable, 2010), and contributes a new framework for conceptualizing HIV 
disparities to promote tertiary HIV prevention. Moreover, results substantiate 
comprehensive treatment of syndemic factors among African-American PLHIV (Senn et 
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al., 2010). While the SUMIC Syndemic is non gender-specific, interventions must 
consider gender differences in outcomes such as HIV medical adherence, such that 
women may have unique contextual factors which reduce their likelihood of adherence. 
These factors may include less financial resources and more homelessness, lower 
perceived social support, and competing priorities that interfere with medical adherence, 
such as having an HIV-positive significant other for whom they provide care (Blank, 
2014; Edwards, 2006; Knowlton et al., 2011). Therefore, future research should consider 
homelessness and syndemic factors in HIV medical adherence among PWID PLHIV. 
From an intervention standpoint, the present findings and other recent literature suggest 
that structural competence training with healthcare providers may increase their 
understanding of how social systems impact the patient outcomes, beyond culture (Metzl 
& Hansen, 2014). This comprehensive approach, coupled with gender-specific and 
culturally-appropriate interventions are needed to reduce stigmatization of substance use, 
barriers to HIV-related care, and mental illness treatments, to ultimately improve HIV 
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Table 5.1. Demographic characteristics of all participants (N=383) 
Demographic                                                                       Total                                                                                                                                                                     
Characteristic            N(%) or Mean (SD) 
Race  
  African-American/Black 351   (91.6) 
  White 27       (7.0) 
  Other 5         (1.4) 
Education  
  8th grade or less 26       (6.8) 
  Some high school 150   (39.2) 
  High school diploma/GED 145   (37.9) 
  Some college/tech school 45     (11.7) 
  College degree 10       (2.6) 
  Any graduate training 7         (1.8) 
Monthly income  
  $0-$499 87     (22.7) 
  $500-$999 219   (57.2) 
  $1000+ 77     (20.1) 
Relationship status  
  Married 36       (9.4) 
  In a committed relationship 97     (25.3) 
  Separated 28       (7.3) 
  Divorced 33       (8.6) 
  Widowed 15       (3.9) 
  Single 174   (45.5) 
Usual healthcare provider  
  Medical clinic at a hospital 270   (70.5) 
  Med clinic not at a hospital 108   (28.2) 
  Hospital emergency room 1         (0.3) 
  Some other type of place 4         (1.0) 
Physical functioning  
  Low 135   (35.2) 
  Medium 116   (30.3) 
  High 132   (34.5) 
Optimal acute care utilization  
  Suboptimal 188   (49.1) 
  Optimal 
Viral suppression 
195   (50.9) 
  Detectable viral load 
  Undetectable viral load   
131   (34.2) 
252   (65.8) 
Ever been in jail/prison  
  Yes 322   (84.1) 
  No 61     (15.9) 
Sex  
  Males 
  Females 
Age (years) 
235   (61.4) 
148   (38.6) 
48.2    (6.3) 
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Table 5.2. SUMIC Syndemic frequencies among African-American participants (N=351) 
 
Syndemic Factor and                                              Total                                                       














  Active substance use   
    Opiates in last 30 days 52    (14.8) 
    Marijuana in last 30 days 56    (16.0) 
    Heroin in last 30 days 73    (20.8) 
    Cocaine or crack in last 30 days 117  (33.3) 
    Hallucinogens in last 30 days 3        (0.9) 
    Prescription drugs in last 30 days 
 
  Most frequently co-occuring substances used 
    Heroin/cocaine in last 30 days 
    Marijuana/cocaine in last 30 days 
    Marijuana/heroin in last 30 days 
 
17      (4.8) 
 
 
63    (17.9) 
39    (11.1) 
25      (7.1) 
  Mental illness  
    Diagnosed with depression 209  (59.5) 
    Diagnosed with bipolar disorder 116  (33.1) 
    Diagnosed with anxiety or PTSD 89    (25.4) 
    Diagnosed with schizophrenia 34      (9.7) 
    Diagnosed with other psychiatric illness 18      (5.2) 
 
  Most frequently co-occuring mental illnesses 
    Diagnosed with depression/bipolar disorder 




109  (31.1) 
81    (23.1) 
  Familial conflict  
    Family rarely/never talks about problems 105  (29.9) 
    Family rarely/never problem solves together 99    (28.2) 
    Family rarely/never shows caring for each other  
 
  Most frequently co-occuring familial conflict 
    Family rarely/never talk/problem solve together 
29      (8.3) 
 
 
80    (22.8) 
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Table 5.3. Probability of endorsing SUMIC Syndemic statements by latent class among 










 Active substance use        
   Opiates in last 30 days 13.8***  08.1ǂ   7.3***       33.1***  
   Marijuana in last 30 days 14.2***  03.0  21.8***       47.9***  
   Heroin in last 30 days 20.6***  01.9  23.6***       71.3***  
   Cocaine or crack in last 30 days 33.4***  04.2  41.4***       100  
   Hallucinogens in last 30 days 02.1ǂ    ---    ---        ---  
   Prescription drugs in last 30 days 04.0*    ---   04.0ǂ       25.5**  
       
 Mental illness        
   Diagnosed with depression 27.0**  92.5***  64.8***       95.2***  
   Diagnosed with bipolar disorder   ---  68.6***  33.5***       75.6***  
   Diagnosed with anxiety or PTSD 03.6  43.0***  29.4***       61.2***  
   Diagnosed with schizophrenia   ---  13.5**  09.6**       42.6***  
   Diagnosed with other psychiatric illness 01.9  07.6*  07.4*       06.7  
       
 Familial conflict        
   Family rarely/never talks about problems 06.6**  12.4*  93.9***       25.4*  
   Family rarely/never problem solves together 04.3ǂ  05.9  95.9***       31.2**  
   Family rarely/never shows caring to each  
   other  
   ---  03.0  28.6***       09.7  
  C1: (43%)      C2: (25%)     C3: (23%)     C4: (9%) 
Moderate SU/MI        High MI      Moderate SU/MI/C   High SU/MI 
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                                                                                                                             Parameter 
  
Class 1: Moderate SU/MI 
 
Class 2: High MI 
 




















       
        0.21**          (0.01, 0.61) 
 
 
        0.46             (0.12, 1.77) 
 
 








        2.26             (0.73, 6.99) 
 
       
       4.60**           (1.48, 14.29) 
 
 
       4.68*                  (1.26, 17.36) 
 
Optimal acute care utilization 
 
(Ref: 1 or more ED 
admissions/hospitalizations in 
the past 6 months) 
 
       
        5.03*                 (1.38, 18.39) 
 
 
       2.40             (0.70, 8.30) 
 
 
       6.56*                  (1.80, 23.78) 
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 4220.4                           0.75 
 4144.3                           0.83 
 4121.4                           0.85 
 4142.5                           0.84 
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Introduction: Research suggests a syndemic of substance use, mental illness, and 
familial conflict is associated with HIV medical non-adherence among persons living 
with HIV (PLHIV). Other factors, including informal care receipt, may facilitate 
adherence. This study explores these as correlates of HIV medical adherence, defined as 
undetectable viral load (UVL) and optimal acute care utilization (OAU). Methods: Data 
were from the BEACON study, which examined health outcomes among injection drug-
using PLHIV. OAU was operationalized as no ER visits and/or overnight admissions in 
the past 6 months, and dichotomized. Latent class analyses identified syndemic classes. 
Poisson regression identified associations between correlates, UVL, and OAU. Results: 
Nine percent of participants had high substance use/mental illness prevalence (Class 4); 
23% had moderate levels of all factors (Class 3); 25% had high mental illness (Class 2); 
43% had moderate substance use/mental illness (Class 1). In adjusted analyses, SUMIC 
Syndemic Classes 3 had 1.4 times the likelihood of UVL as Class 1 (95% Confidence 
Interval [95% CI] = 1.15, 1.67). Individuals whose main supporter was their main partner 
had 35 percent higher likelihood of UVL, as compared to individuals whose main 
supporter was neither kin nor a main partner (Adjusted Incidence Rate Ratio [AIR]  = 
1.35; 95% CI = 1.05, 1.74). Individuals with frequent health-related support had nearly 
30 percent lower likelihood of OAU, compared to individuals with low health-related 
support (AIR = 0.73; 95% CI = 0.55, 0.97). Finally, physical functioning moderated the 
relationship between main supporter type and OAU. Discussion: Results suggest that 
informal care receipt was not consistently associated with UVL and OAU. Conversely, 
higher syndemic burden may have facilitated adherence, through necessitating increased 
rates of healthcare engagement. Healthcare professionals should elicit discussion of 









Widespread availability of antiretroviral therapy has increased life expectancy of 
persons living with HIV (PLHIV). Despite these advancements, only twenty-eight 
percent of PLHIV are aware of their status, on antiretroviral therapy (ART), and 
managing their illness (CDC, 2010). A clinical trial of ART adherence found patients 
enrolled in hospitals were seventy to eighty percent adherent (Mannheimer, Friedland, 
Matts, Child, & Chesney, 2002). Among those with mental illness, and/or racial/ethnic 
minorities, rates were approximately sixty-five percent under managed hospital care 
(Wolf et al., 2007; Mannheimer et al., 2002). Adherence rates have been estimated as 
fifty to sixty percent among persons who inject drugs (PWID; Wolf et al., 2007). 
Therefore, disparities in HIV health outcomes place racial and gender minorities at risk of 
non-adherence. A related controversy, however, is measurement of adherence itself.  
A new framework of adherence 
ART adherence refers to medication adherence, defined as conformity to provider 
recommendations about day-to-day treatment with respect to timing, dosage, and 
frequency of prescriptions (Cramer et al., 2008). Much of the HIV literature addresses 
medication adherence, utilizing viral suppression as primary data. However, viral 
suppression is an outcome of medication adherence, not a direct measure of medication 
adherence. Conversely, therapeutic adherence refers to how much global health behaviors 
(i.e., taking medication, getting health screenings, eating healthily, and attending follow-
up appointments) coincide with the recommendations by his/her health care provider (Jin, 
Sklar, Min Sen Oh, & Li, 2008). Therapeutic adherence globally refers to a PLHIV’s 
maintenance of behaviors such as accessing HIV primary care, healthy lifestyle choices, 
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including abstaining substance use abstinence (Mannheimer et al., 2002; Chesney, 2006). 
Thus, therapeutic adherence includes medication adherence, yet the latter does not 
include the former. Therefore, operationalization of adherence is contingent upon factors 
such as patient literacy and resource constraints (Chesney, 2006).  
In consideration of these issues, this study advocates the term “HIV medical 
adherence”, (e.g. viral suppression and optimal acute care utilization). Viral suppression, 
defined as an HIV viral load of 40 copies per milliliter or less (Schumacher et al., 2007), 
is a biomarker outcome of medication adherence (Chesney, 2006; Mannheimer et al., 
2002; Howard et al., 2002; Paterson et al., 2000; DiMatteo, Giordani,  Lepper, & 
Croghan, 2002). The HIV Cost and Service Utilization Study defines optimal services 
utilization as prompt engagement in HIV care after diagnosis, minimization of emergency 
room visits and inpatient care, and successful management of HIV illness through use of 
ART (Fremont et al., 2007). The present study recruited individuals who were nearly all 
insured and enrolled in care, therefore the outcome of interest in optimal acute care 
utilization, rather than healthcare utilization in general. Thus, “HIV medical adherence” 
is inclusive of medication and therapeutic adherence, both of which are contextualized to 
this research population.  
HIV medical adherence - personal factors 
While few factors have consistently predicted HIV medical adherence, individual 
and socio-contextual correlates of adherence have been identified (Barclay et al., 2007). 
Individual factors refer to personal vulnerability to HIV medical non-adherence, such as 
lack of knowledge and skills required to protect oneself (Joint United Nations Programme 
on HIV/AIDS [UNAIDS], 1998). For example, Levy (1998) showed that HIV incidence 
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among middle-aged and older adults is growing. Other studies, conversely, have 
demonstrated that older age is predictive of ART adherence (Barclay et al., 2007). 
Therefore, what may be more indicative of adherence is time since HIV diagnoses, rather 
than age itself. Similarly, physical health status has been correlated, albeit with 
conflicting results, to ART adherence.  
Previous literature in quality of life (QoL) among PLHIV defines this construct as 
inclusive of physical health (Imam, Karim, Ferdous, & Akhter, 2011; Ryff et al., 2006; 
Ware et al., 1995). Physical limitations, or poor physical health status limiting one’s 
ability to care for themselves independently, are generally associated with poor adherence 
outcomes among PLHIV and lower QoL (Rai, Dutta, & Gulati, 2010; Cunningham, 
Crystal, Bozzette, & Hays, 2005). Mental health is also a dimension of QoL. Blashill et al 
(2013) found that low physical activity predicted more mental illness and less ART 
adherence. However, De Socio, Fanelli, Longo, and Stagni (2004) showed that patients 
diagnosed with bipolar disorder, in care and on ART, had over 90 percent ART 
adherence.  
Investigations of co-morbidities among PLHIV suggest that mental illness is a 
mutually reinforcing risk and consequence of HIV infection. Moreover, Singer (1996) 
proposed a syndemic of substance abuse, intimate partner violence, HIV risk, and 
depression among low-income urban women. A syndemic refers to co-morbid conditions, 
which interact synergistically and increase disease burden (Singer, 1996; Singer & Clair, 
2003). Subsequent studies have shown substance use and mental illness as syndemic 
factors among PLHIV which, combined with racial disparities in HIV, place African-
American PLHIV at risk of decreased QoL and non-adherence (CDC, 2012).  
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HIV medical adherence - socio-contextual factors 
Socio-context refers to cultural norms, practices, and/or laws that disempower, 
and impede positive HIV health outcomes (UNAIDS, 1998). African-American PLHIV, 
particularly if PWID, have lower ART adherence compared to Whites and/or non-
substance users, (CDC, 2010; Reynolds et al., 2004). African-American women have 
higher risk of HIV due to having male partners who have sex with men (Hall, An, 
Hutchinson, & Sansom, 2008; Melkote, Muppidi, & Goswami, 2000; CDC, 2010). 
Pervasive stigma of homosexuality leads many African-American men to maintain 
heterosexual relationships, yet unlikely to use condoms during sex, thus potentially 
infecting both African-American male and female partners (Melkote et al., 2000; Buseh 
& Stevens, 2008).   
Perceived HIV-related stigma is ubiquitous and impedes adherence among 
PLHIV (Jeffries, Marks, Lauby, Murrill, & Millett, 2013; Galvan, Davis, Banks, & Bing, 
2008). HIV stigma results from moral judgments of PLHIV, and stereotypes of how HIV 
is transmitted (Jeffries et al., 2013; Galvan et al., 2008). Stigma may reduce PLHIV’s 
access to social support, which is purported to increase adherence (Galvan et al., 2008). 
Research among African-American PWID PLHIV suggests health-related support, or 
informal care provided by family or friends, facilitates adherence (Knowlton & Latkin, 
2007; Kalichman, Cherry, & Brown, 1999; Edwards, 2006). However, more research is 
needed to differentiate the effects of various social support dimensions on adherence.  
Purpose 
 The objective of present study was to identify psychosocial correlates of HIV  
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medical adherence among African-American PLHIV. Specifically, we sought to: (a) 
identify individual and socio-contextual correlates of HIV medical adherence; and (b) 
assess the effects of social support on HIV medical adherence. This study builds upon 
extant literature and simultaneously examined both individual and socio-contexual 
correlates of adherence, with implications for interventions among PWID PLHIV. 
METHODS 
Procedure 
Data were from baseline of the BEACON study, which examined psychosocial 
health outcomes among PLHIV. A total of 383 participants completed baseline surveys 
(267 current PWID, 116 former PWID). Inclusion criteria were: (a) age of 18 years or 
older; (b) HIV seropositivity; (c) injection drug use; (d) use of ART in the prior 30 days; 
and (e) willingness to recruit main supporter(s) to the study. Participants were recruited 
via an HIV clinic and street outreach. The Johns Hopkins Bloomberg School of Public 
Health Institutional Review Board approved all study activities. 
Measures                          
Dependent variables 
HIV medical adherence was defined as viral suppression and optimal acute care 
utilization. Viral suppression was measured as <40 copies per mL, by the Roche Cobas 
Amplicor (Schumacher et al., 2007), where 0 = detectable viral load, and 1 = 
undetectable viral load (UVL). Optimal acute care utilization (OAU), was measured by 
“In the past 6 months, how many times have you gone to an emergency room (ER) for 
your health care?”, and “In the past 6 months, how many times were you admitted to a 
hospital, that means that you stayed there overnight?” Responses were summed and 
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dichotomized, where 0 = 1 or more ER visits and/or hospitalizations in the last 6 months, 
and 1 = none (Fremont et al., 2007; MacCallum, Zhang, Preacher, & Rucker, 2002).   
 Independent variables 
Predictor variables included individual factors (SUMIC Syndemic class, physical 
functioning, age, sex, education) and socio-contextual factors (HIV stigma, negative 
social exchange, main supporter relationship, ART-related support, health-related 
support). Latent class analyses (LCA) categorized individuals along the spectrum of a 
latent SUMIC Syndemic (identified by participants’ substance use (SU), mental illness 
(MI), and familial conflict (C; Collins & Lanza, 2010). Substance use was defined as use 
of opiates, marijuana, heroin, cocaine or crack, hallucinogens, and/or prescription drugs, 
where 0 = no substance use, 1 = active use in the past 30 days. Mental illness was coded 
as having ever been diagnosed by a doctor with depression, bipolar disorder, anxiety or 
post-traumatic stress disorder (PTSD), schizophrenia, and/or any other psychiatric 
condition, where 0 = not diagnosed, and 1 = diagnosed. Familial conflict was coded as 
family members rarely discussing problems, problem-solving together, or show caring for 
one another, where 0 = no, and 1 = yes (Straus, 1979; Table 6.2). In regression analyses, 
a 4-level categorical variable represented syndemic class.  
 Physical functioning was assessed by the Medical Outcomes Study Physical 
Functioning Measure (McDowell & Newell, 1996). Items included “How much does 
your health affect your ability to bend, lift, or squat down?” Responses were reverse 
scored, and trichotomized, where 0 = low physical functioning, 1 = moderate physical 
functioning, and 2 = high physical functioning (Fong, 2014). Age was dichotomized at 
the median, where 0 = less than 49 years, and 1 = age 49 years and older (MacCallum et 
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al., 2002). Educational attainment was assessed by, “What is the highest level of 
education you've had?” Responses were collapsed, where 0 = 8th grade or less, 1 = some 
high school, 2 = high school diploma or GED, 3 = some college or above. Sex was 
assessed by a single item, and coded 1 = males, and 2 = females.  
 HIV stigma was assessed via a scale by Wight et al (2006), including, “Thinking 
about having HIV, how much do you feel that you need to hide it?”, Responses were on a 
4-point Likert scale, ranging from “Not at all” to “Very much”. Responses was 
trichotomized, where 0 = low stigma, 1 = medium stigma, and 2 = high stigma (Fong, 
2014). Negative social exchange was measured by items including, “In the past 30 days, 
how often did you feel that someone you know was not paying enough attention to you?” 
Participants’ responses were on a 3-point Likert scale, ranging from “None of the time” 
to “All of the time” (Newsom, Nishishiba, Morgan, Rook, & 2003). Responses were 
trichotomized, where 0 = low negative exchange, and 1 = moderate negative exchange, 
and 2 = frequent negative exchange (Fong, 2014). Main supporter relationship was coded 
as 0 = other relationship/or no main supporter, 1 = main partner, and 2 = kin.  
 ART-related support was assessed by, “How often does your main supporter talk 
to you about your HIV medications or side effects?” (Barrera, Jr. & Gottlieb, 1981). 
Responses were on a 4-point Likert scale, from “Never” to “Very often”. Responses were 
trichotomized, where 0 = low ART-related support, 1 = moderate ART-related support, 
and 2 = high ART-related support (Fong, 2014).  Health-related support was assessed 
with items from the Arizona Social Support Inventory (Barrera, Jr. & Gottlieb, 1981), 
including “In the last year, has anyone gone with you to a doctor's appointment or to the 
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ER to get medical care?” Responses were dichotomized at the median, where 0 = low 
health-related support, and 1 = high health-related support (MacCallum et al., 2002). 
Data analyses 
Univariate frequencies were generated for all variables on the total sample 
(N=383). Bivariate analyses were conducted between the outcome and predictors to 
determine which factors would remain in multivariate analyses. Marginally-significant 
variables (p<.10; Gordon, 2012), were entered into a Poisson regression model invoking 
robust standard errors. Poisson regression is appropriate for binary outcome data, for non-
rare outcomes (McNutt, Wu, Xue, & Hafner, 2003). Robust standard errors accounted for 
heteroskedasticity (inconstant variation; Long, 1997). Regression analyses were restricted 
to African-Americans, due to lack of race variation among participants (N=351). Post-hoc 
analyses tested for interactions. Analyses were conducted on complete cases (less than 
10% missing; Bennett, 2001), in STATA Version 11.2 SE (StataCorp, 2009). 
RESULTS 
Descriptive statistics 
 Participants were predominantly African-American (91.6%), and male (61.4%); 
mean age was 48.2 years (N=383; Table 6.1). Nearly half of participants reported high 
rates of HIV stigma (45.7%), and a kin main supporter (45.2%). Table 6.2 reports LCA of 
SUMIC Syndemic latent classes among African-Americans (N=351). Forty-three percent 
of participants had moderate substance use/mental illness (Class 1), 25% had high mental 
illness (Class 2), 23% had moderate levels of all factors (Class 3), and 9% had high 
substance use/mental illness prevalence (Class 4).  
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Poisson regression results: Correlates of UVL   
 In adjusted analyses, SUMIC Syndemic Classes 3 individuals had 1.4 times the 
likelihood of UVL as Class 1 (95% Confidence Interval [95% CI] = 1.15, 1.67; Table 
6.3). Individuals with high physical function had 20% higher likelihood of UVL, as those 
with low physical function (Adjusted Incidence Rate Ratio [AIR] = 1.23; 95% CI = 1.01, 
1.51). Individuals whose main supporter was their main partner had 35% higher 
likelihood of UVL, as individuals whose main supporter was neither family nor a main 
supporter (AIR = 1.35; 95% CI = 1.05, 1.74).    
Poisson regression results: Correlates of OAU  
 Mode1 1 in Table 6.4 reports main effects of adjusted analyses. Individuals in 
Classes 2 and 4 had between 30% to 70% lower likelihood of OAU as Class 1 (N=331). 
Individuals with frequent ART-related support had 26% lower likelihood of OAU, than 
individuals reporting rare ART-related support (AIR = 0.74; 95% CI = 0.57, 0.95). 
Individuals with frequent health-related support had 30% lower likelihood of OAU, 
compared to individuals with low health-related support (AIR = 0 .73; 95% CI = 0.55, 
0.97).  
Post-hoc analyses 
Analyses revealed that physical functioning moderated the relationship between 
main supporter role relation and OAU (Table 6.4). A parameter test of the interaction 
term was marginally-significant (Chi-square statistic [2] = 9.00; p=.06; Ai & Norton, 
2003). Model 2 reports a categorical variable, denoting each of the nine combinations of 
the variables (e.g., 1 = low physical functioning and main supporter is non-kin and non-
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partner). Thus, main and interactive effects are easily interpretable and account for 
differing interactive effects by level (Gaskin et al., 2013). Compared to those with low 
physical functioning, individuals with high physical functioning and Non-kin/non-
partner/Other main supporter had 2.5 times the likelihood of optimal acute care 
utilization (AIR = 2.49; 95% CI = 1.19, 5.19). Figure 6.1 depicts marginal effects of 
OAU and the interaction of main supporter type and physical functioning among African-
Americans (N=331), holding all other covariates at their means (StataCorp, 2009). 
Probability of OAU was highest for individuals with high physical functioning and an 
“Other” supporter, and lowest for those with low physical functioning and an “Other” 
supporter (0.67 vs. 0.27).  
DISCUSSION 
The purpose of the present study was to assess HIV medical adherence among 
African-American PLHIV. Findings suggest that individual and socio-contextual factors 
function uniquely in their associations with HIV medical adherence. This is congruent 
with the HIV literature, as PLHIV have complex personal and interpersonal 
characteristics impacting their health. Mechanisms which explain these relationships, 
however, differ by outcome (Tables 6.3 and 6.4). Results indicated that, surprisingly, 
individuals with moderate SUMIC Syndemic burden (Class 3) had 1.4 times the 
likelihood of UVL as individuals with low burden (Class 1). It is possible that higher 
rates of concurrent substance use, mental illness requires more engagement in healthcare, 
thereby promoting ART adherence. Given that the main difference between the classes 
was higher presence of familial conflict in Class 3, future research should explore factors 
associated with familial conflict, healthcare engagement, and adherence. 
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Highly physically functioning individuals had twenty percent higher likelihood of 
UVL as low functioning individuals, which is consistent with previous research among 
PLHIV (Cunningham et al., 2005). Higher education was also predictive of UVL; thus, 
healthcare providers should address educational and/or literacy factors among African-
American PLHIV (Osborn, Paasche-Orlow, Davis, & Wolf, 2007). Individuals with kin 
or main partner supporters had higher likelihood of UVL, suggesting that informal 
caregivers are critical to engage in health interventions (Mosack & Petroll, 2009). 
Correlates of OAU included physical functioning, main supporter relationship, 
and SUMIC Syndemic class. Contrary to UVL, and as expected, higher SUMIC 
Syndemic burden predicted lower likelihood of OAU, which is consistent with previous 
HIV syndemic and health services research (Meyer, Springer, & Altice, 2011). Other 
novel findings include that a higher level of health-related support was associated with 
thirty percent lower likelihood of OAU. It is possible health-related support is being 
provided to PLHIV, without clear communication about expectations with main 
supporters, particularly if these Indexes are also in worse physical health. 
Post-hoc analyses revealed physical functioning moderated the relationship 
between main supporter type and optimal acute care utilization (Table 6.4 and Figure 6.1). 
Research suggests that highly physically-functional individuals should have had the 
highest OAU, yet this was only true for individuals with non-kin and non-partner 
supporters. For all other levels of physical functioning, however, having a kin or partner 
supporter was promoted optimal acute care use. Thus, this finding suggests that a 
complicated relationship exists when partners or kin are main supporters. It is plausible 
that these individuals may worry more about participants, and show caring by 




This study has several limitations. First, data were cross-sectional, which prevents 
assessment of temporal fluctuations in the variables of interest. Second, other correlates 
may have merited inclusion in statistical models, such as adherence to medications to 
treat mental illnesses, which were highly prevalent among this sample. Third, participants 
were African-American PWID, in medical care, and on ART. While this population is 
underrepresented in research, it is unclear if similar findings exist for other race/ethnic 
groups, or African Americans who live in suburban and rural areas.   
Next, while the use of optimal acute care utilization builds on the prior HCSUS 
study definition (Fremont et al., 2007), reasons for acute care utilization in the sample 
were unknown and therefore use may not be suboptimal. Finally, the marginal 
significance of the Main supporter X Physical function interaction on OAU may be 
because interaction terms are less powered than main effects. While the term was retained 
for theoretical meaning (Greenland, 1993), future research should investigate this with a 
larger sample. 
Nonetheless, the present study has also several strengths to its credit. As stated, 
this study examined both individual and socio-contexual correlates of adherence. 
Similarly, one of the individual-level predictors (Syndemic class), is the result of an 
empirical latent class analyses which is only the second of its kind to associate syndemic 
class and adverse adherence outcomes (Blashill et al., 2014). Next, the outcome of 
interest, medical adherence, comprises a nuanced and contextualized definition of 
medication adherence (e.g. viral suppression), and therapeutic adherence (e.g. optimal 
acute care utilization). Finally, this study is one of few to examine adherence outcomes 




The present study lends support to the importance of examining syndemic factors 
as predictive of adherence outcomes. Additionally, study findings suggest that social 
support is not clearly protective among African-American PLHIV. Next, medication and 
therapeutic adherence outcomes have unique relationship between syndemic and social 
support factors. Future training with healthcare providers in structural competence should 
conceptualize individual and socio-contextual factors within the healthcare context, 
potentially improving adherence and other health outcomes among PLHIV (Metzl & 
Hansen, 2014). Next, results suggest that even among individuals enrolled in HIV 
primary care and on ART, use of emergency health care was high (49%). Moreover, 
individual factors such as active substance use, age, and mental illness were more highly 
associated with UVL, than socio-contextual factors such as HIV stigma and negative 
social exchange. The surprising relationship between health-related support and OAU, 
and interaction between main supporter and physical functioning on OAU, suggest that 
socio-contextual factors may be important for OAU. This is fitting, as OAU may require 
PLHIV to access their informal care networks. This may also explain why higher SUMIC 
Syndemic burden predicted higher UVL and lower OAU.  
Finally, this study is unique in proposing and testing a congruent model to 
compare two adherence outcomes. The differing effects of SUMIC Syndemic class on 
medication (UVL) versus therapeutic adherence (OAU) should be addressed by future 
studies, to clarify the role of these factors in HIV outcomes. Findings lend support to 
assessing adherence dimensions to improve health outcomes among African-American 
PLHIV. Finally, the importance of mental and physical health in HIV medical adherence 
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Table 6.1. Demographic characteristics of all participants (N=383) 
Demographic                                                                     Total                                                                                                                                                                     


























  African-American/Black 351   (91.6) 
  White 27       (7.0) 
  Other 5         (1.4) 
Education  
  8th grade or less 26       (6.8) 
  Some high school 150   (39.2) 
  High school diploma/GED 145   (37.9) 
  Some college/above 62     (16.1) 
HIV stigma  
  Low 107   (27.9) 
  Medium 101   (26.4) 
  High 175   (45.7) 
Negative social exchange  
  Low 160   (41.8) 
  Medium 127   (33.2) 
  High 96     (25.1) 
Health-related support  
  Low 148   (38.6) 
  Medium 105   (27.4) 
  High 130   (34.0) 
Main supporter type  
  Other 89     (23.3) 
  Main partner 121   (31.6) 
  Kin 
ART-related support 
173   (45.2) 
  Rarely  42     (11.7) 
  Sometimes 
  Often 
Physical functioning 
129   (35.9) 
188   (52.4) 
  Low 135   (35.2) 
  Medium 116   (30.3) 
  High 132   (34.5) 
Optimal acute care utilization  
  Suboptimal 
  Optimal 
188   (49.1) 
195   (50.9) 
Viral suppression  
  Detectable viral load 131   (34.2) 
  Undetectable viral load 252   (65.8) 
Sex  
  Males 
  Females 
Age (years) 
235   (61.4) 
148   (38.6) 
48.2    (6.3) 
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Active substance use        
   Opiates in last 30 days 13.8***  08.1ǂ  17.3***      33.1***  
   Marijuana in last 30 days 14.2***  03.0  21.8***      47.9***  
   Heroin in last 30 days 20.6***  01.9  23.6***      71.3***  
   Cocaine or crack in last 30 days 33.4***  04.2  41.4***      100  
   Hallucinogens in last 30 days 02.1ǂ     ---     ---       ---  
   Prescription drugs in last 30 days 04.0*     ---   04.0ǂ      25.5**  
       
 Mental illness        
   Diagnosed with depression 27.0**  92.5***  64.8***     95.2***  
   Diagnosed with bipolar disorder   ---  68.6***  33.5***     75.6***  
   Diagnosed with anxiety or PTSD 03.6  43.0***  29.4***     61.2***  
   Diagnosed with schizophrenia   ---  13.5**   09.6**     42.6***  
   Diagnosed with other psychiatric illness 01.9  07.6*   07.4*     06.7  
       
 Familial conflict        
   Family rarely/never talks about problems 06.6**  12.4*  93.9***     25.4*  
   Family rarely/never problem solves together 04.3ǂ  05.9  95.9***     31.2**  
   Family rarely/never shows caring for each     
   other  
   ---  03.0  28.6***     09.7  
   C1: (43%)     C2: (25%)      C3: (23%)       C4: (9%) 
Moderate SU/M I      High MI        Moderate SU/MI/C    High SU/MI 
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ǂmarginally significant p<.10, *p<.05, **p<.01, ***p<.001    aIRR = Incidence Rate Ratio     bAIR = Adjusted 
Incidence Rate Ratio      c CI = 95% Confidence Interval       
 
Table 6.3. Correlates of viral suppression - African-American Indexes (N=331) 
 
                                                        Unadjusted                          Adjusted 
 
                                                        IRR
a
                CI
c                               
AIR
b
               CI                 
                                                        ____           ________               ____           ________           
SUMIC Syndemic class     
  High Mental illness 1.31** (1.10, 1.55) 1.35*** (1.12, 1.62) 
  Moderate SU/MI/C 1.29** (1.09, 1.54) 1.38*** (1.15, 1.67) 
  High Sub use/Men illness 0.68ǂ (0.44, 1.05) 0.81 (0.53, 1.24) 
  (ref: Moderate SU/MI) 1.00  1.00  
     
Physical functioning     
  Moderate physical functioning 1.18ǂ (0.97, 1.44) 1.16 (0.96, 1.40) 
  High physical functioning 1.25* (1.04, 1.50) 1.23* (1.01, 1.51) 
  (ref: Low physical functioning) 
 
1.00  1.00  
HIV stigma      
  Moderate stigma 
  High stigma 











     
Education     
  Some high school 1.49 (0.89, 2.47) 1.52ǂ (0.93, 2.48) 
  High school diploma/GED 1.61ǂ (0.97, 2.68) 1.52ǂ (0.93, 2.47) 
  Some college or above 1.78* (1.06, 2.98) 1.72* (1.04, 2.85) 
  (ref: 8th grade or less) 1.00  1.00  
     
Negative social exchange     
  Medium exchange 1.02 (0.86, 1.20) 1.05 (0.88, 1.24) 
  High exchange 0.92 (0.75, 1.12) 1.02 (0.82, 1.28) 











  Main partner  1.11 (0.90, 1.37) 1.35* (1.05, 1.74) 
  Kin 
  (ref: Other/No supporter) 
1.08 
1.00 
(0.88, 1.31) 1.27* 
1.00 
(1.00, 1.62) 
     
ART-related support 
  Sometimes 
  Often 
  (ref: Rarely) 
 
Health-related support 
  Medium support 
  High support 
  (ref: Low support) 
 
Age (49 years & up) 
 





























































Table 6.4. Correlates of optimal acute care utilization - African-Americans (N=331) 
 
                                            Unadjusted                        Model 1d                          Model 2e 
                                        IRR
a
              CI
c
               AIR
b                    
CI                AIR              CI                                   
                                        ____          ________         ____        ________          ____        ________      
 
SUMIC Syndemic class       
  High Mental illness 0.63** (0.47, 0.84) 0.66** (0.48, 0.89) 0.63** (0.46, 0.86) 
  Moderate SU/MI/C 1.05 (0.85, 1.30) 1.10 (0.87, 1.38) 1.03 (0.82, 1.30) 
  High Sub use/Mental illness 0.31** (0.15, 0.65) 0.35** (0.16, 0.77) 0.34** (0.16, 0.72) 
  (ref: Moderate SU/MI) 1.00  1.00  1.00  
       
ART-related  support       
  Sometimes 0.89 (0.68, 1.17) 0.89 (0.70, 1.13) 0.93 (0.73, 1.18) 
  Often 0.65** (0.49, 0.86) 0.74* (0.57, 0.95) 0.77* (0.60, 1.00) 
  (ref: Rarely) 
 
1.00  1.00  1.00  
HIV stigma        
  Moderate stigma 
  High stigma 


















       
Education       
  Some high school 0.91 (0.59, 1.42) 1.08 (0.70, 1.66) 1.04 (0.68, 1.59) 
  High school diploma/GED 1.08 (0.70, 1.66) 1.23 (0.81, 1.88) 1.19 (0.79, 1.81) 
  Some college or above 0.97 (0.60, 1.57) 1.17 (0.72, 1.88) 1.07 (0.66, 1.74) 
  (ref: 8th grade or less) 1.00  1.00  1.00  
       
Negative social exchange       
  Medium exchange 0.94 (0.74, 1.20) 0.87 (0.69, 1.11) 0.86 (0.68, 1.08) 
  High exchange 1.06 (0.83, 1.35) 1.07 (0.83, 1.38) 1.05 (0.81, 1.35) 















  Medium support 0.76* (0.60, 0.97) 0.83 (0.66, 1.06) 0.83 (0.66, 1.05) 
  High support 













       
Sex (Females) 
 
Age (49 years & older) 
 
Physical functioning 
  Medium physical function. 
  High physical functioning 
  (ref: Low physical function.) 
 
Main supporter relationship 
  Main partner 
  Kin 
  (ref: Other/No supporter) 
 


















































































ǂmarginally significant p<.10, *p<.05, **p<.01, ***p<.001  aIRR = Incidence Rate Ratio   bAIR = Adjusted Incidence Rate Ratio  c CI = 95% Confidence 
Interval    d=Main effects model   e=Model with main effects and interaction term (Main supporterXPhysical Functioning)  
1.59        (0.69, 3.66)     
1.32        (0.61, 2.86)       
1.33        (0.54, 3.27)         
2.13ǂ            (0.99, 4.59)    
2.20*           (1.05, 4.61)   
2.49*           (1.19, 5.19)    
1.83        (0.87, 3.85)     
1.72        (0.83, 3.55)   
1.00 
Low phys func X Partner              
Low phys func X Kin                    
Med phys func X Other               
Med phys func X Partner              
Med phys func X Kin                   
High phys func X Other                
High phys func X Partner            
High phys func X Kin                  




Figure 6.1. Marginal effects depicting interaction of physical functioning on association between main supporter relationship and 


















































































The overarching purpose of this dissertation research was to identify correlates of 
HIV medical adherence among African-American persons living with HIV (PLHIV), in 
order to make recommendations to researchers and healthcare providers to improve their 
health outcomes. By examining factors such as sex differences, latent syndemics among 
HIV-positives, and differing dimensions of adherence, this research has contributed a 
comprehensive analysis of correlates of adherence – at both individual-level and  
interpersonal-level determinants of health. Overall, study results suggest that 
achievement of undetectable viral suppression (UVL) was more common than optimal 
acute care utilization (OAU) among this cohort of African-American persons who inject 
drugs and are living with HIV (PWID PLHIV; 65.8% vs. 50.9%, respectively) 
This dissertation research also contributes to a growing body of literature on the 
effects of Syndemic Theory in HIV, yet contributes a unique syndemic analysis of HIV 
tertiary prevention of health burden, rather than HIV primary prevention of HIV risk. 
Moreover, this research considered the definition and measurement issues surrounding 
adherence. Additionally, this research proposed and tested a new definition of adherence 
which considers both medication and therapeutic adherence elements among persons who 
inject drugs, who are traditionally under-represented in health services research and HIV 
adherence literature as well.  
The present chapter summarizes the investigation of each research aim, along 
with relevant findings and conclusions from each aim. These aims were accomplished via 
quantitative secondary analyses of a study which examined psychosocial health outcomes 
among a cohort of low-income, predominantly African-American, current or former 
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injection drug-using PLHIV in Baltimore, Maryland. Considering the context of 
Baltimore City, African-American females now represent the majority of new HIV 
diagnoses (Baltimore City Commission on HIV/AIDS Prevention and Treatment, 2005). 
As a result, the devastation is so vast in certain areas of the city that it rivals HIV rates in 
sub-Saharan Africa (U.S. Department of Health and Human Services Health Resources 
and Services Administration, 2008). Nine out of every ten new HIV cases in Baltimore 
are among African-Americans, and among African-American females in Baltimore, the 
rate of AIDS diagnoses is more than twenty times that of White females (Baltimore City 
Commission on HIV/AIDS Prevention and Treatment, 2005). Therefore, research to 
inform HIV-related, and/or sex-specific interventions in this area is vital and very timely. 
SUMMARY OF FINDINGS 
Study Aim One and Hypothesis One 
The first aim of the proposed research was to examine the association between 
sex and HIV medical adherence (defined as optimal acute care utilization and ART 
adherence) among a sample of urban African-American adult persons who inject drugs 
currently engaged in HIV medical care. Correspondingly, the accompanying hypothesis 
for this aim was that females would report lower rates of HIV medical adherence as 
compared to males. In Manuscript One (Chapter Four), the results of statistical analyses 
to address this research aim were detailed.  
Consistent with observations of racial/ethnic and sex disparities, African-
American women were estimated to have higher HIV incidence, and lower viral 
suppression than other groups (Agency for Healthcare Research and Quality [AHRQ], 
171 
 
2012; Prejean et al., 2011). First, purported barriers to viral suppression among PLHIV 
include active substance use and mental illness (AHRQ, 2012). Additionally, substance 
use, mental illness, and HIV are all factors which may create tension in the PLHIV’s 
social environment, resulting in familial conflict, or chronic disagreements between 
family members (Dunbar, 1990; Chesney & Folkman, 1994; Feaster et al., 2010). In 
contrast, research suggests that health-related support and support reciprocity (mutuality) 
have been found to facilitate achievement of viral suppression (Edwards, 2006; Tucker, 
Burnam, Sherbourne, Kung, & Gifford, 2003; Knowlton et al., 2011; Mosack, & Petroll, 
2009). Therefore, extant research informed the research aims, hypothesis, and variables 
utilized in analyses.    
In these analyses, viral suppression was the only outcome of interest. This 
outcome was binary (1 = undetectable viral load vs. 0 = detectable viral load; 
Schumacher et al., 2007). Predictor variables in the present analyses were active 
substance use, mental illnesses diagnoses, familial conflict, patient-provider 
communication, and social support (e.g. main supporter relationship, religious activity, 
health-related support, and support reciprocity). Physical functioning and educational 
attainment were utilized as sociodemographic control variables, and analyses included 
Poisson regression with robust standard errors to account for data heteroskedasticity 
(inconstant variation; Long, 1997). The same model was run for separately for males and 
females in order to address Research Aim One, and only among African-American 
participants, due to theoretical importance. 
Similarities between males and females’ correlates of viral suppression (UVL) 
were identified. First, physical health and mental health are quality of life indicators 
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which were statistically significant correlates of viral suppression among males (physical 
health and mental illness), and females (mental illness). Also, for both sexes, it was 
protective to have main supporters who were either main partners or kin. Divergent from 
prior research and theoretical rationale, reciprocating support was negatively associated 
with viral suppression for females, where high reciprocity was associated with only one-
third the likelihood of undetectable viral load, as females reporting low reciprocity to 
caregivers. Moreover, African-American female Indexes were more likely than African-
American male Indexes to report that their main supporter was their main partners (36% 
vs. 28%, respectively; p<.05). They were also less likely to achieve viral suppression than 
males (67.1% vs. 65.9%, respectively; non-significant), thus providing support to 
Hypothesis One.  
Study results indicated that males and females differences exist in the relationship 
between substance use, mental illness, social support, and achievement of UVL. Findings 
suggest that sex differences may also exist in utilization of informal caregivers and social 
support networks to engage in health behaviors among PLHIV. Therefore, healthcare 
providers should consider the impact of health-related quality of life among persons 
whom inject drugs and also are living with HIV (PWID PLHIV). Future research should 
also consider sex-specific health-related physical functioning and quality of life 
interventions to improve health outcomes among PWID PLHIV.  
Study Aim Two and Hypotheses Two  
The second research aim of interest was to determine the relationship between the 
‘SUMIC’ Syndemic (e.g. Substance Use, Mental Illness, and Familial Conflict) and HIV 
medical adherence among a sample of urban African-American adult persons who inject 
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drugs currently engaged in HIV medical care. The accompanying hypothesis was that 
individuals with higher SUMIC Syndemic burden would report lower HIV medical 
adherence as compared to individuals who had lower syndemic burden. Syndemic Theory 
refers two or more co-morbid conditions, which interact synergistically, and collectively 
increase disease burden in a given population (Singer, 1996; Singer & Clair, 2003). 
 The ‘SUMIC’ Syndemic places African-Americans, and particularly African-
American women, at high risk of death and/or disability related to HIV/AIDS in the 
United States. Therefore, the present analyses (Chapter Five) examined the role of 
Syndemic Theory in HIV-related health burden. In Chapter Five, the SUMIC Syndemic 
was investigated as a latent class regression, where individuals were classified into their 
most likely class membership based on their recent substance use, lifetime mental illness 
diagnoses, and existing levels of familial conflict. In Chapter Six, SUMIC Syndemic class 
was utilized as a categorical predictor of aforementioned HIV medical adherence.  
Latent class analyses (LCA) identified unique patterns of behavioral risk (Ahn et 
al., 2008; Collins & Lanza, 2010). Active substance use was coded as use of opiates, 
marijuana, heroin, cocaine or crack, hallucinogens, and/or prescription drug use in the 
past month; mental illness was coded as having ever been diagnosed by a doctor with 
major depression, bipolar disorder, anxiety or post-traumatic stress disorder (PTSD), 
schizophrenia, and/or any other psychiatric condition; familial conflict was coded as 
family members rarely discussing problems, problem-solving together, and/or show 
caring for one another.  
 HIV medical adherence was defined as no acute care utilization and HIV viral 
suppression. Optimal acute care utilization (OAU) was defined as no Emergency  
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Department visits or overnight hospitalizations in the prior 6 months. HIV viral 
suppression was defined as previously identified. Sex was coded as 1= Males, vs. 2 = 
Females. Analyses included univariate statistics, factor analyses, and latent class logistic 
regression. Model fit statistics and theoretical significance identified a four-class solution. 
   Based on LCA among African-American participants (N=351), 9% of 
participants had high substance use/mental illness prevalence (Class 4); 23% had 
moderate levels of all 3 factors (Class 3); 25% had high mental illness (Class 2); and 43% 
had moderate substance use/mental illness (Class 1). Compared to Class 4, females had 
79% lower odds of being in Class 1 or Class 3 (p<.01 and p<.01, respectively). 
Moreover, Class 4 was overwhelmingly female (68%), and represented the individuals 
with the highest syndemic burden. Overall, odds of HIV medical adherence were two to 
four higher in Classes 1-3 as compared to Class 4, thereby addressing Research Aim Two 
and providing support to Hypothesis Two.  
 Although only two previous studies have applied Syndemic Theory to HIV 
adherence outcomes, some parallels can be drawn between our results and previous 
investigations (Blashill et al., 2014; Mizuno et al., 2014). First, as with most of the 
previous syndemic models, the present sample was low-income racial minorities, with 
high rates of substance use, mental illness, and moderate to high rates of familial conflict 
(violence; Senn et al., 2010; Blashill et al., 2014; Mizuno et al., 2014). Our results 
suggest that women had the highest rates of concurrent substance use and mental illness 
diagnoses, and lowest HIV medical adherence, which is similar to findings by 
Illangasekare et al (2013). Therefore, while the SUMIC Syndemic is non-gender specific, 
interventions must consider gender differences in syndemic burden and HIV medical  
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adherence, such that women may have unique contextual factors which reduce their 
likelihood of adherence.  
Study Aim Three and Hypothesis Three 
 The final dissertation research aim was to examine sex and social support as 
potential moderators in the relationship between the SUMIC Syndemic and HIV medical 
adherence among a sample of urban African-American adult persons who inject drugs 
engaged in HIV medical care. The corresponding hypothesis was that females would 
report higher rates of the SUMIC Syndemic and lower rates of HIV medical adherence as 
compared to males. While research suggests that HIV medical non-adherence is 
problematic, relatively few individual and socio-contextual correlates of adherence have 
been consistently associated with increased medical adherence.  
 Individual factors refer to a person’s characteristics which may make them 
vulnerable to HIV medical non-adherence (Joint United Nations Programme on 
HIV/AIDS [UNAIDS], 1998), while socio-context refers to cultural norms and practices, 
that act as barriers to positive HIV health outcomes (UNAIDS, 1998; Galvan, Davis, 
Banks, & Bing, 2008). Therefore, these analyses utilized both individual-level correlates 
(e.g. age, sex, education) and socio-contextual correlates (e.g. HIV stigma, negative 
social exchange). The outcomes of interest were HIV medical adherence: viral 
suppression (UVL) and optimal acute care utilization (OAU). Analyses included 
univariate frequencies, bivariate analyses, and multivariate Poisson regression with 
robust standard errors. Regression analyses were run with African-Americans only. Post-
hoc analyses were conducted to test for potential interactions between social support  
176 
 
variables (e.g. negative social exchange, main supporter relationship, ART-related 
support, and health-related support), sex, and other correlates of interest.  
 Results indicated that SUMIC Syndemic class membership was a significant 
predictor of viral suppression. Conflicting with expectations, individuals with moderate 
SUMIC Syndemic burden had 1.4 times the likelihood of UVL as individuals with low 
syndemic burden (Adjusted Incidence Rate Ratio [AIR] = 1.38; 95% Confidence Interval 
[95% CI] = 1.15, 1.67). Contrary to its associations with UVL, higher SUMIC Syndemic 
burden predicted lower likelihood of OAU. Nonetheless, this finding is supported by 
previous research in HIV syndemics, where increased syndemic burden has been 
consistently associated with lower engagement in HIV medical care and positive health 
outcomes (Meyer, Springer, & Altice, 2011). Post-hoc analyses revealed that physical 
functioning moderated the relationship between main supporter type and optimal acute 
care utilization. While theory would posit that highly physically-functional individuals 
should have had the lowest use of acute care services (OAU), this only held for 
individuals with non-kin and non-partner supporters. For all other levels of physical 
functioning, having a kin or partner supporter increased the likelihood of UVL and OAU. 
African-American females were less likely than males to achieve both viral suppression 
(67.1% vs. 65.9%; non-significant) and optimal acute care utilization (53.9% vs. 48.5%; 
non-significant).   
African-American females were also nearly seventy percent of the SUMIC 
Syndemic class with the highest burden; thus Hypothesis Three was supported. The 
surprising relationship between health-related support and OAU, and the interaction 
between main supporter relationship and physical functioning on OAU, suggest that  
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socio-contextual factors may be important for OAU.  
The present study lends support to the importance of examining syndemic factors 
as predictive of adherence outcomes. Additionally, medication and therapeutic adherence 
outcomes (UVL and OAU) had distinct relationships with syndemic and social support 
factors. Overall, among both sexes, UVL was more common than OAU. Results suggest 
that even among individuals enrolled in HIV primary care and on ART, overuse of 
emergency health care was high (49%). It is possible that viral suppression is a more 
individualized measure of adherence, and therefore under the control of the PLHIV, 
while acute care utilization is more interpersonally-influenced. Therefore, future studies 
should also examine these factors to make treatment recommendations to improve 
adherence and reduce unnecessary health care utilization.  
STUDY STRENGTHS AND LIMITATIONS 
Limitations 
The contributions of this study are subject to several limitations. First, all of the 
analyses conducted within this study were cross-sectional. Research suggests, however, 
that factors such as HIV medical adherence, active substance use, and social support (e.g. 
main outcome and study correlates) fluctuate over time. Therefore, inference regarding 
the longitudinal relationship between these factors cannot be ascertained. Similarly, there 
is dissent regarding establishing the temporality of the aforementioned syndemic factors 
of substance use, mental illness, and familial conflict. As discussed in Chapters One, 
Three, and Five, research suggests that these factors are each individually established 
correlates, co-morbidities, and outcomes related to HIV (Centers for Disease Control and 
Prevention [CDC], 2012). From a treatment perspective, however, results suggest that 
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presence of SUMIC Syndemic factors may hold more precedence than temporality for 
treatment, and require comprehensive strategies for tertiary prevention among PLHIV.  
Next, while HIV medical adherence was defined and studied in these analyses, 
distinction must be made between types of adherence. Medication adherence refers solely 
to an individual’s ability to adhere to the prescription regimen recommended by a 
healthcare provider (Burke & Dunbar-Jacob, 1995; DiMatteo, 2004). Beyond this issue, 
however, is the determination of what adherence is (Machtinger & Bangsberg, 2005).  
Additionally, viral suppression was conceptualized in this study as a biomarker proxy for 
medication adherence. However, it is possible for PLHIV to report ART adherence, 
which may or may accompany achievement and maintenance of viral suppression. Next, 
in consideration of operationalization of adherence, large differences may exist between 
an individual’s likelihood to adhere to HIV medication, versus their ability to adhere to 
their healthcare provider’s larger list of recommendations (DiMatteo, 2004). Therefore, 
inferences regarding factors such as lack of transportation to attend regular follow-up 
appointments, or change in health insurance status due to loss of coverage cannot be 
made (Gullette, Wright, Booth, & Steward, 2010).  
Similarly, a related limitation is illuminated, as the very nature of HIV medical 
adherence implies access to regular medical care, which is often not reflective of the 
population experiencing syndemic risks (Gullete et al., 2010; Booker, Harding, & 
Benzeval, 2011). All of the individuals in this study had medical insurance and/or access 
to regular HIV medical care, and are not necessarily representative of the population with 
highest syndemic risk. Thus, SUMIC Syndemic individuals are a highly unique group 
with respect to their HIV risk, health practices, and antiretroviral therapy (ART) 
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adherence. Similarly, while the definition of optimal acute care utilization builds on the 
prior HCSUS study definition (Fremont et al., 2007), reasons for acute care utilization in 
the sample were unknown and therefore use may not be suboptimal.  
It is possible that acute care services were used appropriately, for issues other than 
chronic HIV-related illness. Nonetheless, because this cohort of PLHIV were relatively 
engaged in care, there should have been little need for acute care services, thereby 
justifying focus on OAU as an outcome of interest. Moreover, research to identify factors 
associated with OAU are critical, as persons who inject drugs are especially vulnerable to 
sub-optimal acute services use. Next, several of the constructs included in this study 
could have been operationalized differently.  
For example, active substance use also includes alcohol use and/or binge drinking, 
which was excluded in the present analyses due to results of factor analyses. Similarly, 
the items referred to as familial conflict may be more specifically measuring family 
problem-solving constructs. Therefore, differential syndemic burden may be identified 
with inclusion of items which measured more overt conflicts between family members. 
Similarly, definitions of what constitutes a family vary widely, and therefore could result 
in differential conflict prevalence as well. Finally, three measures, Relationship to main 
support, ART-related support, and Religious activity were identified with a single item; 
therefore no factor analyses or reliability estimate were ascertained. However, inclusion 
of single items has been defended in previous research, namely because they may identify 
specific behavioral factors associated with outcomes of interest in a given study 
population (Rossiter, 2008). 
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As discussed, the PLHIV included in this study were nearly all African-American 
and low-income, and all had a history of injection drug use (primarily heroin and 
cocaine). Therefore, this study’s findings may not be widely generalizable to all PWID 
PLHIV. Next, stratified analyses may have led to a loss of statistical power to detect 
findings. However, these decisions, which included sex stratification and race-specific 
analyses were theoretically justified and meaningful. Finally, “sex” and “gender” were 
used interchangeably in analyses and interpretation of findings. However, the former 
refers to physical and biological characteristics, while the latter refers to socio-cultural 
identity (American Psychological Association [APA], 2011). Within the context of HIV, 
many individuals face increased HIV risk and negative health outcomes due to 
differences they perceive between their sex and gender, such as transgender individuals. 
Therefore, future studies should include measurement of both of these factors, as well as 
increased inclusion of transgendered PLHIV, to further understand the role of social 
support and syndemic factors in adherence (APA, 2011; CDC, 2012).   
Strengths 
 Despite these limitations, the proposed study fills a critical gap in the HIV 
literature, by identifying unique correlates of adherence in one of the most vulnerable 
populations currently being ravaged by HIV/AIDS in the U.S. First, the parent project, 
the BEACON study, was one of few to recruit almost exclusively low-income, African-
American HIV-positive individuals (PLHIV), who are underrepresented in HIV 
disparities research. Moreover, all of these individuals were current or former persons 
who inject drugs (PWID), whom represent a “hard-to-reach” population for research and 
intervention (Needle et al., 2005). Second, this study contributes evidence of sex 
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differences in medical adherence outcomes, among a marginalized population of African-
American PWID PLHIV. Moreover, these disparities were framed with consideration of 
both a conceptual framework (Social Cognitive Theory of Gender Differentiation) and a 
theoretical orientation (Theory of Gender and Power; Chapter Two and Chapter Four), 
which has implications for future research and interventions.  
Third, this study simultaneously evaluated several dimensions of social support, 
which is a unique contribution to the literature. Extant research purports that social 
support is protective from negative HIV health outcomes such as non-adherence; yet 
most studies do not differentiate multiple types and sources of social support and HIV 
outcomes. The present dissertation research tested multiple sources including: 
relationship between main caregiver and care recipient, enacted health-related support 
(beyond main caregiver), religious activity (conceptualized as organizational or 
communal support), and enacted ART-related support. Therefore, this study highlights 
that social support itself is not sufficient for prevention of negative health outcomes, 
Therefore, future research and interventions should expand on these findings, by 
including informal caregivers in HIV outcomes research, along with evaluation of 
syndemic factors over time among PWID PLHIV. 
Fourth, the present research critically examined the current state of Syndemic 
Theory in the HIV literature. Since the initial appearance of the SAVA Syndemic 
(substance use, violence, HIV risk among low-income urban women; Singer, 1996), 
several other syndemic models have been theorized to conceptualize HIV infection risk. 
HIV-positive individuals with a history of substance use and/or mental illness represent 
an extremely vulnerable population with respect to risk for HIV infection, as well as poor 
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health outcomes such as lower rates of ART adherence. However, to date only two 
studies have applied Syndemic Theory to assess HIV-related adherence outcomes 
(Blashill et al., 2014; Mizuno et al., 2014). However, no studies have applied this theory 
to assess adherence among exclusively African-American PWID PLHIV. Therefore, this 
study defined and tested a new syndemic model. The present study findings suggest that 
SUMIC Syndemic (Substance Use, Mental Illness, and Familial Conflict) factors had 
adherence implications. Individuals with higher syndemic burden had lower likelihood of 
OAU (Chapter Six). Moreover, syndemic burden was disproportionately seen among 
females, and African-American females had lower overall HIV medical adherence rates 
than males (Chapter Five and Chapter Six).  
Finally, previous research studies have established controversy surrounding 
several aspects of defining and measuring adherence. These issues include variations in 
the literature regarding on issues such as appropriate data sources, and cutoff criteria to 
define adherence-related outcomes (Machtinger & Bangsberg, 2005). The present 
research defined ‘HIV medical adherence’ as both viral suppression (UVL) and optimal 
acute care utilization (OAU). The former outcome is a specific proxy for medication 
adherence outcome, while the latter is a therapeutic adherence term defined by The HIV 
Cost and Service Utilization Study, and refers to minimization of emergency room visits 
and inpatient care (Shapiro et al., 1999). Consideration of UVL is additionally 
conceptualized as an individual-level adherence outcome, while OAU is an interpersonal-
level adherence outcome. Consideration of multiple levels of socio-environmental factors, 
as was the case in the present dissertation research, is critical to improvement of health 




Research and intervention implications 
 The methods and findings from this dissertation suggest several areas that merit 
further investigation. First, Social Cognitive Theory of Gender differentiation has 
relevance to disparities in HIV medical adherence among African-American women 
PLHIV. One construct of this theory is self-efficacy, or an individual’s personal agency 
or belief in their ability to produce desired outcomes (Bussey & Bandura, 1999; Bandura, 
1998). Extant research demonstrates that African-American women consistently report 
lower levels of perceived self-efficacy with respect to engaging in HIV-related health 
behaviors (Gullette, Wright, Booth, & Stewart, 2010; Edwards, 2006; Buseh & Stevens, 
2008; Schröder, Hobfoll, Jackson, & Lavin, 2001; Wingood & DiClemente, 2000). 
Reynolds et al., (2004) and Schneider, Kaplan, Greenfield, Li, and Wilson (2004) 
found interventions to increase self-efficacy among African-American females were 
predictive of increased ART adherence and increased engagement in care with HIV 
health care providers. Combined with gender-specific findings from the present research, 
future health programs should specifically target African-American women, and include 
activities to increase their health self-efficacy. Consistent with these previous findings, 
study results indicated that African-American females were less likely than males to 
achieve both viral suppression and optimal acute care utilization. Results also suggested 
that women were more likely than men to report that their main HIV supporter was their 
significant other (37.2% vs. 28%, respectively; p<.05).  
Therefore, one possible avenue to increase African-American females’ self- 
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efficacy and HIV medical adherence could be a couples-based intervention for African-
American PLHIV women and their male partners in Baltimore. The intervention would 
be evidence-based, building off of previous interventions among African-American 
PLHIV women (Holstad, DiIorio, & Magowe, 2006). Additionally, a recent study of 
PLHIV women who are racial/ethnic minorities found that among these women, those 
with functional limitations also reported nearly twice as many mentally unhealthy days in 
the past month, as compared to the general US population (Quinlivan et al., 2015). 
Similar associations with quality of life factors were found with in the present study; 
therefore, future interventions should address physical and mental health factors among 
PLHIV women (Chapter Four).  
In such an intervention, a health education program with PLHIV women 
participants could identify specific areas of intervention they are interested in, and 
delivered via motivational interviewing techniques (Holstad et al., 2006). The health 
education would incorporate physical activity, as well as stress reduction techniques to 
improve and maintain mental health outcomes. Additionally, this intervention would be 
with couples, and would include gender-specific communication skills, and couples role-
playing issues such as antiretroviral therapy. As such, future intervention work could 
incorporate targeted interventions for PLHIV women of color, with unique and specific 
health-related quality of life needs, and integrating behavioral health care with somatic 
health care (Quinlivan et al., 2015; Holstad et al., 2006).  
Irrespective of gender, study results indicated that SUMIC Syndemic factors 
(Substance Use, Mental Illness, and Familial Conflict) may be contributing to negative 
health outcomes among African-American PLHIV (Chapter Five and Chapter Six). 
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Results indicated that active substance use, mental illness, and familial conflict rates were 
high in this population (Chapter Five). Moreover, while viral suppression was achieved 
by nearly two-thirds or participants, half of participants were utilizing Emergency 
Department services despite having resources such as insurance and access to primary 
care (Chapter Five and Chapter Six).  
Previous research suggests factors such as substance use and familial conflict can 
be effectively addressed in group-based settings (Rotheram-Borus et al., 2012; Rowe et 
al., 2007). Given the prevalence of both of these issues in the present study, findings also 
suggest the potential effectiveness of a family-focused intervention. Rather than the 
aforementioned dyadic intervention, the family would be considered as a single unit, to 
collectively learn coping skills to reduce the burden of these issues. In this type of 
program, individuals experiencing syndemic burden would identify areas of health 
education as well, but also learn conflict resolution techniques, along with with family 
members who are willing to participate.  
Zea, Reisen, Poppen, Bianchi, and Echeverry (2005), Rotheram-Borus et al. 
(2011) and Tolle (2009) cite integrated HIV and family therapy as reducing rates of 
mental illness and substance use among participants, irrespective of age and/or type of 
familial conflict (e.g. inter-spousal disagreement, parent-child, sibling). Furthermore, 
typical HIV research and interventions do not address the social context of patients’ non-
adherence (McNair & Prather, 2004). Therefore, the proposed dyadic and family-level 
interventions consider socio-contextual factors to increase medical adherence in SUMIC 
Syndemic individuals (Gray et al., 2011; Longshore, Grills, Atiglin, & Annon, 1997).  
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Lastly, study findings indicate that patient-provider communication was a 
significant predictor or viral suppression among African-American women PLHIV 
(Chapter Four). Study results also suggest that while temporal patterns of the onset of 
syndemic factors may vary, the presence of SUMIC Syndemic factors may hold more 
precedence than temporality, from a treatment standpoint (Chapter Five). Extant literature 
also supports cross-cultural medical education as a means to reduce such HIV disparities 
(Saha et al., 2013). As such, healthcare provider education may serve as a crucial 
pathway to increase adherence among these individuals.  
A possible intervention may be with healthcare providers, to train them in 
evidence-based community skills and cultural competence, both of which are shown to 
increase adherence outcomes (Saha et al., 2013). The proposed intervention could also 
expand beyond cultural competence via implementation of structural competence training 
with providers (Metzl & Hansen, 2014). While closely related to cultural competency, 
structural competence acknowledges health-related factors beyond patient ethnicity, such 
as food access, institutional racism, and political infrastructure (Metzl & Hansen, 2014). 
This type of training may better prepare providers to understand the etiology of syndemic 
factors in PLHIV patients, as well as the larger impact of structural factors such as wealth 
disparities. Also, the intervention could include training nurses, who often serve as the 
bridge between physicians and patients, and may be more responsible for these patients’ 
adherence (Radcliff, 2000). Ultimately, educating patients, family members or support 
network members, and healthcare providers is a multi-pronged approach with greater 
potential to reduce HIV disparities than individual-focused intervention approaches.   
Policy and programmatic implications  
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The implications of this dissertation research have grounding in several major 
legislative initiatives. First, in 1984, when the HIV epidemic began in the United States, 
the federal government created block grant legislation requiring every state to set aside 
five percent of its block grant allocation to provide new or expanded substance abuse 
treatment services for women (Tracy & Martin, 2007; Bride, 2001; Breitbart, Chavkin, & 
Wise, 1994). States were encouraged to develop ‘women’s set-aside funds’ for the 
creation of ancillary services for women, and women-only treatment centers (Bride, 
2001; Breibart et al., 1994). Despite this, several studies posit that use of the “women’s 
set-aside” has been unevenly implemented across states, and is declining in priority due 
to other critical shortages in HIV treatment, and funding cuts for HIV-specific research 
studies (Tracy & Martin, 2007). 
The current state of research that includes the women originally included in “set-
aside” funding is specific to low-income women with substance abuse history. The 
present dissertation research demonstrates that African-American PLHIV women had 
disparate outcomes as compared to their male counterparts. Specifically, these women 
did not benefit from the presence of social support, which correlated in both lower rates 
of viral suppression, and higher rates of Emergency Department utilization (Chapter Four 
and Chapter Six). Moreover, these women comprised the majority of individuals with 
SUMIC Syndemic burden (Chapter Five). Therefore, the present research provides 
additional evidence to support the increased and continued need for set-aside funding and 
interventions specifically targeting low-income, African-American women PLHIV.  
Second, much of the recommendations set forth in the recent National HIV/AIDS 
Strategy (NHAS) identify critical areas for addressing improvement in HIV health 
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disparities. Two of the main goals for the NHAS are to: 1) improve access to medical 
care and health outcomes; and 2) reduce HIV health disparities (Yehia & Frank, 2011). 
However, nearly half of PLHIV progress to an AIDS diagnosis within three years of 
being diagnosed with HIV. Thus, many PLHIV have substantial barriers to linkage and 
retention in care (Yehia & Frank, 2011; CDC, 2009). In Baltimore, Maryland, where the 
present study was conducted, the situation is even more dire.  
In 2010, the average time from HIV diagnosis to AIDS diagnosis was five years 
among PLHIV in Baltimore (Maryland Infectious Disease and Environmental Health 
Administration [MIDEHA], 2012). Thirty-five percent of these PLHIV were diagnosed 
with AIDS within one year of their HIV diagnosis (MIDEHA, 2012). Therefore, 
interventions to improve medical services use and health outcomes in this population are 
critical. While the initiative has remained under-funded, a recent assessment of the 
NHAS has suggested that health care coverage for PLHIV has been improved for 
millions of PLHIV, including those at-risk of, or currently facing, homelessness (U.S. 
Department of Health and Human Services [HHS], 2012).  
Moreover, in 2012, the HHS began funding the Care and Prevention in the United 
States demonstration project (CAPUS) to reduce HIV-related disparities in eight cities 
(CDC, 2014). The increasing prevalence of HIV/AIDS in the area, coupled with findings 
from this research, demonstrate the need for the CAPUS program in Baltimore to 
continue addressing the epidemic needs of this population. Third, beginning in 2014, the 
Affordable Care Act (ACA) requires that all new small group and individual market 
plans cover mental health and substance use disorder services, at equal parity with 
medical and surgical benefits (Beronio, Po, Skopec, & Glied, 2013). As such, this 
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regulation is an extension of the Paul Wellstone and Pete Domenici Mental Health Parity 
and Addiction Equity Act of 2008.  
The ACA is purported to extend coverage for up to one-third of people with 
individual market coverage, to include treatment of substance use disorders and mental 
illness (Beronio et al., 2013).  However, findings of this research suggest that additional 
efforts must be used to target PLHIV. While PLHIV may qualify for disability through 
Social Security, which offers more behavioral healthcare coverage than Medicaid alone, 
most do not meet the necessary qualifications for coverage until years after their initial 
HIV diagnosis (Social Security Administration, 2005). As a result, many individuals with 
concurrent HIV, substance use disorders, and mental illnesses are unable to access the 
services they qualify for, even when they attempt to enroll in care. In the present study, 
suboptimal acute care utilization and syndemic burden were extremely high, which 
adversely affected HIV treatment outcomes, even in this sample of PWID PLHIV 
engaged in medical care. Therefore, insurance coverage and linkage to care is merely one 
step to improving quality of life and health outcomes among PLHIV.  
Finally, the lifetime cost of HIV care for HIV-positive individuals in the United 
States is nearly half a million dollars, and it increases every year (Schackman et al., 2006). 
These increased expenditures translate to rising health care costs across many urban areas, 
where HIV is approaching generalized epidemic proportions. As demonstrated in the 
present research, tertiary prevention of HIV disparities is crucial. Beyond the issue of 
cost, however, is that of disability and quality of life. African-American female PLHIV, 
and those with syndemic substance use, mental illness, and familial conflict, suffer years 
and quality of life lost due to their illness burden. Even with early linkage and retention 
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in care, African-American females still stand to lose ten years of their lives prematurely 
due to HIV illness (Schackman et al., 2006; Losina et al., 2007). Integration of behavioral 
healthcare, and primary somatic healthcare services, is critical now more than ever, and 
has the potential reduce healthcare costs by reducing unnecessary acute care services use.  
CONCLUSIONS 
Despite increasing rates of HIV morbidity and mortality, relatively few studies of 
tertiary HIV prevention among African-American persons living with HIV (PLHIV) and 
persons who inject drugs have been conducted (El-Bassel, Caldeira, Ruglass, & Gilbert, 
2009; Schröder, Hobfoll, Jackson, & Lavin, 2001). Therefore, this study of medical 
adherence among African-American PWID PLHIV addresses a critical gap in the 
literature. This dissertation research contributes simultaneously to understandings of the 
role of perceived and enacted syndemic factors and social support, which yielded further 
understanding sex differences in the effects of social support on HIV health outcomes.  
This dissertation research tested both a new definition of adherence, and a new 
Syndemic Theory among African-American PLHIV in Baltimore, Maryland, which has 
the fifth highest number of AIDS cases among U.S. cities. (Baltimore City Commission 
on HIV/AIDS Prevention and Treatment, 2005). Nationally, the rates of HIV/AIDS 
among African-American women have increased faster than every other racial/ethnic 
group (CDC, 2012). In Baltimore, the same trend is seen among African-American 
females as compared to males. (Baltimore City Commission on HIV/AIDS Prevention 
and Treatment, 2005). Study findings also have important implications beyond the 
context of Baltimore, Maryland.  
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The advent of antiretroviral therapy and increased HIV education and testing has 
seen a national reduction in HIV rates in the last two decades (CDC, 2012). However, 
these advancements are lost in key groups such as African-Americans, and in urban areas 
such as Baltimore. Moreover, strained social support and community resources predict 
both higher risk of HIV infection, and higher risk of negative HIV health outcomes 
among African-Americans, and females especially (Robertson, 2006; Herek, Capitanio, 
& Widaman, 2002).  
As mentioned, collective efficacy is reduced in African-American communities 
via less access to resources, as well as the overabundance of disjointed family units and 
multiple caregivers usually present in the African-American household (Wingood & 
DiClemente, 2000; Robertson, 2006). Next, current behavior change interventions are 
usually exclusive of social support structures (Beatty, Wheeler, & Gaiter, 2004; Neumann 
et al., 2002). Findings suggest that social support dynamics and structures, at both the 
interpersonal and familial levels may be predictive of adherence. The present dissertation 
research provides evidence of the need for inclusion of informal caregivers, in healthcare 
programs designed to increase adherence among PWID PLHIV.  
Therefore, the contributions of this research can directly inform interventions to 
improve health outcomes among those most negatively impacted by the HIV epidemic: 
low-income, African-American PWID PLHIV. Findings suggest that social support 
structures are important determinants of health outcomes in this population, and that 
health education may improve health outcomes such as optimal acute care utilization. 
Finally, results suggest that training healthcare providers to screen and treat syndemic 
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SUMMARY OF ADDITIONAL ANALYSES 
 Included in these appendices are analyses not detailed in Chapter One through 
Chapter Seven. Appendix A.1 summarizes HIV medical adherence among participants by 
sex at Baseline (Time 1), and 6-months follow-up (Time 2). Longitudinal analyses were 
not conducted, due to sample size (statistical power) limitations, and an insufficient 
number of time points. Next, structural equation measurement models were assessed for 
each SUMIC Syndemic factor, and are depicted in Appendices A.2 through A.4. 
Appendix A.5 is a figure depicting the rates of HIV medical adherence by SUMIC 
Syndemic latent class among the full sample of 383 participants. Appendix A.6 depicts 
latent class analyses (LCA) conducted on the full sample. Appendix A.7 summarizes fit 
statistics of the LCA, which yielded a four-class solution (Chapter Five).    
 The findings summarized in Appendices A.5 through A.8 were omitted in the 
main text, because of theoretical significance of assessing these factors among African-
American Indexes only (N=351). Similarly, Appendix A.8 depicts a multivariate logistic 
regression of correlates of HIV medical adherence among the full sample, and 
instrumental support refers to whether someone helped you run errands in the last year. 
However, these analyses were omitted for several reasons: 1) Poisson regression was 
more appropriate for non-rare binary outcome data; 2) a simple count of number of 
syndemic factors did not address the unique variation in type of factors; 3) African-
Americans only analyses addressed the dissertation research aims more appropriately.  
 Appendix A.9 depicts HIV medical adherence by syndemic factors among males,  
and Appendix A.10 depicts this among females. Regression and latent class analyses  





Appendix A.1. HIV medical adherence of Indexes over time by sex (BEACON dataset) 
 
 
Viral suppression over time by sex 
 
 Percentage who achieved viral suppression  
N (%) 
Sex Time 1 
(baseline) 








Females   97 (65.5)    79 (57.7)  
     
 
Optimal acute care utilization over time by sex 
 
 Percentage reporting fewest ED visits and hospitalizations 
N (%) 
Sex Time 1 
(baseline) 








Females   48 (32.4)  43 (31.4)ǂ  
     
 ǂ






















Appendix A.2. Measurement model of substance use factor loadings and fit (N=383)a 
 
Syndemic Factor and                    Model 1      Model 2                Model 3         
Indicators                                                 Standard(SE)          Standard(SE)         Standard(SE) 
 
aEach model has a variance fixed at 1, rather than a factor loading fixed at 1, to ensure each model’s 
identifiability. The shaded model was selected for theoretical underpinnings, and acceptable fit statistics 
(Model 3).   







Active substance use     
  Opiates in last 30 days 0.44*** (0.10) 0.50*** (0.10) 0.49*** (0.10) 
  Marijuana in last 30 days 0.54*** (0.10) 0.51*** (0.10) 0.50*** (0.07) 
  Heroin in last 30 days 0.86*** (0.06) 0.85*** (0.05) 0.84*** (0.05) 
  Cocaine or crack in last 30 days 0.97*** (0.07) 0.98*** (0.05) 0.99*** (0.06) 
  Hallucinogens in last 30 days  ---  --- 0.38**   (0.06) 
  Prescription drugs in last 30 days  ---  0.69*** (0.10) 0.69*** (0.10) 
    
Residual variances    
  Opiates in last 30 days 0.81**  (0.07) 0.75**  (0.08) 0.77**    (0.07) 
  Marijuana in last 30 days 0.71*** (0.08) 0.74*** (0.08) 0.75*** (0.07) 
  Heroin in last 30 days 0.26*** (0.11) 0.28*** (0.09) 0.29*** (0.09) 
  Cocaine or crack in last 30 days 0.06*** (0.13) 0.05*** (0.11) 0.02*** (0.11) 
  Hallucinogens in last 30 days ---  ---  0.85**  (0.05) 
  Prescription drugs in last 30 days --- 0.53*** (0.11) 0.53*** (0.11) 
    
R2    
  Opiates in last 30 days 0.19** 0.25** 0.23** 
  Marijuana in last 30 days 0.29*** 0.26*** 0.25*** 
  Heroin in last 30 days 
  Cocaine or crack in last 30 days 
  Hallucinogens in last 30 days 













    
Fit statistics 
  χ2 (df) 
  CFI 















Appendix A.3. Measurement model of mental illness factor loadings and fit (N=383)a 
 
 
Syndemic Factor and                              Model 1            Model 2             Model 3         
Indicators                                                            Standard(SE)     Standard(SE)       Standard(SE) 
 
aEach model has a variance fixed at 1, rather than a factor loading fixed at 1, to ensure each model’s 
identifiability. The shaded model was selected for theoretical underpinnings, and acceptable fit statistics 
(Model 1).   






Mental illness     
  Ever received therapy or medication  --- 0.10    (0.10) -0.17** (0.07) 
  Diagnosed with depression 0.89*** (0.05) 0.90*** (0.05) 0.88*** (0.05) 
  Diagnosed with bipolar disorder 0.89*** (0.05) 0.90*** (0.05) 0.89*** (0.05) 
  Diagnosed with anxiety or PTSD 0.73*** (0.06) 0.71*** (0.06) 0.73*** (0.06) 
  Diagnosed with schizophrenia 0.68*** (0.07) 0.68*** (0.07) 0.68*** (0.07) 
  Diagnosed with other psychiatric illness 0.36**   (0.12) --- 0.49*** (0.11) 
    
Residual variances    
  Ever received therapy or medication --- 0.99    (0.02) 0.97    (0.02) 
  Diagnosed with depression 0.20*** (0.09) 0.19*** (0.09) 0.23*** (0.09) 
  Diagnosed with bipolar disorder 0.20*** (0.09) 0.20*** (0.09) 0.20*** (0.09) 
  Diagnosed with anxiety or PTSD 0.47*** (0.08) 0.49*** (0.10) 0.47*** (0.10) 
  Diagnosed with schizophrenia 0.54*** (0.10) 0.54*** (0.10) 0.54*** (0.10) 
  Diagnosed with other psychiatric illness 0.87    (0.08) --- 0.76*     (0.11) 
    
R2    
  Ever received therapy or medication --- 0.01  0.03 
  Diagnosed with depression 0.80*** 0.81*** 0.77*** 
  Diagnosed with bipolar disorder 
  Diagnosed with anxiety of PTSD 
  Diagnosed with schizophrenia 













    
Fit statistics 
  χ2 (df) 
  CFI 















Appendix A.4. Measurement model of familial conflict factor loadings and fit (N=383)a 
 
 
Syndemic Factor and                                                   Model 1                                        
Indicators                                                                                         Standard(SE) 
 
 
aEach model has a variance fixed at 1, rather than a factor loading fixed at 1, to ensure each model’s 
identifiability. The shaded model was selected for theoretical underpinnings, and acceptable CFI and 
RMSEA.   
















Familial conflict  
  Family rarely/never talks about problems 
  Family rarely/never problem solves together 
  Family rarely/never shows caring for each other  
 
Residual variances 
  Family rarely/never talks about problems 
  Family rarely/never problem solves together 
  Family rarely/never shows caring for each other  
 
R2 
  Family rarely/never talks about problems 
  Family rarely/never problem solves together 
  Family rarely/never shows caring for each other  
 
Fit statistics 
  χ2 (df) 
  CFI 


























aSignificant association between viral suppression and SUMIC Syndemic class (2=14.18, p<.01)                   






































SUMIC Syndemic latent classes








Appendix A.6. Probability of SUMIC Syndemic statements by latent class (N=383) 
 
 
                                                                                   Class 1    Class 2           Class 3         Class 4         
Items                                                               LO Syndemic    LO/MED Syndemic   MED/HI Syndemic   HI Syndemic 
 


















Active substance use        
   Opiates in last 30 days 13.9***  06.7*  13.5**   37.5***  
   Marijuana in last 30 days 12.6***  02.8  20.8***   42.3***  
   Heroin in last 30 days 19.4***  01.5  18.0**   70.3***  
   Cocaine or crack in last 30 days 30.8***  04.6  34.6***   100  
   Hallucinogens in last 30 days 01.9     ---    ---    ---  
   Prescription drugs in last 30 days 03.9*     ---   03.5   30.3***  
       
 Mental illness        
   Diagnosed with depression 31.5***  94.0***  63.5***   95.5***  
   Diagnosed with bipolar disorder   ---  80.1***  34.5***   74.9***  
   Diagnosed with anxiety or PTSD 05.6*  50.0***  32.4***   51.9***  
   Diagnosed with schizophrenia   ---  14.1***   08.7*   40.0***  
   Diagnosed with other psychiatric illness 02.0  11.1**   06.8*   06.7  
       
 Familial conflict        
   Family rarely/never talks about problems 06.2**  11.5ǂ  94.5***   35.1**  
   Family rarely/never problem solves together 03.8*  08.4  93.6***   38.0**  
   Family rarely/never shows caring for each  
   other  




Appendix A.7. Latent class analysis fit statistics 
 
 
---      Number of Latent     Akaike Information   Bayesian Information    Entropy                                                                    


















































4196.2                                               
   4663.2                          0.75 
   4563.0                          0.83 
   4522.3                          0.85 
   4529.5                          0.85 





Appendix A.8. Unadjusted and adjusted correlates of HIV medical adherence (N=359) 
 
 
                            Viral suppression                                  Optimal acute care utilization 
 
                  ORa          CIc           AORb          CI              OR              CI             AOR         CI  
                 ____      ________      ____      ________       ____        ________      ____    ________       
 
SUMIC Syndemic         
 1 factor 0.87 (0.42, 1.78) 0.98 (0.44, 2.16) 0.42* (0.21, 0.86) 0.44* (0.20, 0.97) 
 2 factors 0.69 (0.34, 1.41) 0.84 (0.37, 1.87) 0.35*** (0.17, 0.71) 0.46ǂ (0.21, 1.03) 
 3 factors 0.89 (0.39, 2.00) 1.36 (0.53, 3.48) 0.44* (0.20, 0.97) 0.54 (0.22, 1.32) 
 (ref: 0 factors) 1.00  1.00  1.00  1.00  
         
Health status         
 Very good 1.52 (0.68, 3.39) 1.27 (0.53, 3.09) 0.86 (0.42, 1.72) 1.00 (0.46, 2.19) 
 Good 0.67 (0.36, 1.26) 0.51ǂ (0.25, 1.03) 0.50* (0.28, 0.91) 0.61 (0.31, 1.17) 
 Fair 0.55ǂ (0.28, 1.10) 0.47* (0.22, 1.01) 0.35** (0.18, 0.68) 0.36** (0.17, 0.75) 
 Poor  0.19** (0.07, 0.53) 0.14** (0.04, 0.47) 0.16*** (0.05, 0.50) 0.24* (0.07, 0.80) 
 (ref: Excellent) 1.00  1.00  1.00  1.00  
         
Education         
 Some high school 2.42* (1.04, 5.65) 2.15 (0.84, 5.48) 0.77 (0.33, 1.78) 0.74 (0.29, 1.88) 
 High school/GED 2.76* (1.18, 6.46) 2.35ǂ (0.91, 6.10) 1.05 (0.46, 2.43) 0.90 (0.35, 2.31) 
 Some college 3.75* (1.35, 10.41) 3.78* (1.21, 11.84) 0.57 (0.22, 1.51) 0.57 (0.19, 1.73) 
 College degree 5.45ǂ (0.96, 30.89) 3.60 (0.53, 24.20) 2.00 (0.42, 9.49) 1.10 (0.16, 7.53) 
 Graduate school   ---    ---  2.14 (0.35, 13.12) 2.27 (0.19, 27.65) 
 (ref: 8th grade/less) 1.00  1.00  1.00  1.00  
         
Monthly income         
 $500-$999 1.47 (0.88, 2.46) 1.35 (0.75, 2.45) 1.00 (0.61, 1.64) 0.90 (0.51, 1.61) 
 $1000+ 1.56 (0.82, 2.97) 0.97 (0.45, 2.06) 2.20* (1.17, 4.14) 1.81 (0.86, 3.83) 





















 Medium  0.42** (0.23, 0.77) 0.33*** (0.17, 0.65) 0.62 (0.35, 1.09) 0.51* (0.27, 0.95) 
 High 
 (ref: Low) 
0.52* 
1.00 
(0.30, 0.91) 0.46** 
 
(0.25, 0.84) 0.64ǂ 
1.00 
(0.39, 1.04)   0.62 
1.00 
(0.35, 1.09) 
         
Inform. ART supp 
 Sometimes 
 Often 





































































ǂmarginally significant p<.10, *p<.05, **p<.01, ***p<.001 aOR = Unadjusted Odds Ratio   bAOR = Adjusted 
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